Vacuum evaporation of pharmaceuticalmolecules for the creation of medicallyactive nanostructures with enhancedactivities by Zarie, Eman
Vacuum evaporation of pharmaceutical
molecules for the creation of medically
active nanostructures with enhanced
activities
Dissertation
Zur Erlangung des akademischen Grades
Doktor der Ingenieurwissenschaften
(Dr.-Ing.)
der Technischen Fakultät
der Christian-Albrechts-Universität zu Kiel
Eman Zarie
Kiel 2013
1. Gutachter: Prof. Dr. Rainer Adelung ......................
2. Gutachter : Prof. Dr. Hartwig Steckel ......................
(ggf.3. Gutachter) ......................
Datum der mündlichen Prüfung: 5.07.2013
Self Declaration
I hereby declare that the work represented in this PhD thesis is my own except some
cited sources.
I declare that this thesis: “Vacuum evaporation of pharmaceutical molecules for
the creation of medically active nanostructures with enhanced activities” has not
been prepared with any illegal help. I also assert that other authors’ contributions used
in the thesis or led to some ideas in it are properly referenced in written form. I am
aware that a PhD thesis, developed under guidance, is part of the examination and
may not be commercially used or transferred to a third party without written
permission from my supervising professor.
Kiel,
……………………………………………………..
Signature
Acknowledgements
i
Acknowledgements
First and foremost, thanks are due to Allah, the Almighty, for giving me
health, time and patience to complete this PhD thesis.
I would like to express my deepest gratitude to my supervisor, Prof. Dr.
Rainer Adelung for his guidance, ideas, encouragement, and understanding. His
consistent and considerate support, insight advice, fruitful scientific discussions,
generosity in sharing his expertise helped me throughout the development of this
work and made it all possible. I am also grateful to him for warm welcome and help
during my stay in Germany, the very thing that I will never forget. His supervision not
only improved my research abilities but also broadened my view and my interest in
the field of science and nano-science.
Also, I would like to express my heartiest thanks to Prof. Dr. Hartwig
Steckel (Director of the Pharmaceutics and Biopharmaceutics, Christian Albrechts
University Kiel) for his efforts, guidance, ideas, encouragement, and understanding. I
honestly state that this thesis wouldn't have been possible without his modifications,
continuous encouragement, enthusiasm, and innovative ideas.
I wish to thank Dr. Franz H. Furkert, and Dr. Regina Scherließ who have
initiated this project and provided experimental facilities, chemicals and technical
guidance on biological applications. This biological screening of this research project
has been conducted by Prof. Dr. Hartwig Steckel, Dr. Franz H. Furkert, and Dr.
Regina Scherließ at the Department of Pharmaceutics and Biopharmaceutics,
Christian Albrechts University Kiel.
Also, I would like to express my heartiest thanks to Prof. Dr. Franz Faupel
and Prof. Dr. Mady Elbahri for their invaluable support and for allowing me to work
in their laboratories.
I am grateful to thank Dr. Yogendra K. Mishra and Dr. Seid Jebril for their
assistance, fruitful scientific discussions and support in several descriptive studies as
well as in Laboratory experiments. My sincere gratitude is directed to MSc. Dawit
Gedamu for his cooperation in measuring field effect transistor and electrical current.
My deep thanks are to Dr.-Ing. Sebastian Wille and Dr. Dipl. -Ing. Kristina
Schlüter for teaching me how to use atomic force microscopy.
Acknowledgements
ii
I would like to express my genuine appreciation to engineers Dipl.-Ing.
Stefan Rehders and Dipl.-Ing.Christoph Ochmann who construct the deposition
chamber and solve technical problems. Also, thanks are to Dipl.-Ing. Rainer Kloth
and Christian Newe for computer support. My sincere gratitude is to our secretaries
Dipl.-Geol. Beate Minten, Mrs. Christiane Otte-Hüls, Dipl.-Chem. Sieglinde
Kastaun and for their help concerning official work. I thank Dipl.-Min. Marlies
Schwitzke for teaching me how to use the scanning electron microscopy. It is
pleasure for me to express my sincere thanks to Prof. Dr. Klaus Raetzke for teaching
me how to use the X-Ray Diffraction.
Special thanks to MSc. Ramzy Abdelaziz for his kind help performing certain
measurements (SEM) for my thesis.
I also thank all members in the group of Functional Nanomaterials and
Multicomponent Materials who helped me in completing my thesis successfully and
in creating a very good working atmosphere. I would like to thank hiwi students who
did many of the experiments during their master and bachelor thesis: MSc. Charline
Wolpert and MSc. Viktor Kaidas.
Certainly, I greatly appreciate the financial support extended to me by the
Egyptian government. I am very thankful to my professors in National Research
Centre, Dokki, Cairo, Egypt, for encouraging and motivating me throughout my
study.
I would like to express my utmost gratitude and debt towards my brothers
and sisters whose continuous love, help, patience and encouragement motivated me
to overcome all the obstacles to complete my work.
I dedicate this thesis to my father Said Zarie and my mother for they have supported
me with their prayers and motivation the whole way through from Egypt.
Special thanks to Duygu Disci for being good friend of mine.
Finally, I wish to express my sincere gratitude to my husband Ramzy and my
kids who were patient and encouraging, and without whose unending support and
assistance this work would have never been brought into light.
Contents
iii
Table of Contents Page
Acknowledgements .......................................................................................................i
List of Figures.............................................................................................................xii
List of Tables ............................................................................................................xxii
Chapter 1 ......................................................................................................................1
1 Introduction...........................................................................................................1
Chapter 2 ......................................................................................................................5
2 Theoretical Considerations ..................................................................................5
2.1 Limitations of Techniques for Solubility Enhancement .................................5
2.2 Vacuum deposition .........................................................................................8
2.2.1 Thermal evaporation .................................................................................9
2.2.1.1 Thermal evaporation of organic materials .............................................9
2.2.1.2 Evaporation of Metals by vacuum deposition ....................................11
2.2.2 Sputter Deposition ..................................................................................14
2.3 Growth mechanism .......................................................................................16
2. 4 Growth mechanism equations......................................................................18
2.5 Nanotechnological aspects............................................................................20
2.6 Potential applications of thermal evaporation in medical science ................22
2.6.1 Stents.......................................................................................................22
2.6.2 Biofilm formation as microbial development .....................................................24
Chapter 3 ....................................................................................................................27
3 Characterization Techniques.............................................................................27
3.1 Light Microscopy..........................................................................................27
3.2 Atomic force microscopy (AFM) .................................................................29
3.2.1 Probe-sample interaction ........................................................................31
3.2.2 Contact Mode..........................................................................................31
3.2.3 Non-contact Mode ..................................................................................32
3.3 Scanning electron microscopy (SEM) ..........................................................33
3.3.1 Basic principle ........................................................................................33
3.3.2 Instrumentation .......................................................................................34
3.3.3 Interaction volume ..................................................................................37
3.4 Energy Dispersive X-Ray Analysis ..............................................................39
3.5 Raman Spectroscopy (RS) ............................................................................40
Contents
iv
3.6 X-Ray Diffraction (XRD) .............................................................................43
3.7 Profilometer ...............................................................................................46
Chapter 4 ....................................................................................................................48
4 Experimental part...............................................................................................48
4.1 Introduction...................................................................................................48
4. 2 Evaporation chamber ...................................................................................48
4.3 Evaporation of Materials...............................................................................50
4.3.1 Evaporation of active selected pharmaceutical molecules......................50
4.3.2 Evaporation of polymer ..........................................................................58
4.4 Biological screening of vacuum deposited pharmaceutical molecules......58
4.5 Current-Voltage (FET) Response ..............................................................59
4.6 Analysis by Optical, Atomic Force, Scanning Electron and Raman
Microscopies ....................................................................................................60
Chapter 5 ....................................................................................................................64
Results and Discussions .........................................................................................64
5.1 Results ...................................................................................................................68
5.1.1 Structural engineering of Parabens .........................................................68
5.1.1.1 Optical microscopy results of Nipasol nano-microstructures ..........68
5.1.1.2 AFM of Nipasol ...............................................................................69
5.1.1.3 SEM of Nipasol................................................................................71
5.1.1.4 Raman spectrum of Nipasol.............................................................71
5.1.1.5 Raman spectrum of Nipagin ............................................................72
5.1.2 Structural engineering of Pilocarpine-HCl .............................................74
5.1.2.1 Optical microscopy of Pilocarpine-HCl...........................................74
5.2.2.2 SEM of Pilocarpine-HCl..................................................................75
5.1.2.3 Raman Spectroscopy of Pilocarpine-HCl ............................................75
5.1.2.3.1 Raman Spectroscopy of Pilocarpine-HCl on Ti............................75
5.1.2.3.2 Raman Spectroscopy of Pilocarpine-HCl on polymer foil ...........76
5.1.3 Structural engineering of Pindolol ..........................................................77
5.1.3.1 Optical microscopy of Pindolol nano-microstructures ....................77
5.1.3.2 AFM of Pindolol nano-microstructures ...........................................78
5.1.3.3 Raman Spectroscopy of Pindolol nano-microstructures......................79
5.1.3.3.1 Raman Spectroscopy of Pindolol nano-microstructures on Ti .........79
5.1.3.3.2 Raman Spectroscopy of Pindolol deposited on Si ........................79
Contents
v
5.1.4 Structural engineering of 5-Fluorouracil ................................................81
5.1.4.1 Optical spectroscopy of 5-Fluorouracil ...........................................81
5.1.4.2 AFM of 5- Fluorouracil ...................................................................81
5.1.4.3 Raman microscopy of 5-Fluorouracil nano- microstructures ..........82
5.1.5 Structural engineering of Chloramphenicol............................................84
5.1.5.1 Optical spectroscopy of Chloramphenicol.......................................84
5.1.5.2 Raman spectroscopy of Chloramphenicol nano-microstructures ....86
5.1.6 Structural engineering of Tetracaine-HCl...............................................88
5.1.6.1 SEM of Tetracaine-HCl nano-microstructures ................................88
5.1.6.2 AFM of Tetracaine-HCl nanomicrostructures .................................90
5.1.6.3 Raman Spectroscopy of Tetracaine-HCl .........................................90
5.1.6.4 EDX Results of Tetracaine-HCl nano-microstructures with silver
and gold........................................................................................................92
5.1.7. Structural engineering of Acetyl Salicylic acid .....................................93
5.1.7.1 SEM of Acetylsalicylic acid ............................................................93
5.1.7.2 AFM of Acetylsalicylic acid............................................................94
5.1.7.3 Raman spectrum of Acetylsalicylic acid..........................................94
5.1.8 Structural engineering of Metronidazole ................................................95
5.1.8.1 SEM of Metronidazole.....................................................................95
5.1.8.2 AFM of Metronidazole nano-microstructures .................................95
5.1.8.3 Raman spectrum of Metronidazole..................................................96
5.1.9 Structural engineering of Clotrimazole...................................................97
5.1.9.1 Optical Light Spectrum of Clotrimazole nano-microstructures.......97
5.1.9.2 AFM of Clotrimazole nano-microstructures........................................98
5.1.9.3 SEM of Clotrimazole nano-microstructures ....................................98
5.1.9.4 Raman Spectrum of Clotrimazole nano-microstructures.................99
5.1.10 Structural engineering of Trimethoprim .............................................100
5.1.10.1 AFM of Trimethoprim nano-microstructures ..............................100
5.1.10.2 Raman spectrum of Trimethoprim nano-microstructures............101
5.1.10.3 XRD Spectrum of Trimethoprim nano-microstructures ..............103
5.1.11 Structural engineering of Sulphathiazole............................................104
5.1.11.1 AFM of Sulphathiazole nano-microstructures.............................104
5.1.12 Characterization of Tetracycline-HCl nano-microstructures..............105
5.1.12.1 AFM of Tetracycline-HCl nano-microstructures.........................105
Contents
vi
5.1.13 Structural engineering of Erythromycin .............................................105
5.1.13.1 AFM of Erythromycin nano-microstructures ..............................105
5.1.14 Structural engineering of Tobramycin ................................................106
5.1.14.1 AFM of Tobramycin nano- microstructures ................................106
5.1.15 Structural engineering of Ascorbic acid .............................................107
5.1.15.1 SEM of Ascorbic acid nano-microstructures...............................107
5.1.16 Characterization of Adipic acid nano-microstructures .......................108
5.1.16.1 SEM of Adipic acid micro-nanostructures ..................................108
5.1.16.2 Raman Spectrum of Adipic acid nano-microstructures ...............109
5.1.17 Structural engineering of Caffeine......................................................110
5.1.17.1 SEM of Caffeine nano-microstructures .......................................110
5.1.17.2 Raman spectrum of Caffeine nano-microstructures ....................110
5.1.18 Structural engineering of Cholesterol .................................................112
5.1.18.1 SEM of Cholesterol nano-microstructures.......................................112
5.1.18.2 Raman-spectra of Cholesterol nano-microstructures.......................113
5.1.19 Structural engineering of SM nano-microstructures...........................114
5.1.19.1 Optical image of SM nano-micro structures................................114
5.1.19.3 AFM of SM nano-microstructures...............................................115
5.1.20.1 SEM image of PLGA...................................................................116
5.1.21 Structural engineering of Indometacin................................................117
5.1.21.1 SEM of Indometacin nano-microstructures .................................117
5.1.21.2 Raman spectrum of Indometacin nano-microstructures. .............117
5.1.22 Structural engineering of multilayers..................................................119
5.1.22.1 Characterization of two layers .........................................................119
5.1.22.2 Characterization of (4 Layers) .........................................................120
5.2 Discussion............................................................................................................120
5.2.1 Control over the crystallinity of the deposited drug films and their
morphology................................................................................................................120
5.2.2 Time-related Process................................................................................125
5.2.3 Temperature-related Process....................................................................128
5.2.4 Control over the lateral structuring of the deposited drug films..............130
5.2.5 Characterisation of chemical composition and Raman shifting ..............131
5.3.6 Sequential deposition: Multilayers of different drugs and hybrid materials
....................................................................................................................................137
Contents
vii
Chapter 6 ..................................................................................................................143
6-Application of Thermal Evaporation..............................................................143
6.1 Antimicrobial screening:.............................................................................143
6.2 Controlled drug release from biodegradable polymers...............................151
6.3 Thermal evaporation for enhanced activities...........................................152
6.4 Pharmaceutical field effect transistor (PFET)..........................................153
6.5 Room Temperature Current - Voltage Characteristic.................................155
6.6 The unique requirements of thermal evaporation .......................................156
Chapter 7 ..................................................................................................................158
7 Summary and Outlook .........................................................................................158
Bibliography ..................................................................................................................i
xii
List of Figures
Chapter2
Figure 2.1: Setup for thermal evaporation of organic materials. ................................10
Figure 2.2: The sketch shows the metal evaporator with a power feed through (a), and
both the external (b) and the internal (c) part of the metal evaporator cell. ................12
Figure 2.3: (a) Crucible rack for thermal evaporation, (b) Target material distribution
from a small area source, (c) Distribution of evaporated material following cosine-
law. (These images were taken from the following website,
http://www.ep4.rub.de/imperia/md/content/skripte/ss04/thinfilmmagnetism/hcs.pdf).
......................................................................................................................................14
Figure 2.4: Picture of magnetron sputtering chamber a) outer part b) inner part, the
numbers in the inside chamber correspond to parts of the (1) Pt magnetron (2) Copper
magnetron (3) quartz monitors (4) sample holder. ......................................................16
Figure 2.5: Thin film growth mechanisms. (a): Volmer-Weber (island) growth, (b):
Frank-van-der-Merwe (layer-by-layer) growth, (c): Stranski-Krastanov growth .......18
Figure 2.6: The growth mechanism of a thin film layer through evaporation of
molecules is demonstrated schematically. ...................................................................20
Figure 2.7: shows the differing patterns of restenosis and in- stent restenosis (ISR).
(source of this image in website: cvi.med.nyu.edu).....................................................22
Figure 2.8: Pathophysiology of in-stent restenosis and the mechanisms of action of
different therapeutic agents . (Abbreviations: ECM, extracellular matrix; SMC,
smooth muscle cells)....................................................................................................23
Figure 2.9: Schematic representation of biofilm formation .......................................25
Chapter 3
Figure 3.1: Optical microscope: (a) optical path of the light beam in an optical
microscope, (b) Picture of a typically optical microscope...........................................29
Figure 3.2: Schematic representation of general components of an AFM and their
function (a), the inset shows the close view of the tip-surface interaction. The tip-
effect (b) and the force-displacement curve (c) are also shown. .................................30
xiii
Figure 3.3: Sketch depicting contact mode (a) and noncontact mode (b) of the AFM.
......................................................................................................................................33
Figure 3.4: Schematic diagram of a scanning electron microscope (a), and Ray paths
in SEM; standard arrangement for image formation (b) .............................................34
Figure 3.5: Schematic diagram illustrating the volume of material that is probed by
an incident electron beam together with the volumes from which x-rays and
backscattered, Auger and secondary electrons emanates. ...........................................38
Figure 3.6: EDX spectra of the as-synthesized Tetracaine-HCl with Ag which
confirms the presence of Cl, C, O, N as well as Ag. ...................................................39
Figure 3.7: Schematic of the sample, incident light and collection optics in The
Raman spectrometer where illumination and collection are performed through
microscope objective. ..................................................................................................40
Figure 3.8: Three types of scattering by a molecule are excited by a photon with
energy E = hν. The most common transition is marked with bold arrows. .................43 
Figure 3.9: The sketch shows the schematic diagram of the setup for XRD and
Schematic of incoming x-rays diffracted at lattice planes under a specific angle
fulfilling Bragg’s law...................................................................................................45
Figure 3.10: The sketch shows Dektak 8000 profilometer (Veeco) (a), and diamond
tip scanning over the surface of the sample (b). ..........................................................47
Chapter 4
Figure 4.1: Schematic showing the deposition chamber used for thin film
preparation: photo (a) and inner part of evaporation chamber(b)................................49
Figure 4.2: Photographs of the evaporator. In the middle the fitting for the crucible is
situated. The crucible itself is shown in (b) and (c) with its dimensions tagged. ........49
Figure 4.3: Illustrated the optical image of titanium substrate before deposition (a)
and the growth of thin film by vapour deposition on titanium plate (b)......................57
Figure 4.4: This is a photo of the microchip holder device which was used to measure
the electrical properties of various pharmaceutical molecules. The inset (top left)
shows the microchip consists of horizontal organic molecules at each of the contact
junctions, and the number refers to the contact points.................................................60
xiv
Chapter 5
Figure 5.1: ( a-d) Optical images of various Nipasol micro-nanostructured
morphologies on different substrates like Ti (a) Si pre-coated with 8 nm thick Au thin
film (b), glass (c), polymer foil (d), Si Pre-coated with ZnO 50 nm thick thin film (e
and f) respectively........................................................................................................68
Figure 5.2: Three-dimensional AFM height image of Nipasol grown on Ti substrate
at various substrate temperatures ranging from -100 0C with different magnifications
(a-b) to room temperature (c).......................................................................................69
Figure 5.3: Two-dimensional AFM height image of Nipasol on Ti substrate at
different evaporation temperatures @ ~ 165 °C (10 min) (a) and @ ~ 220°C (27
min)(b). ........................................................................................................................70
Figure 5.4: SEM images of Nipasol deposited on ZnO nanostructures at different
magnifications (a and b) and microspheres on titanium substrate with substrate
temperature at -100 0C (c)............................................................................................71
Figure 5.5: The Raman spectrum of Nipasol control sample. The inset shows the
optical microscope image of the control sample..........................................................72
Figure 5.6: The Raman spectrum of Nipasol deposited sample. The inset shows the
optical microscope image of the deposited sample......................................................72
Figure 5.7: The Raman spectrum of Nipagin control sample. The inset shows the
optical microscope image of the control sample..........................................................73
Figure 5.8: The Raman spectrum of Nipagin deposited sample. The inset shows the
optical microscope image of the deposited sample......................................................73
Figure 5.9: a-e Representative optical images of various pilocarpine-HCl micro or
nano structured morphologies on different substrates like polymer foil (a), glass (b),
Ti (c), soft contact lens (d), copper grid on Ti substrate (e) and large grains size
deposited on ZnO substrate (f).....................................................................................74
Figure 5.10: (a-c) SEM images of Pilocarpine-HCl micro-nanostructures grown on Si
pre-coated with 50 nm thickness ZnO thin film with different magnifications...........75
Figure 5.11: Example of Raman identification (green: spectrum of Pilocarpin-HCl
raw material, red: spectrum of Pilocarpine-HCl layer vacuum deposited on titanium
carrier)..........................................................................................................................76
Figure 5.12: Raman-spectrum and optical microscope image (inset) of Pilocarpine-
HCl reference drug.......................................................................................................77
xv
Figure 5.13: Pilocarpine-HCl sample after deposition on polymer foil with its optical
image(inset) and Raman-spectrum. .............................................................................77
Figure 5.14: Both optical images show deposited Pindolol on polymer foil (a) and Ti
substrate (b) respectively. ............................................................................................78
Figure 5.15: a-b Two- and three dimensional AFM (non contact mode) images of
Pindolol nano-microparticles deposited on Ti substrate. .............................................78
Figure 5.16: Raman identification (red: spectrum of Pindolol raw material, blue:
spectrum of Pindolol layer vacuum deposited on Ti carrier).......................................79
Figure 5.17: The Raman spectrum of Pindolol control sample. The inset shows the
optical microscope image of the control sample..........................................................80
Figure 5.18: Raman-spectrum with its appropriate optical image (inset) of Pindolol
sample after deposition. ...............................................................................................80
Figure 5.19: Optical images of 5-Fluorouracil with (a) 20 x and (b) 50 x
magnification grown on titanium substrate that show crystallization process after
thermal evaporation deposition....................................................................................81
Figure 5.20: Two-dimensional AFM height images of 5-Fluorouracil on Ti substrate
with a scan area of (a) 5 x 5 µm2, (b) 1 x 1 µm2. Also, three-dimensional AFM height
image of Fluorouracil on Ti is shown with a scan area of 1 x 1µm2 and a maximum
height of 0.1 µm...........................................................................................................82
Figure 5.21: Raman spectrum and optical image (inset) of 5- Fluorouracil reference
drug. .............................................................................................................................83
Figure 5.22: Raman spectrum and optical image (inset) of 5- Fluorouracil after
deposition.....................................................................................................................83
Figure 5.23: (a) and (b): Images for different positions on the sample show
Chloramphenicol deposited on glass illustrated with a magnification of 10 x. Images
were taken 1 min after evaporation. Images (c) and (d) were taken 3h after
evaporation. They show different positions on glass sample with droplets of deposited
Chloramphenicol. The magnification is 10 x...............................................................84
Figure 5.24: Chloramphenico microstructures deposited on glass substrate after 1 day
(10 x magnification)(a, and b) after 2 days (c). ...........................................................85
Figure 5.25: Optical micrographs show the initial specific area of Chloramphenicol
on glass after 10 days (a) and its higher surface area Blossom-like crystalline structure
after heating 1 h at 100 °C on glass at lower and higher magnification b and c
xvi
respectively. Chloramphenicol on polymer foil appears after 1 month (d). b) after 2
days (c).........................................................................................................................85
Figure 5.26: Raman spectrum and optical image (inset) of Chloramphenicol reference
drug. .............................................................................................................................86
Figure 5.27: Raman spectrum and optical image (inset) of Chloramphenicol
deposited drug directly after evaporation. ...................................................................87
Figure 5.28: Raman-spectrum and optical image (inset) of deposited
Chloramphenicol sample after a certain time. .............................................................87
Figure 5.29: a-h Representative SEM images of various Tetracaine-HCl
nanostructures morphologies grow on different substrates: Silicon wafer at higher
temperature (a), Silicon wafer at lower temperature (b), Titanium substrate(c),
Silicon coated with 20 nm Au thin film (d), Silicon coated with 4 nm Au thin film(e)
co-deposition of Tetracaine-HCl with Ag on silicon wafer(f) and Ti substrate (g) and
co-deposition of Tetracaine-HCl with Au on Si substrate( h) The inset is a high-
magnification SEM images..........................................................................................89
Figure 5.30: Two-dimensional AFM height image of Tetracaine-HCl on Ti. The scan
area is about 20 µm x 20 µm. ......................................................................................90
Figure 5.31: The Raman spectrum of Tetracaine-HCl control sample. The inset
shows the optical microscope image of the control sample.........................................91
Figure 5.32: Tetracaine-HCl sample is shown after deposition with its appropriate
optical image (inset) and Raman-spectrum.................................................................91
Figure 5.33: EDX spectrum of co- deposition of Tetracaine-HCl nanostructures with
Ag by thermal evaporation...........................................................................................92
Figure 5.34: EDX spectrum of co-deposition of Tetracaine-HCl nanostructures with
Au by thermal evaporation...........................................................................................92
Figure 5.35: Representative SEM images of Acetylsalicylic acid grown on Ti
substrate (a, b) and though a copper grid as micro scale shadow mask (c, d) with
different magnifications. ..............................................................................................93
Figure 5.36: Two-and-three dimensional image of the topography of Acetylsalicylic
acid with a scan area of 10 x 10 µm2. ..........................................................................94
Figure 5.37: Microscopic images of Acetylsalicylic acid deposited on Ti substrate
and copper grid through a microscopic shadow mask (a, b) respectively and Raman
spectra of the deposited and reference Acetylsalicylic acid (c). ..................................94
xvii
Figure 5.38: a-c SEM images of Metronidazole nano-microstructures fabricated on
titanium substrate with different magnifications. ........................................................95
Figure 5.39: AFM 2D and 3D images of Metronidazole deposited on glass substrate
with a scan area of (a, b) 10 x 10 µm2. ........................................................................95
Figure 5.40: The reference sample of Metronidazole with optical microscope image
(inset) and its Raman spectrum...................................................................................96
Figure 5.41: Metronidazole sample after deposition with its appropriate optical image
(inset) and Raman-spectrum. .......................................................................................97
Figure 5.42: Optical images of Clotrimazole micro-nanostructures deposited on Si
coated with ZnO nanostructures (a) and Ti substrate (b)............................................97
Figure 5.43: Two-dimensional and three-dimensional AFM height images of
Clotrimazole growing on Ti (a and b) and two-dimensional AFM of clotrimazole on
glass substrate(c). .........................................................................................................98
Figure 5.44: SEM images of Clotrimazole deposited on Ti substrate. .......................99
Figure 5.45: The reference sample of Clotrimazole with optical image (inset) and its
Raman-spectrum. .........................................................................................................99
Figure 5.46: Clotrimazole sample after deposition with its appropriate optical image
(inset) and Raman-spectrum. .....................................................................................100
Figure 5.47: Two dimensional AFM and a three-dimensional AFM height image of
Trimethoprim on Ti with different scan area of 10 x 10 µm2 (a-b) and 6 x 6 µm2(c-d)
....................................................................................................................................101
Figure 5.48: The reference sample of Trimethoprim shows optical image (inset)) with
its Raman-spectrum. ..................................................................................................102
Figure 5.49: Trimethoprim sample after deposition with appropriate optical image
(inset) and it’s Raman-spectrum. ...............................................................................102
Figure 5.50: XRD pattern of Trimethoprim deposited on glass substrate at different
growth times after 1h (blue line), 3 day (red line)s and ten days (black line). ..........103
Figure 5.51: AFM 2D and 3D image of Sulphathiazole deposited on Ti with different
magnifications............................................................................................................104
Figure 5.52: AFM 2D and 3D images of Tetracycline-HCl deposited on Ti(a-b) and
glass (c-d) with different scan area. ...........................................................................105
Figure 5.53: AFM 2D and 3D images of Erythromycin deposited on Ti with different
magnifications............................................................................................................106
xviii
Figure 5.54: AFM 2D image of Tobramycin deposited on Ti. The scan area is about
10 µm x 10 µm. The surface roughness is minor as the legend on the left implies a
maximum height of < 30 nm......................................................................................107
Figure 5.55: AFM 3D image of Tobramycin on Ti is shown with a scan area of
10 µm x 10 µm and a maximum height of 0.1 µm. ...................................................107
Figure 5.56: a-c SEM images of Ascorbic acid on Ti substrate with different
magnifications............................................................................................................108
Figure 5.57: (a-c) SEM images of Adipic acid grown on Ti substrate with different
magnifications............................................................................................................108
Figure 5.58: The Raman spectrum of Adipic acid control sample. The inset shows the
optical microscope image of the control sample........................................................109
Figure 5.59: The Raman spectrum of Adipic acid deposited sample. The inset shows
the optical microscope image of the deposited sample..............................................109
Figure 5.60: SEM images show different magnifications of Caffeine nanostructures
deposited on Ti substrate. ..........................................................................................110
Figure 5.61: The Raman spectrum of Caffeine control sample. The inset shows the
optical microscope image of the control sample........................................................111
Figure 5.62: Caffeine sample after deposition with its appropriate optical image
(inset) and Raman-spectrum. ....................................................................................111
Figure 5.63: SEM image of Cholesterol nonostructures deposited on Ti (a, b) and Si
coated with 4 nm Au thickness (c, d) with different magnifications. ........................112
Figure 5.64: Raman spectrum and optical image (inset) of Cholesterol reference drug.
....................................................................................................................................113
Figure 5.65: Raman-spectrum and optical microscope image (inset) of Cholesterol
sample after evaporation. ...........................................................................................113
Figure 5.66: (a) Small droplets of SM directly after deposition on glass sample with
a magnification of 50 x. (b) shows droplets of SM also directly after deposition but on
titanium sample with a magnification of 20x. ...........................................................114
Figure 5.67: a-c SEM images of SM grown on Ti with different magnifications
revealing uniform dispersity. .....................................................................................115
Figure 5.68: AFM 2D image of SM on Ti substrate. The lighter parts in the image
display particles that are higher than 2 µm. The particle size amounts roughly < 2 µm.
....................................................................................................................................115
xix
Figure 5.69: AFM 3D images of SM. (a) has a scan area of 10 x 10 µm2 whereas (b)
has a scan area of 2 x 2 µm2. The maximum height is around 1.5 µm......................116
Figure 5.70: SEM image of PLGA on Ti substrate. The images are taken directly
after evaporation. They show small droplets of PLGA. ............................................116
Figure 5.71: SEM images of Indometacin with hierarchical structures growing on Ti
with different magnifications.....................................................................................117
Figure 5.72: Microscopic image of Indometacin deposited on titan (film (a) reference
sample (b) its Raman spectra of Indometacin reference substance (blue) and as film
deposited substance on titanium substrate (red). .......................................................118
Figure 5.73: Microscopic image of Indometacin deposited on polymer foil (film (a)
reference sample (b) its Raman spectra of Indometacin reference substance (blue) and
as film deposited substance on polymer foil (red). ....................................................118
Figure 5.74: Raman spectra of Indometacin reference substance (blue) and deposited
substance crystal on titanium substrate (red) after one week. ...................................119
Figure 5.75: SEM of two layers sample composed of (1) Metronidazole, (2) PLGA
with higher and lower magnification a and b respectively. .......................................119
Figure 5.76: SEM of a four-layers sample composed of (1) SM, (2) Cholesterol, (3)
Fluorouracil and (4) SM on Ti substrate with higher and lower magnification a and b
respectively. Thicknesses of the single layers are: (1) >20 µm, (2) 15 µm, (3) few nm,
(4) >20 µm. ................................................................................................................120
Figure 5.77: SEM images of Acetylsalicylic acid on Ti substrate after and before
deposition a and b respectively. The inset shows higher magnification SEM image.
....................................................................................................................................122
Figure 5.78: a-c SEM images of Tetracaine HCl deposited on Si pre-coated with 20
nm Au thin film at different magnifications. .............................................................123
Figure 5.79: a-b SEM images of Tetracaine- HCl Si pre-coated with 4 nm Au thin
film at different magnifications. ................................................................................124
Figure 5.80: SEM images of Tetracaine-HCl grown on Si substrate at different
evaporation times with 16 min (a), 23 min (b) and 30 min (c). .................................127
Figure 5.81: SEM images of Chloroamphenicol deposited on glass substrate which
obtained after 3 h.(a) and 10 days(b) respectively. ....................................................128
Figure 5.82: XRD pattern of Chloroamphenicol deposited on glass substrate at
different times of 3h and 10 days...............................................................................128
xx
Figure 5.83: Representative Structure-zone model after Movchan and Diminishin
relating the substrate temperature to the corresponding arising thin film structure . 129
Figure 5.84: SEM images of lateral structures of Pilocarpine-HCl (a) and
Acetylsalicylic acid (b) respectively. .........................................................................131
Figure 5.85: Raman spectra of the deposited and reference 5-Fluorouracil, showing
clear Raman peaks in the thermally deposited 5-Flurouracil on titanium substrate. .132
Figure 5.86: Raman spectra of the deposited and reference Metronidazole.............132
Figure 5.87: Raman spectra of the deposited and reference Clotrimazole. ..............133
Figure 5.88: Raman spectra of the deposited and reference Adipic acid. ................133
Figure 5.89: Raman spectra of the deposited (on polymer foil) and reference
Pilocarpine-HCl. ........................................................................................................135
Figure 5.90: Raman spectra of the deposited (on glass at different time) and reference
Chloroamphenicol......................................................................................................136
Figure 5.91: Raman spectra of the deposited and reference Nipagin. ......................136
Figure 5.92: SEM images of co-deposition of Tetracaine-HCl with gold (a and b) and
silver (c and d). ..........................................................................................................139
Figure 5.93: a-d SEM images of Nipasol coated on the surface of ZnO nano-
microstructures...........................................................................................................141
Figure 5. 94: EDX spectra of the as-synthesized Nipasol grown on ZnO nano
structures which confirms the presence of Zinc, carbon as well as oxygen. .............142
Chapter 6
Figure 6.1: shows the antimicrobial activity of Erythromycin against Staphylococcus
aureus, positive control (a), deposited film (b). .........................................................144
Figure 6.2: SEM images of Erythromycin as bulk material before evaporation (a) and
deposited film after evaporation (b)...........................................................................144
Figure 6.3: illustrates the antimicrobial activities of deposited films of Nipasol (a),
Tetracycline-HCl (b), Chloramphenicol (c) against Staphylococcus aureus.............145
Figure 6.4: The antimicrobial activity of Itraconazole against Candida albicans,
positive control (a), deposited drug (b) by evaporation under vacuum. ....................146
Figure 6.5: SEM images of Itraconazole as bulk material (a) and deposited drug (b)
by evaporation under vacuum....................................................................................146
xxi
Figure 6.6: Illustrates the antimicrobial activity of Tobramycin against Staph aureus,
Negative Control (Anod. Ti type II) (a), Positive Control (Tobramycin) (b), deposited
Tobramycin film grown on Titanium oxide (c), Titanium (d), stales steel (e). .........149
Figure 6.7: 3D AFM images of nano-microstructured pharmaceutically active
molecules. ..................................................................................................................150
Figure 6.8: Illustrates drug release profile of Metronidazole. .................................151
Figure 6.9: SEM images of Metronidazole as bulk material (a) and deposited drug (b)
by vacuum evaporation. The inset shows higher magnification SEM image............152
Figure 6.10: The basic layout and conductivity curves of a PFET based on
Pilocarpine-HCl by deposition through a shadow mask directly on a silicon
microchip. ..................................................................................................................154
Figure 6.11: The I-V characteristic of pilocarpine-HCl thin film deposited on glass
substrate. ....................................................................................................................155
xxii
List of Tables
Table 4.1: Overview of thermally evaporated different drug substances. First part (1-
12) lists the materials which have been successfully nanostructured by thermal
evaporation and have been tested with disk diffusion method. The second part (13-30)
lists the successfully deposited materials. However, the biological tests are under
progress. The last part (31-34) lists the pharmaceutical substances which are not
suitable for thermal evaporation as they are decomposed during deposition........... 52
Table 5.1: Overview of thermally evaporated different drug substances. First part (1-
30) lists the materials which have been successfully nanostructured by thermal
evaporation and have been tested with disk diffusion method. The last part (31-34)
lists the pharmaceutical substances which are not suitable for thermal evaporation as
they are decomposed during deposition. ............................................................. 65
Table 6.1: The bacteriostatic effect of various antibiotics and of Nipasol deposited by
evaporation under vacuum against Staphylococcus aureus ATCC 6538.................145
Table 6.2: The fungistatic effect of antimycotics deposed by evaporation under
vacuum against Candida albicans ATCC 10231................................................... 146
Introduction
1
Chapter 1
1 Introduction
Nanoscience can be defined as the systematic study of materials with properties that
depend critically on length scales on the order of nanometers, see e.g. the definition
by the Royal Society and the Royal Academy of Engineering in 2004 defines
nanotechnology as designing, classification, creation, and maintaining of structures or
systems by controlling their shape and size at the nanometre scale [1].
Nanostructures are functional structures with at least one characteristic dimension
being between 1 nm and 100 nm. Such materials and systems can be designed to
exhibit novel and significantly improved physical, chemical and biological properties
as a result of the limited size of their constituent particles or molecules. Nowadays,
there are different types of nanostructured materials and systems essentially differing
in the number of dimensions which lie within the nanometer range: such as systems
confined to one dimension (nanofilms, nanolayers), systems confined to two
dimensions (nanowires, nanorods, nanocolumn, nanotubes), and systems confined to
three dimensions (nanoclusters of different shapes).
By reducing the particle size, nanosystems can reveal several multifunctional physical
effects based on quantum phenomena like quantum entanglement, electron
confinement, electron tunnelling, ballistic transport, and near-field optical properties.
Furthermore, a very important aspect of nanoscale objects is their increased surface
area to volume (S/V) ratio. Nanotechnology exhibits huge potential for different
applications such as semiconductor industry, metrology, electronics, biotechnology,
biomedical engineering, military technology, agriculture and space applications. But
one of the most promising societal impacts of nanotechnology is in the area of
nanomedicine.
As stated earlier, the most common characteristic of nanotechnology is very small
scale of the involved matter, which is below 100 nm. In general, there are two
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different approaches for producing structures in nanometer regime: top-down and
bottom-up. In the top-down approach a reduction of a source material from bulk size
to nanoscale is carried out by: grinding processes, electron-beam lithography [2] and
pattern-dependent oxidation methods [3, 4]. On the other hand, the bottom-up
approach is a procedure to make nanostructures by agglomerating smaller entities,
i.e., atoms and molecules in a controlled way and a few examples are molecular beam
epitaxy (MBE), [5] chemical precipitation, [6] sol-gel process, [7] thermal
evaporation, [8, 9] chemical vapour deposition (CVD), [10, 11] laser ablation, [12]
and sputtering [13, 14].
An interesting biomedical aspect of synthetically constructed nano/micro structures is
that their size is smaller than or similar to the natural units such as a cell (10–100 μm),
a virus (20–450 nm), a protein (5–50 nm) or a gene (2 nm wide and 10–100 nm long).
This means that they can deeply interact with biological systems or can be very close
to a biological unit of interest [15].
More than 10 years ago, increasing attention was paid to optimize the
pharmacological and pharmacokinetic properties of already available drugs through
chemical and physical modifications. A promising approach in this respect is
developing the nano/micro scale drug delivery carriers and small-molecule drugs to
reach specifically targeted areas.
Currently, less than 10% of new drug candidates have both high solubility and
permeability [16]. The chemistry of a drug by itself is not alone responsible for this
effect rather its physical structure [17]. The increasing number of drug with poor
water solubility demands development of technologies to improve drug solubility,
reducing the toxic effects, and for promoting the therapeutic benefits. Therapeutic
effectiveness of a drug depends on the bioavailability and hence on the solubility of
drug molecules. Solubility is one of the important parameters to achieve desired
concentrations of drugs in circulatory system of the body for a pharmacological
response. Lower solubility of drugs leads to stability problems, fatal side-effects,
lower bioavailability as well as an increased dose required for the treatment of patient.
Reduction of drug particles size is necessary to facilitate the targeted drug delivery
which has been a topic of renewed interest in pharmaceutical industries. There is a
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variety of techniques employed to reduce the particle size including solid dispersion,
salt formation, spray drying, milling, grinding, super critical fluid, freeze drying,
solvent evaporation, coacervation and in situ polymerization. These techniques
usually include the use of large amount of toxic solvents and/or surfactants which
themselves require further purifying steps for removal the remaining solvent.
Therefore, research efforts have been directed to develop the environmentally safe
methods to produce the drug-loaded micron and submicron size particles. If solvent
impurities remain in the drug-loaded NPs, then these become toxic and may degrade
the pharmaceuticals within the polymer matrix. Important tasks for pharmaceutical
engineering are the molecular scale mixing and structuring of pharmaceutical drugs
for increased solubility. Nanostructuring of drug delivery systems offers many
promising applications like precise control of dissolution and release kinetics,
enhanced activities, flexibility in terms of surface coatings, integration into implants,
designing the appropriate scaffolds or even integrating into microelectronic chips etc.
for different desired applications. In general such kind of structuring is difficult due to
unintentional mixing of chemical solvents used during drug formulations.
In surface science, many techniques exist to form nanostructures and surface coatings
of nanoscopic thickness. Thermal evaporation (TE) processes have already been used
to deposit individual atoms or molecules to form micro or nanostructured thin films
since the last 50 years. The evaporation of drug molecules and their emission to a
specific surface under vacuum led to controlled assembling of the molecules from
vapour phase to solid phase. The most important aspects of thermal evaporation
technique are: solvent-free, precise control of size, possibility of fabricating
multilayer/hybrid, and free choice of substrates.
The aim of this thesis deals with the combination of nanotechnological methods,
explicitly thermal evaporation, with pharmaceutical research to control the particle
size/shape of pharmaceutical ingredients to overcome the aforementioned problem of
drug insolubility. Furthermore nano and micro-structured thin films of active and non-
active pharmaceutical layers shall be fabricated using the lowest drug concentration
and decreasing the adverse effects related with drugs. This includes coating of
implants for multifunctional applications, or creation of hybrids/ multilayers from
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different drugs and carriers for designing the controlled and sequential release of
drugs.
In general, the dissertation is devoted to the following two strategies: firstly, the
synthesis of both pharmaceutical thin film and their multilayer structures; and
secondly, the integration of these functional nano-microstructures into medical
science. This dissertation is categorized into seven chapters including the current one.
Chapter 2 discusses some of the theoretical concepts of vacuum evaporation system.
It begins with introducing the limitations of the conventional techniques which are
used for improving drug solubility. The thin film deposition technique and some of its
basic concepts regarding the atomistic thin film growth mechanisms are also
discussed.
Chapter 3 discusses the successful experimental technique used by thermal
evaporation for producing thin film from various pharmaceutical molecules, polymers
and metals. Details about the thin film preparation and multilayer processes by co-
evaporation used mainly for increasing the solubility of drugs and controlling the drug
release are given. The antimicrobial experiment is also illustrated.
The description of techniques used for elemental, morphological, and structural
analysis of these nano/microstructures appears briefly in chapter 4. The next two
chapters focus on the main work of the dissertation including experimental results and
discussion.
Chapter 5 describes the most important results of different spectroscopic techniques
regarding the nucleation and growth of pharmaceutical thin films on various
substrates prepared by thermal evaporation. Chapter 6 presents the application of
thermal evaporation in medicine and electrical engineering, such as biological
screening of deposited films, control the release of drug and field effect transistor.
Finally, chapter 7 concludes the dissertation with a summary of the obtained results
and a brief discussion of the experiments followed by an outlook.
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Chapter 2
2 Theoretical Considerations
Due to the interdisciplinary character of this thesis, it is necessary to give a basic
background about pharmaceutical and materials science aspects which are important
in this work. This chapter is divided into three main sections. First, important
pharmaceutical aspects about solubility and hydrophobicity of drugs are introduced in
the subchapter 2.1, the basic concepts regarding to the advantages and limitations
associated with each process used for preparing drug delivery systems are discussed.
The second section, subchapters 2.2- 2.5, presents the material science aspects
ranging from vacuum vapour deposition techniques for various thin film depositions
and the basic concepts of the growth mechanism, as well as a few words on
nanotechnology. The last section discusses stents (subchapter 2.6.1) and biofilm
formation (subchapter 2.6.2), both are important for potential applications of the
thermal evaporation in biomedical research which is introduced in the following
chapter.
2.1 Limitations of Techniques for Solubility Enhancement
In current medical scenario, the main challenge is to development different forms of
drugs with appropriate size, defined solubilities/wettabilities, and desired
functionalities in a versatile way. Indeed, various new drugs failed to reach the market
due to their hydrophobic nature [18, 19] which lead to stability problems and high
dose therapy. It is mainly difficult to build up a novel molecule with high-quality
pharmacological activity and preferred solubility and permeability. According to the
biopharmaceutical and classification system, class II drugs are solubility-limited and
are estimated to account for about 30% of both commercial and developmental drugs
[20, 21]. The solubility of a solute can be identified as the maximum quantity of
solute that can be dissolved in a certain quantity of solvent to form a solution at a
specific temperature. Therefore, drug dissolution is defined as ‘drug molecules
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undergo from a solid phase to a solution phase’. In addition, water insoluble drugs
show lower dissolution rates [22]. The solubility behaviour of active pharmaceutical
substances remains one of the most challenging aspects in formulation development
[23]. From pharmaceutical point of view, solubility is one of the most important
parameters to achieve the desired concentrations of drugs in systemic circulation for a
pharmacological response. The poorly soluble drugs have a number of disadvantages
such as repetition of the dosage, administration frequency, stability problem and the
resultant occurrence of side effects. In general, therapeutic effectiveness of a drug
depends on the bioavailability and solubility of the drug molecules. Important tasks in
pharmaceutical engineering are the molecular scale mixing and structuring of
pharmaceutical drugs for increased solubility. This includes coating of implants for
creation of hybrids and multilayers from different drugs and carriers for designing the
drug controlled release and multifunctional applications. However, due to the nature
of fluids this multilayer formation is difficult to achieve with conventional solvent
based methods.
The chemistry of a drug by itself is not alone responsible for its effect. Therefore,
different techniques are employed for engineering the drug particles through
processing protocols for example, spray coating [24], supercritical point drying [25],
drug precipitation, milling, or matrix assisted pulsed laser deposition (PLD) [26].
Impressively, PLD was already used to deposit complex proteins like glucose oxidase.
To carry out the aforementioned approaches, however, methods are rare in which
solvent is not used. The degradation and toxicity of pharmaceutical molecules might
result from the remaining of solvent with them during their formulation.
Current formulation strategies that are used to improve solubility and dissolution rate
of poorly water soluble drugs are associated with some disadvantages. For instance,
adjustment of lattice structure or crystallinity to form polymorphs, solvates, or
anhydrous solids acquire stability problem due to their metastable nature [27, 28].
Synthesis of new derivatives to get water soluble compounds by chemical method
needs a lot of efforts to evaluate the effectiveness and safety of novel products.
Altering chemical structure might drastically vary pharmacological activity by
modifying the affinity of the drug for its receptor. Development of water-soluble
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derivatives is costly however because of the need to investigate efficacy and safety of
the new chemical species.
The use of solubilizing excipients in drug solubilization is limited due to their
toxicity. Higher concentrations of surfactants can also cause toxicity problem and
allergic reactions in definite individuals [29]. For example, adding Cremophor EL as a
vehicle to Paclitaxel (Taxol) to improve its solubility. It was found that Cremophor
EL can cause serious hypersensitivity reactions and nephrotoxicity in human subjects
[30, 31].
Crystal and particle engineering strategies have notable potential to solve the
problems of low aqueous solubility of drug substances [32]. These methods are
applicable not only to molecules of a specific physical and chemical nature, but also
to a wide range of crystalline materials.
The methods discussed above require the use of organic solvents, which are
hazardous to the environment as well as to the physiological system [33]. While
supercritical fluid technology is suitable for mass production, it has disadvantages.
For instance, the majority of polymers show little or no solubility in supercritical
fluids [34]. Modification of pH method might cause chemical instability and local
tissue irritation or necrosis near the injection site at significant pH.
Besides chemical methods, which have their own side-effects and limited
applicability, one can resort to physical aspect of the drug particles too for improving
the solubility. Although micronisation increases the dissolution rate of drugs through
increased surface area, it does not increase equilibrium solubility [35]. It was found
that micronisation is not satisfactory because micronized products like amorphous
materials exhibit the tendency of agglomeration, which leads to decrease in the
effective the surface area to volume (S/A) ratio required for dissolution higher rate.
From an engineering point of view the control over the drug particle size is very
essential for increasing the (S/A) ratio. A smaller particle size (particularly in
nanodimensions) leads to higher rates of dissolution [36, 37]. Considerably, the
general physical activity of a material can be tuned by adjusting its shape or size. In
addition, enhancement of drug solubility resulted from increasing the surface area of
drug by diminishing the particle size of the solid materials obtainable for dissolving
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compound and/or by improving the wetting characteristics of the compound surface
as discussed by Noyes Whitney equation [38].
The effect of particle size on the solubility can be also described by the following
equation [39].
RTr
V
S
S
303.2
2log
0

 (2.1)
Where S is the solubility of infinitely large particles, S0 is the solubility of fine
particles, V is molar volume,  is the surface tension of the solid, and r is the radius of
the fine particle.
Therefore, design features like particle size, surface energy, distribution, surface
rugosity, surface area, particle density, porosity, and micro viscosity must be
controlled by all different techniques used for improving solubility such as spray
drying.
High absorption of pharmaceutical materials through inhalation can be achieved by
controlling all of the above mentioned features. For example, engineered particles are
employed for immune modulation. The delivery of antibodies and inhaled vaccines
achieved by continuous proceed are anticipated by using smart therapeutics are
capable of active targeting and intracellular trafficking [40].
Considering advantages and the limiting efficacy of all methods mentioned above of
preparation and formulation of drugs, there is still room for alternative methods in
drug processing.
2.2 Vacuum deposition
Physical vapour deposition (PVD) is referred to as vacuum deposition for coating
processes, "physical" means without further reaction. In the other hand, if the source
of material includes the chemical vapor precursors which they chemically reacted to
produce desired deposit in higher performance, this process is called chemical vapour
deposition (CVD). PVD is one of the most essential techniques used in coating
technology of electronic devices. Nowadays it is even used for the formation of
biomaterial compounds. PVD is a fast and easy method to deposit micro and nano
structured thin films from various materials on different substrates with desired
thicknesses. Generally, physical approaches involve heating the solid materials to be
vaporized. The vaporized molecules then travel across a region of preferably low
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pressure. Finally, they reach the substrate, where they condense and form the desired
thin film deposited. Several kinds of methods underlie this principle, e.g.,
evaporation, sputter deposition, pulsed laser deposition or molecular beam epitaxy to
assist the transfer of the atoms from a solid or molten source onto a substrate. The thin
film depositions in this work were done using an ultra high vacuum chamber. Finally,
it could be interesting for introducing some information about thin film deposited by
thermal evaporation and sputtering technique.
2.2.1 Thermal evaporation
2.2.1.1 Thermal evaporation of organic materials
Thermal evaporation (TE) processes [41] have been used to deposit individual atoms
or molecules to form micro or nanostructured thin films since at last 50 years. While
thermal evaporation is mainly used for inorganic or ceramic materials [42], a
widespread variant of the thermal evaporation in vacuum is known as thermal organic
vapour phase deposition which is commercially used for the fabrication of organic
light emitting diodes (OLED) [43] for flat panel displays. The main advantage of
thermal evaporation is that it is a solvent free technique and can be routinely used to
fabricate specimens which require a shape control down to the nanoscale. As a bottom
up growth technique, individual atoms or molecules can be evaporated and assembled
on the desired substrates of larger units and in new structures. Even the fabrication of
multilayers is possible by using thermal evaporation. Laterally structured systems are
possibility formed with the help of lithographic techniques or shadow masks. Even
without further structuring, the internal deposited structure can be controlled [44]..
Growth of thin films in vacuum is very well understood for decades [45]. Only by
varying the deposition parameters like evaporation rate [46], oven or substrate
temperature, the degree of organization of the deposited materials from amorphous to
single crystalline and the surface roughness from atomically flat to macroscopically
rough can be tuned.
Figure 2.1 shows a typical setup, a substrate holder is placed in the vacuum chamber
in such a way that it is directly facing to the crucible containing the precursor
materials to be evaporated. A vacuum of at least 10-5 mbar is maintained because a
lower pressure entails a higher mean free path (MFP) of the evaporated particles. The
MFP can be a multiple of the distance between target and substrate. In general, 100
Theoretical Considerations
10
mm to 1 km can be attained within high vacuum [47]. If the MFP is high, the effective
evaporation rate meaning molecules that reach the substrate holder is higher. Besides,
pressure has always to be kept below the gas pressure of the evaporating material. The
whole thermal evaporation process can be divided into three main events:
evaporation, transport and condensation. Considering the evaporation procedure, the
solid material is in a graphite or refractory metal crucible and has to be heated to
allow vapor particles to travel directly to the target object (substrate), where they
might condense back to a solid state. The evaporation process takes place above the
melting temperature in vacuum to transform into vapor phase [48]. Increasing the
temperature means providing more energy to leave the crucible on the on hand, on the
other hand there is more energy to break the bonds of the organic chemical
compounds that are evaporated. Typically, the crucible is heated by resistive heating
elements connected with a regulated power supply, the heating temperature can be
adjusted by changing the current.
Figure 2.1: Setup for thermal evaporation of organic materials.
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2.2.1.2 Evaporation of Metals by vacuum deposition
While molecular organic substances are tightly bound within the molecule by strong
covalent bonds, weak van der Waals forces or polar control the interaction between
individual molecules. In contrast, metals are characterized by metallic bonds. In
metals the outermost valance electrons of each atom form part of a collective free
electron cloud or gas that permeates through entire lattice. This free-electron gas has a
strong electrostatic attraction with the positive ion cores. On the application of metals
in medical science, chemotherapeutic drugs including Platin such as Oxaliplatin,
Cisplatin, and Carboplatin are able to be passively targeted to solid tumours during
the enhanced permeability and retention effect [49]. Moreover, gold nanoparticles
(NPs) have various potential applications as catalysis, bioanalysis, and imaging. Gold
NPs can also be used as an ideal drug-delivery scaffold due to their non-toxicity and
non-immunogenicity behaviours [50]. On the other hand, Platinum-based
chemotherapy drugs and gold nanoparticles can be used for solid tumours and
leukaemia treatment. Surface modifications may be introduced through conjugation
with targeting moieties (e.g., antibodies, peptides, small molecules, aptamers,
fluorescence dyes, genes, or drugs) to provide multimodal functionalities [51, 52].
Exposure of metal NPs to infrared light or magnetic fields [53] resulted in generation
of hyperthermia for solid tumour treatment [54]. Furthermore, it is known that silver
ions have been used against gram positive and gram negative bacteria. Various
generic forms of silver have been confirmed to be efficient against burns, severe
chronic osteomylitis, urinary tract infection and central venous catheter infections
[55]. Furthermore, Nanostructures from silver and gold nanoparticles capped with
mercaptoethane sulfonate can be used as antiviral activities [56, 57]. In addition, it
was found that cobalt/silica carriers are presently being examined for their use in eye
surgery to fix disconnected retinas [58].
This method is capable of using the film-forming material making up the thin layer
with higher efficiency owing to heating materials while preventing the substrate and
the thin layer from being adversely affected by heat from the heating source materials.
When a sufficient vacuum, e.g., 10-6 mbar is achieved, the crucible is heated above
the melting temperature of the contained material. The external and internal schematic
designs of a typical metal evaporator of Knudsen cell type, which is used in this work,
are illustrated in Figure 2.2.
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Figure 2.2: The sketch shows the metal evaporator with a power feed through (a),
and both the external (b) and the internal (c) part of the metal evaporator cell.
The Tantalum (Ta) heater coil filament was selected to transmit the high current and
produce the heat required to evaporate the charge. Ta also has a high melting point, a
sufficient degree of thermal shock resistance, and a high ductility among the
refractory metals. Basically, the rate of deposition of metal atoms in resistively heated
evaporators depends on the temperature of the crucible which is itself controlled by
the electrical power and the amount of exporting material. In general, compared with
the evaporation of organic material, the evaporation rate of metals is very low,
typically at least a factor of 10. In this design, the Ta heater coil is minimally
supported within notched ceramic support rods to reduce heat sinking. The coil
extends well below the bottom of the crucible so that the thermocouple touching the
crucible bottom is immersed within the same heating environment as the crucible and
thus stabilizes at the same temperature.
Moreover, the coil is extended towards the crucible mouth, above the level of the
evaporation material, which leads the mouth of the crucible to be at higher
temperature than the temperature of the evaporation material. This prevents
condensation of evaporant droplets at the mouth and also prevents evaporants which
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wet the crucible from migrating out of it. In addition, the radiation heat shielding
consists of several wraps of corrugated Ta foil is used to reflects radiation from the
coil and crucible, thereby improving source temperature and reducing out gassing of
nearby hardware.
A cup shaped crucible sources (length =17 mm, and inner diameter =3 mm) made of
aluminium oxide, molybdenum, and boron nitride can be used as a source of the
evaporant. The boron nitride crucible was found to be the best type for the
evaporation of Au and Ag as compared to others. In some cases, diffusion of
evaporant materials into the crucible material and crack formation in the crucible was
observed in case of Au evaporant and molybdenum crucible. Crucible materials
should be chosen whose residual contaminants are the least harmful to the film being
deposited. However, much of the volatile contaminants were removed from the
crucibles and associated components by firing it at a higher temperature than the
desired evaporation temperature prior to the filling with new evaporant. The areic
evaporation rate results from equation:
T
Mpa ScV 
4104.4 (2.2)
αV indicates evaporation rate, meaning the evaporated mass per time and unit area in
g/(cm2.s), αc is the evaporation coefficient (being 1 for ideal evaporation), pS is the
saturation vapour pressure of evaporation material at evaporation temperature in Pa
and M is the atomic/molecular mass of evaporation particles in g/mol [59]. This
explains why the rate of deposition of organic molecules is in general much higher
than in metals.
The characteristic propagation of the evaporated material depends on the geometry of
the evaporation source. In this work a crucible is used as a small area source. A small
area source is defined as having small dimensions of the evaporating area compared
to its distance to the substrate (r). The evaporation rate is a directional quantity.
Concerning the angle φ between substrate position and the vertical to the source, the
rate also depends on the distribution of the evaporating material. Thereby it follows a
cosine law:
 coscos  nVa (2.3)
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with n ≥ 0, the bigger n the more directed the flux as shown in Figure 2.3.
Figure 2.3: (a) Crucible rack for thermal evaporation, (b) Target material
distribution from a small area source, (c) Distribution of evaporated material
following cosine-law. (These images were taken from the following website,
http://www.ep4.rub.de/imperia/md/content/skripte/ss04/thinfilmmagnetism/hcs.pdf).
2.2.2 Sputter Deposition
This is a commonly used process for thin film deposition, etching and analytical
techniques. Compared to evaporation of metals, it has a much higher deposition rate.
In sputtering, atoms are ejected from a solid material under the bombardment by fast,
heavy and by positive-ion (Ar+) of typical energies 500 eV-10 keV, ejection of atoms
of binding energies 1-5 eV. Thus, a minimum binding energy needed to supply to the
atoms in order that sputtering may occur since sputtering is driven by momentum
exchange between the ions and atoms in the material due to collisions. The incident
ions set off collision cascades in the target. When such cascades recoil and reach the
target surface with energy above the surface binding energy, an atom can be ejected.
Sputtering is widely used for thin film depositions because it has unique combination
of advantages over the other techniques. Any material can be volatilized by
sputtering, compounds are volatilized stoichiometrically, and the film deposition rate
can be maintained uniform over very large areas. Here, the deposition of metals (such
as gold, platinum, palladium etc. with 99.99% purity) was mainly done by magnetron
sputtering.
Sputtering has a wide variety of applications on metals, metal alloys, semiconductors,
or insulators. Due to the high impact energies of the ions, it can not be utilized for
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organic molecules. For these different materials, different modes of sputtering such as
DC, RF, magnetron, or reactive sputtering are used. The choice of the techniques for
example depends on the type of the target used in sputtering it out. For instance, DC
sputtering is used for conducting targets and RF sputtering for insulator targets.
Magnetron sputtering is widely used variant of DC sputtering. In addition, magnetron
sputtering is practiced in RF and reactive variants which can significantly increase the
efficiency of the process. Magnetron sputtering is presently the most widely
commercially practiced sputtering method due to its high deposition rates. These are
typically order of higher rates than attained by conventional sputtering techniques. It
incorporates a crosswise magnetic field over the cathode which prolongs the electrons
residence time in the plasma and thus enhances the probability of ion collision.
The electron within the dual field (i.e. both magnetic- and electric fields) experiences
the well known Lorenz force in addition to an electric field force:
)( BuEq
dt
mduF  (2.4)
Where q, m and u are the electron charge, mass and velocity, respectively. This leads
to the larger discharge current and thus increased sputter deposition rate. In other
words, this magnetic field greatly increases their mean free path length before they
finally escape to the anode by scattering. Because the path of electrons is much longer
than the electrode gap, the minimum pressure to sustain the plasma is much lower for
the magnetron than for the planar diode. The sputtered atoms retain most of their
kinetic energy on reaching the substrate. Besides, the deposition rate is increased
because of reduced scattering and re-deposition of sputtered atoms on the cathode.
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Figure 2.4: Picture of magnetron sputtering chamber a) outer part b) inner part, the
numbers in the inside chamber correspond to parts of the (1) Pt magnetron (2)
Copper magnetron (3) quartz monitors (4) sample holder.
Figure 2.4 shows the image of the magnetron chamber used in our laboratory for
sample preparation. The chamber consists of sputter targets, evaporation sources, two
quartz microbalances for an in-situ film thickness monitoring and a sample holder.
The Chamber is equipped with a rotary pump (Pfeiffer DUO 005 M), to generate the
pre-vacuum (10−1 torr) together with a turbomolecular pump (Pfeiffer TMU 260) that
is used for creating the end-vacuum in the range of 10−7- 10−8 torr. A relatively good
vacuum condition is required to reduce collision of the transported material with the
residual gas. Thus, the reduction in the rate of deposition and oxidation of the
materials are prevented. During thin film deposition process, the target must be well
bonded to a water-cooled Cu backing plate to dissipate. The heat is created by
bombardment to prevent out gassing or melting of the target material.
2.3 Growth mechanism
Growth of thin films, as in the phase of transformation, involves the processes of
nucleation and growth on the substrate surface. The nucleation process plays a very
important role in determining the crystallinity and microstructure of the resultant
films. For the deposition of thin films with thickness in the nanometer region, the
initial nucleation process is important. From a thermodynamic point of view, the size
and the shape of the initial nuclei are assumed to be solely dependent on the change of
the volume of Gibbs free energy due to supersaturation, and the combined effect of
surface and interface energies governed by Young’s equation. No other interactions
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between the film or nuclei and the substrate were taken into consideration. In practice,
the interaction between film and substrate plays a very important role in determining
the initial nucleation and the film growth. Therefore, the condensed atoms have to
form clusters. When these clusters reach a critical radius, where they are
thermodynamically stable, a nucleus is formed. Three major growing mechanisms of
film formation have pointed basic growth modes island (Volmer-Weber), layer-by-
layer (Frank-van der Merwe), and Stranski-Krastanov. Figure 2.5 demonstrates these
three basic modes of initial nucleation in the film growth. The Volmer-Weber
mechanism is also called island growth mechanism. The deposited atoms are bound
together in three-dimensional islands where the cohesive forces are stronger than the
adhesive forces to the substrate. Nucleation starts from small clusters that form on the
substrate. Further arriving atoms bind to the already existing islands and enlarge them
until they coalesce and build up a uniform thin layer. The Frank-van-der-Merwe
mechanism is also called layer-by-layer growth. The adhesive forces between
deposited atoms and surface atoms are stronger than the cohesive forces. After the
first two-dimensional monolayer has formed the second layer starts to grow. The
Stranski-Krastanov mechanism combines the previous mechanisms. Initially the
Frank-van-der-Merwe is predominant until a critical layer thickness is reached. This
critical layer thickness is dependent on physical and chemical properties of the
substrate and the film. Many systems of metals or organic materials on insulator
substrates, alkali halides, graphite and mica substrates display the Volmer-Weber
mechanism [60], this type of nucleation during the initial film deposition. Subsequent
growth results in the islands to coalesce to form a continuous film. The layer growth
is the opposite of the island growth, where growth species are bound more powerfully
to the substrate than to each other. First complete monolayer is formed, before the
deposition of second layer occurs. The most important examples of layer growth
mode are the epitaxial growth of single crystal films. The island-layer growth is an
intermediate combination of layer growth and island growth. Such a growth mode
typically involves the stress, which is developed during the formation of the nuclei or
films.
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Figure 2.5: Thin film growth mechanisms. (a): Volmer-Weber (island) growth, (b):
Frank-van-der-Merwe (layer-by-layer) growth, (c): Stranski-Krastanov growth [61].
2. 4 Growth mechanism equations
As indicated by optical microscope, atomic force microscopy (AFM) and scanning
electron microscopy (SEM) results (see chapter 5), the thin film formation starts with
island growth. For instance, the nucleation process has to be considered. When the
material vapour condenses at the substrate surface, interfaces are formed between the
film and substrate due to change in the Gibbs free energy. An energy gain comes from
the formation of new volume, and a loss of energy arises from the creation of a new
surface. The change in energy can be given by the equation (2.5).
 
23 4
3
4 rGrG V (2.5)
The free energy change accompanying the formation of an aggregate of mean
dimension r is given by
svsffvfvV rararaGrG 
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3  (2.6)
The chemical free-energy change per unit volume, ΔGv, drives the condensation
reaction. There are several interfacial tensions, and these are identified by the
subscript f, s, and v representing film, substrate and vapour, respectively. The
formation of new phases results a reduction of Gibbs free energy, but an increase in
the total surface energy. The nucleation is stable only when its size is larger
than the critical size, i.e., r > r*:
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Correspondingly, ΔGv evaluated at r = r* is 
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where GV is the free energy change per unit volume, r is the radius of nucleus formed,
α is the surface tension, a and γ indicate the interfacial areas and energies and f, v and 
s stand for film, vapour and solid, respectively. For three different cases of layer,
island and layer-island growth the relations between the interface energies are varied.
For island growth, the surface energy between solid and vapour will be smaller than
the sum of the other two as:
fvsfsv   (2.9)
For layer growth, the interface energy between solid and vapour equals the sum of the
other two because the substrate will be covered completely. So, one gets:
fvsfsv   (2.10)
When both mechanisms are combined, the surface energy between solid and vapour is
bigger due to in- situ induced stresses during growing process [62].
fvsfsv   (2.11)
To explain the thin film growing within thermal evaporation, the fundamental
properties of the material should be considered during evaporation like melting point,
and density. In this thesis, organic compounds and particularly pharmaceutical
substances are deposited by a thermal evaporation process. The materials are heated
to their specific melting points. If the surface of the sample material in the crucible
has enough energy, evaporation will start. Thus small-sized particles attain to the
vapour flux and condense at the substrate. They will increase in size when further
molecules reach there. Due to stability issues, some monomers are not able to stay at
the top of the islands (see Figure 2.6). But, they rather fall down on the substrate
surface where they have been bound to surface layer atoms. This is the point where
layer formation arises. The corresponding surface energies are referred to equations
mentioned above. The nucleation and growth processes depend on different factors.
For instance, the substrate surface plays a key role on island formation. High
roughness of the surface may lead to non-uniform thin films or different island sizes
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and heights. Also the concentration of the evaporated material is relevant because
higher concentration means more molecules reaching the substrate. This might lead to
faster layer formation as the molecules coalesce at numerous places to small islands
which will in turn coalesce, as the inter-island distance is small. Also, aspects
considering diffusion processes are the energies of the evaporated molecules as well
as the time component of evaporation itself. The more energy and time is available
during the whole process, the higher the probability to form clusters on the surface.
This will be elaborated more precisely in chapter 5. Bulk diffusion does not matter
because the organic molecules are quite big if compared to the substrate atoms and
thus will not diffuse into the substrate. In addition, it is possible that not only
monomers can be evaporated but also possible to evaporate the dimers or even
trimers.
Figure 2.6: The growth mechanism of a thin film layer through evaporation of
molecules is demonstrated schematically.
The different colours of the molecules should signify the different stages of molecule
arrivals. Firstly individual small islands form until a whole layer derives. The outer
right part shows the instability of a molecule on top of an island and its degradation.
2.5 Nanotechnological aspects
Nanotechnology approaches are necessary to study the materials and structures at the
nanoscale level of around 1-100 nanometers (nm) or fewer. Generally, nanoscience
provides the study of matter and system in atomic and molecular levels. The objects
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studied in this range of sizes, are larger than atoms and small molecules. But, these
objects are smaller than the structures typically produced for using microtechnologies
(e.g., microelectronics, photonics, MEMS, and microfluidics). The dimensions of
these systems are often equal to or smaller than the length scales that define the
physical properties of materials. The unique physical properties of nanostructures, in
general, can be attributed to different origins: for example the relatively large fraction
of surface atoms, large surface energy, and spatial confinement. At these sizes,
nanosystems can exhibit useful physical actions based on quantum phenomena
(electron confinement, near-field optical effects, quantum entangle). Some of the
observed phenomena are as follows:
• Significantly low melting point or phase transition temperature and appreciably
reduce constant lattice due to huge fraction of surface atoms.
• One or two order magnitude higher mechanical strength. This effect could be due
to reducing the probability of defects.
• A high resistivity due to dominant surface and grain boundary scattering.
• Significantly different optical properties due to an increase in band gap.
The dimensional dependence of these properties shows that the general physical
activity of a material can be tuned considerably by adjusting its shape or size.
Reduced dimensionality arises when at least one dimension of a physically active
region is in nanoscale region. A condensed matter exhibits some remarkable
properties when their dimension changes from bulk to nanoscale. The properties
observed in this nanoscale dimension material significantly differ from their bulk
counter parts. It was found that the size, surface characteristic and shape of nano-
particles are playing important role in their biodistribution in vivo [63]. The design of
engineering NPs for therapeutic applications is important since particles of less than 5
nm are quickly removed from distribution during extravasations or renal clearance
[64], and the particles of size ranging ~15 µm and above to accumulate in the liver,
the spleen and the bone narrow [65]. Therefore, particles should be in the size ranging
~10 nm to ~15 µm to promote cellular targeted and systematic circulation [66]. In
general, the high surface to volume ratio of nanoparticles induces a higher
decomposition rate. Targeted drug delivery is a process of transporting the medication
to a patient with higher concentration in the tissue of interest without destroying the
healthy tissue and organs [67, 68]. The design of nanostructured drug carriers will
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assist to go through or overcome these barriers to drug delivery as described by
Courrier et al. [69].
2.6 Potential applications of thermal evaporation in medical science
2.6.1 Stents
Nowadays, coronary artery disease (CAD) is one of the dangerous diseases leading to
cause heart-related death and disability in the advanced world. CAD is associated
with the development of atherosclerosis or arteriosclerotic vascular disease within one
or more of the coronary arteries which transport oxygen and essential nutrients to the
heart muscle. It was found that smoking, hypertension, diabetes, higher levels of fatty
substances as cholesterol [70], cellular waste, calcium and other substances in the
internal layer of any artery caused numerous risks such as sufficiently narrow lumen,
limited blood flow to a portion of the heart and result in angina pectoris. From this
finding, the treatment of re-narrowing artery should be done in-stent restenosis (ISR)
[71, 72], as demonstrated in Figure 2.7.
Figure 2.7: shows the differing patterns of restenosis and in- stent restenosis (ISR).
(source of this image in website: cvi.med.nyu.edu)
There are two kinds of stents.
(1) Bare-metal stent (BMS) is non coating stent which is a mesh-like tube of thin
wire. Metal stent is fabricated from metals which do not decompose in biological
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system. Stainless steel and Cobalt-chromium alloy are widely used in cardiac arteries
treatment. Normally, a BMS is a small, tubular, wire-mesh device which is pre-loaded
in a collapsed form onto a catheter balloon, threaded to the narrowed section of the
artery and expanded within the vessel.
(2) Drug-eluting stents (DES)
DES represents one of the most promising advances in interventional cardiology and
radiology. The major development of ISR is at the site of injury as there is locally
smooth muscle cell activation and replication. Three different routes are concerned in
the pathogenesis of ISR as illustrated in Figure 2.8. These consist of: (1) instant
vessel recoil after stretch injury, (2) negative arterial remodelling, and (3) neointimal
hyperplasia.
Figure 2.8: Pathophysiology of in-stent restenosis and the mechanisms of action of
different therapeutic agents [73]. (Abbreviations: ECM, extracellular matrix; SMC,
smooth muscle cells).
Consequently, the most important thing in a stent-based drug delivery system is to
locally deliver a suitable concentration of active molecules to prevent this process and
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toxic effects. The successful system would consist of three components: (1) a metallic
platform, (2) a drug carrier vehicle that stores a therapeutic agent as well as allows the
agent to diffuse into the vascular tissue in a controlled fashion, and (3) an effective
therapeutic agent that reduces the neointimal growth induced by stent implantation.
To facilitate better interaction or adhesion between drug releasing matrix and stent,
using of stable synthetic polymer coating materials such as polyethylene-co-vinyl
acetate (PEVA), poly-n-butyl methacrylate (PBMA), and the tri-block copolymer
poly(styrene-b-isobutylene-b-styrene) (SIBS). The most successful method has been
applied to the surface of the stent stage by using anti-restenotic drugs with polymers
to coat the stents surface. Upon deployment, drug-delivery is driven by diffusion from
the polymeric matrix and the rate of this diffusion is stated by the type, composition
and number of polymers used in the drug–polymer matrix. Through the operation of a
DES, any mechanical injury acquired in the vessel leads to an immediate healing
response in the arterial wall. This healing response is firstly described by the creation
of platelets within the intima, leading to thrombus development and the recruitment of
blood-borne monocytes, neutrophils and lymphocytes. These cells produce mitogenic
and chemotactic factors which trigger the activation of smooth muscle cells (SMCs)
which undergo unrestrained proliferation and migration toward the intimal layer
resulting in neointimal growth and ISR [74]. Consequently, the use of the perfect anti-
restenotic substances should show potent antiproliferative effects but protect vascular
healing. In clinical treatment, using several immunosuppressive agents, such as
Sirolimus, Zotarolimus and Everolimus prevent SMC proliferation in response to
cytokine and growth factor stimulation by binding to the cytosolic FK binding protein
12 (FKBP12). This prevents the activation of the mammalian target of rapamycin
(mTOR) and leads to interruption of the cell-cycle in the G1-S phase. Paclitaxel is
known as a strong antiproliferative agent, suppresses neointimal growth by binding
with and stabilising microtubules.
2.6.2 Biofilm formation as microbial development
Many patients need an internal fixation device or artificial cooperative in advanced
countries [75]. The most familiar diseases which cause bone failure or loss are
periodontitis, perio-implantitis, osteomyelitis and rheumatoid arthritis. These diseases
are caused by bacterial infections such as (gram negative and gram positive bacteria)
Theoretical Considerations
25
and inflammation reactions [76, 77]. Biofilms can be defined as the ability of
microorganisms attached to a surface of solid materials or medical devices [78]. The
contamination of medical implants and devices might come from: (1) a contaminated
of the hands of medical teams during the surgical procedure, (2) the infection of the
surface of implant/device, (3) the patient’s own skin or mucus membrane, (4) isolated
local contaminations in the patient, (5) infected antiseptic, (6) communication with
other patients in the hospital, or family members after involvement [79, 80]. During
the insertion on implant devises, blood or tissue proteins directly adhere to top of the
surface of an implanted device (see Figure 2.9a). The adhesion or adsorption of
larger biomolecules such as protein to a surface, but without actually penetrating the
surface. Protein is of high physiological relevance, and adsorb with different
mechanisms than their molecular or atomic analogs. Some of the major driving forces
behind protein adsorption include Protein adhesion which depends on surface
hydrophobicity, roughness, porosity, chemical composition, as well as composition
and concentration of the protein solution, salt concentrations and pH [81, 82, 83, 84].
The deposition of adsorbed proteins layer has been revealed to be significant for
sticking with free swimming bacteria which is called planktonic state [85]. It will in
vivo adsorb these surface proteins as represented in (Figure 2.9b) [86, 87].
Figure 2.9: Schematic representation of biofilm formation [88].
The sticking bacteria grow rapidly by production or proliferation and mobilization of
other bacteria from the immediate surroundings. Much more bacteria have stuck on
the surface. These can change their gene appearance by mutation. Changing in
bacterial genes might be initiated which are in charge for the production of additional
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cellular polymeric materials, which are necessary in the construction of biofilm [89].
Figure 2.9c contains extracellular polymeric substances (EPS). In principal, the EPS
matrix has changeable composition. And it includes polysaccharides [90]. Also, non-
cellular materials from the direct environment can be formed. The biofilm gradually
develops and microcolonies of bacteria form inside the biofilm as shown in (Figure
2.9d). Finally, small parts of the biofilm can fracture and planktonic bacteria run away
from the biofilm as illustrated in (Figure 2.9e). The formation of biofilm sheet is
required to protect the sessile bacteria from shear stress. It is attacked by the host’s
immune system and (awful or not comfortable for the patient) against antibiotic
substances. The achievement of medical implants is not only based on the
combination between bone and implant, but also on the occurrence of disinfection
around the implant, which will prevent bacterial infection. Infection is one of the most
serious complications that may arise after orthopaedic implant surgery. To regulate
the best approach for fighting the infection of medical device, one can put in his
consideration, the medical implant transported to the patient should be completely
clean and pure. Fighting of foreign bacteria colonized the medical devises may be
achieved by using thermal evaporation technique. Thermal evaporation provides
better adhesion between substrate surfaces and deposited antimicrobial agents such as
pharmaceutical molecules and inorganic materials like silver.
Furthermore, in the framework of the examinations of this thesis the ability to
investigate and control the release of antibiotic and the antimicrobial agents to
increase the activity of antibiotic and antimicrobial substances to prevent bacterial and
fungal adhesion to the biomedical surfaces such as Staphylococcus epidermis,
staphylococcus aureus and Candida Albicans. The PVD process is recognized as the
best choice since it results in good adhesiveness and resistance of metallic or ceramic
coatings and it is extensively used in technical and medical applications [91].
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Chapter 3
3 Characterization Techniques
This chapter introduces the fundamentals of the characterization techniques used for
the investigation of structural, chemical and physical properties of the deposited
organic thin films fabricated by physical vapour deposition. The techniques used in
this study include light optical microscopy, atomic force microscopy (AFM), scanning
electron microscopy (SEM), profilometer for actual thickness measurement, Raman
spectroscopy and x-ray diffraction (XRD).
3.1 Light Microscopy
Optical microscopes were introduced in multiple forms in the 17th century. It is used
initially to look at the majority of the samples that give us first impetration for making
further investigations. Optical microscopes are the oldest design of a microscope
which get better resolution and sample contrast than the naked eye. The image from
an optical microscope can be captured by normal light-sensitive cameras to generate a
micrograph. It is an honestly simple instrument, being essentially an extension of
human eyes which magnifies images of small objects, enabling to directly view
structures that are below its resolving power (0.1 mm). Furthermore, samples could be
used to routinely document the progress of an investigation. The significance of light
microscope in our research appears in investigating the features of thin film of
deposited active pharmaceutical ingredients fabricated by thermal evaporation. The
characterization of thin film morphology, particularly, was often done at different
magnification ranging from 25 x to 1000 x right after deposition. This helps to check
the characteristics of deposited molecules. The arriving light will be reflected on the
surface of the delaminated thin film. Modern established compound microscope use
multiple lenses for magnification. Its optical path is shown in Figure 3.1. Progress
includes better resolution, less aberrations, exchangeable objective lenses and add-on
features like phase contrast or dark field imaging. Standard resolutions achieved that
can be achieved are about 200 nm (half of the blue light wavelength). The light
source, which mostly is a halogen lamp, is seated opposite to the ocular and below the
sample. Condenser lenses focus the light onto the sample. A condenser aperture helps
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to adjust the light intensity on the sample. Objective lenses that lie above the sample
collect light from it and produce a magnified intermediate image. In order to obtain
the total magnification of the final image, the magnification power of the objective
lens and the eyepiece has to be multiplied. This results in a maximum magnification
power of 1000x that is limited by the nature of the specimen, the objective lens, and
the wavelength of light. Limitations to what can be seen in an optical microscope are
not so much related to magnification as they are to resolution, illumination, and
contrast.
Resolution
The optical microscope is limited to a resolution of about 200 nm. The resolution is
related to the numerical aperture (NA) of the objective lens and the wavelength
passing through the lens. Higher numerical aperture and shorter wavelength, better
resolution. The numerical aperture of an optical system such as an objective lens is
defined by
NA= n. sinθ                                                                                                          (3.1) 
n is the index of refraction of the medium in which the lens is working and θ is the 
half-angle of the maximum cone of light that can enter or exit the lens.
Illumination
In order to see the intricacies and detail of the viewed sample, a glare-free, bright and
evenly dispersed light must be displayed from behind and across the viewing field.
Proper illumination occurs through reflected, refracted and transmitted light, or a
combination of all three.
Contrast
Contrast is related to the illumination system and can be adjusted by changing the
intensity of light and the diaphragm or pinhole aperture. Also, chemical stains applied
to the specimen can enhance contrast. In principle, lightning and contrast can be
dramatically improved using modifications such as dark field, phase contrast, and
differential interference contrast. In this thesis, mainly bright field mode is used to
investigate the sample. Dark field mode has been used once to improve the image
contrast.
Most common magnification here is 10 x. To get the real magnification of the final
image one has to multiply the magnifications of the objective lenses and the ocular.
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One very important advantage is that similar to the AFM, only a negligible influence
of the technique on the organic film occurs that avoids e.g. decomposition of the
molecules.
Figure 3.1: Optical microscope: (a) optical path of the light beam in an optical
microscope, (b) Picture of a typically optical microscope.
3.2 Atomic force microscopy (AFM)
AFM is called atomic force microscope. AFM is an important technique in
nanoscience and nanotechnology. Binnig and Quate established atomic force
microscopy (AFM) about 26 years ago [92]. This enabled high-resolution
visualization of structures at the atomic- and nanometer-scales for insulators in
surface analysis for the first time. The materials under investigation include thin film
of organic or inorganic materials, ceramics, composites, polymer, metals synthetic
and biological membranes, and semiconductors. AFM is also used to investigate a
wide range of sample types at ambient conditions and even in liquids or any kind of
material in different gas phases. The fundamental principal of AFM is based on
creation of high resolution topological image by moving sharp tip at the end of a
cantilever on materials surface as illustrated in Figure 3.2. These measurements have
been performed on scales from hundreds of microns down to nanometers and a
maximum height on the order of 10-20 micrometers. The feature of AFM is providing
three dimensional surface profiles. When the tip scans the surface by moving up and
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down, the tip and the surface generate force which causes the cantilever to bend [93].
The deflection of the cantilever can be measured by optical lever including a laser
beam reflected from the back site of cantilever which records a position-sensitive
laser detector. The positional sensitive diode measures the changes of position of laser
beam. A feed back loop will establish always a constant bending by moving the tip up
and down accordingly.
Figure 3.2 : Schematic representation of general components of an AFM and their
function (a), the inset shows the close view of the tip-surface interaction. The tip-
effect (b) and the force-displacement curve (c) are also shown.
The atomic forces between probe and sample surface atoms following Hooke’s law
which states
xkF  (3.2)
k is the spring constant of the cantilever and x is the deflection referred to the
cantilevers equilibrium position. The atomic forces include at bottom mechanical
forces (for contact mode), Van der Waals forces and electrostatic forces. The area of
scanning can be up to 150*150 µm2 where every scanning point will deliver a
transferred image point. It is also possible to image single atoms. This functionality is
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inherent in AFM, which is based on detection of more universal tip-sample
mechanical forces. AFM uses a sharp tip (normally made from Si3N4 or Si) to
investigate the surface under characterization. The tip is located at the last part of
cantilever with a lower spring constant (~1 N.m−2). It transports physical contact with
the surface as shown in Figure 3.2. Nano sized tip is about 500 nm long and 100 nm
wide. The position of the cantilever is very important for example, when the
cantilever approaches the surface, weak attractive Van der Waals is forced between
the cantilever atoms and the surface. Also, the cantilever is pouched into the surface
repulsive forces obtained. Van der Waals force and repulsive forces displace or affect
the cantilever. They are used to measure surface properties and topography as
demonstrated in Figure 3.2.
3.2.1 Probe-sample interaction
This functionality is inherent to AFM. Image contrast obtained can be achieved in
many ways a tip on a cantilever, forming a probe. The three main kinds of interaction
are contact, tapping, and non-contact modes. Here, the non-contact mode is used for
topographically analysing micro-nanostructures of different pharmaceutical thin films.
Hence, the contact and non-contact modes are selectively discussed.
3.2.2 Contact Mode
In contact mode, when the cantilever is pushed into the materials surface, the tip and
sample remain in close contact as the scanning proceeds resulted in the repulsive
regime or repulsive force of the curve of the inter-molecular force recorded (see
Figure 3.2 b). In this mode, the tip never leaves the surface as shown in Figure 3.3
a), so this mode can be used for high resolution image. The maximum vertical force is
also controlled, so the compression of the sample can be limited. As the tip moves
over the surface, the lateral forces can be a problem in some situations, and can be
advantageous in others. The lateral deflection can give information about the friction
between the tip and the sample, and can show areas that may have the same height,
but different chemical properties. In contact mode, the set point value is the deflection
of the cantilever, so a lower value of the set point gives a lower imaging force.
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3.2.3 Non-contact Mode
This mode is suitable for samples with great differences in height and for damageable
samples like polymers and active pharmaceutical molecules because the probe is only
touching the surface slightly for a short time. In non-contact mode, the cantilever
must be oscillated above the surface of the sample at such a distance that it is no
longer in the repulsive regime of the curve of the inter-molecular force as
demonstrated in Figure 3.2b. Its resonance frequency is stimulated through an
external force. The resonance frequency can be calculated with the equation:
m
k

(3.3)
where m is the effective mass. As the probe and the sample are not touching each
other, mechanical forces do not act. Due to the distance, the attractive forces play a
major role. Depending on the change in the distance, the resonance frequency shifts.
This shift measures the interaction force like Van der Waals forces. Non-contact
mode may be used when AFM imaging is very difficult to operate in ambient
conditions. It can be used in organic materials to protect the surface from damaging
by contact mode. The non-contact mode is a dynamic mode since the cantilever is
oscillating at its resonance. The assembly can be seen in Figure 3.3b. The probe
consists of the cantilever with a small fine tip at the end which is scanning the sample
surface. A piezoelectric element moves the probe over the surface. Due to the
interacting forces between tip and surface, the cantilever is deflected. As mentioned
before, this deflection is measured with the help of a laser beam that is aimed on the
top side of the cantilever. When the cantilever is deflected, the laser beam is reflected
differently and is recorded in a photodiode.
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Figure 3.3: Sketch depicting contact mode (a) and noncontact mode (b) of the AFM.
3.3 Scanning electron microscopy (SEM)
3.3.1 Basic principle
Scanning electron microscopy (SEM) is one of the most popular tools used for the
thin films characterization. The SEM has many advantages if compared to traditional
optical microscopes. Since electrons are used instead of light which can produce a
higher resolution in the range of nanometers. The accelerated electrons exhibit much
shorter wavelengths than the visible light. Therefore, closely spaced specimens can be
magnified at much higher levels. Moreover, SEM has a large depth of field about 1
nm. This allows more of a specimen to be in focus at one time.
The SEM is used for imaging the surface of the materials (e.g., topographical
features) with the aid of signals resulting from the interface between the probe
electrons and the specimen. The strength of the SEM lies in its inherent versatility due
to the multiple signals generated, simple image formation process, wide magnification
range, and excellent depth of field. Here in this work, the SEM (Philips X L 30) is
used for thorough topological investigations of various micro nanostructures of
different pharmaceutical molecules. The characteristic of the deposited thin film is
also studied before the micro/ nano structured formations (see images in Chapter 5).
The topography analysis of deposited pharmaceutical organic molecules was done
after condensing the deposited material on different substrates by thermal
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evaporation. The fundamental principle of the SEM is to accelerate electrons to go
faster on sample or near surface and extract information about the later from
interactions with the electrons to get a topographical image. The magnification can
reach 1:1.000.000 with a high depth of field reaching 1 nm. The electron gun operates
typically over a range 0-30 keV that sometimes extends up to 60 keV depending upon
the type of instrument and application where the specimen is maintained at earth
potential.
3.3.2 Instrumentation
Figure 3.4a illustrates a representative diagram of an electron optical column for two
lenses of SEM how they are arranged.
Figure 3.4: Schematic diagram of a scanning electron microscope (a), and Ray paths
in SEM; standard arrangement for image formation (b) [94].
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The setup of the SEM including a source of electron used in vacuum which focused
into a fine probe that is scanned over the surface of the specimen. Vacuums are
needed to stop electrical discharge in the gun assembly (lightning), and to permit the
electrons to travel within the instrument without hindrance. As the electrons go on the
surface, a number of interactions occurring results in releasing electrons or photons
through the surface [308].
When a beam of electrons released from electron gun which passes through condenser
lens and is developed into a thin stream, the objective lens fixes the electron beam
onto the specimen. The objective lens contains a set of coils, which are energized with
changeable voltages. The coils generate an electromagnetic field that applies a force
on electron of electron beam into a sample by scanning it with a high-energy beam of
electrons. The electromagnetic field of the coils also causes a spot of light on a
cathode ray tube to shift at the same rate as the scanning electron beam. The
microscope is a probe forming system where each lens condenses and de-magnifies
the electron source to a focus spot at the specimen surface. The corresponding ray
diagram for a complete microscope is illustrated in Figure 3.4b. Apertures are
integrated at various positions to minimize divergence of the electron beam. To get
the smallest diameter electron probes incident on the specimen the final condenser
lens must have low aberrations. However, the resolution of the final image cannot be
less than the diameter of the scanning electron beam. Small electron beam is of high
resolution if the lens apertures are adjusted to an optimum size ≈150 μm diameter.
A large depth of focus is achieved for these instruments because the electron beam of
the aperture is focused on the specimen surface over a distance of typically ≈15 mm.
If the beam divergence is low (α≈ = 3.3x10−3 rad) this gives the depth focus of several
millimetres. It is the combination of the high resolution with the large depth of focus
which makes SEM suitable to examine topography of the materials such as thin film
of pharmaceutical agents.
Three types of electron guns are in general use today: tungsten (W) and lanthanum
hexaboride (LaB6) thermionic electron guns, and the field emission gun. Tungsten and
lanthanum hexaboride are used as filaments in thermionic electron guns, in which the
filament (cathode) is heated by applying a current. Production of electrons occurs at
high temperatures and requires the gun to be operated in a high vacuum to avoid
oxidation.
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The released electrons are accelerated to high energy by the submission of a negative
voltage to the cathode and a bias voltage to the grid cap with the anode grounded.
This triode system accelerates the electrons and provides an initial focusing into a
probe. Tungsten is popular for its low cost, ease of replacement, and high current
yield, while LaB6 (used here) provides a brighter source (higher current density)
useful for higher resolution. In the emission gun field, a fine tip is placed near a grid
and electrons escape the surface due to the high extracting field created by the first
grid. A second grid provides the accelerating voltage. Emission field requires ultra-
high vacuum. When a beam of electron is emitted from the source and strikes the
solid surface, it penetrates into the microstructure of the solid and interacts with its
atoms.
During this procedure, two different interaction phenomena can take place: elastic and
inelastic scattering. The electrons do not lose considerable energy during elastic
scattering. Instead, they get deflected at the nucleus; it only changes its direction.
Whereas the collision occurs between electrons of the atomic shell, it is accompanied
by an energy transferred due to equal masses of the colliding particles (inelastic
scattering). As a result of that, the incident electron does not only change its direction,
but it also slows down. These two processes operate side by side and simultaneously.
As a consequence of these different scattering events, an electron probe which
originally focuses on vacuum spreads over a greater volume after penetrating the solid
(see Figure 3.5). The shape and the size of this scattering quantity depend upon the
material as well as on the energy and angle of rate of the probe electrons. The most
accurate theoretical values for extension and shape of the scattering volume are
obtained with the aid of Monte Carlo calculations [95, 96] to study of manipulate
matters. The principal images produced in the SEM are of three types: secondary
electrons SE) images, backscattered electrons (BSE) images and elemental x ray
maps. The elemental x ray maps is discussed in the following part. Secondary and
backscattered electrons are conventionally separated according to their energies. The
i0 is a primary beam current, iBSE is the BSE current, iSE is the SE current, and the
sample current transmitted through the specimen to the ground iSC is defined as
(according to Kirchoff current law) [97].
iSCiSEiBSEio  (3.4)
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These signals can be used to form complementary images. As the beam current
increases, each current will also increase. The corresponding yields of the BSE η and 
SE δ, which refer to the number of BSE and SE emitted per incident electron,
respectively, are defined by:
0i
i BSE
 (3.5)
0i
i SE
 (3.6)
This shows how they are arranged. In the upper part of the SEM, the electron source
is located. It consists of a cathode, a Wehnelt cylinder and an anode. The electrons are
generated in the cathode, bundled by the Wehnelt cylinder and accelerated towards
the anode. Typical cathodes are thermionic emission guns or emission guns field. The
principle of a thermionic emitter is to heat a small wire made of tungsten or
lanthanum hexaboride (LaB6). The energy needed overcomes the binding potential so
electrons can be emitted. The emission field is based on the tunnelling effect. Strong
electric fields around a thin tip consists of tungsten lower the potential wall for the
electrons to be emitted. Although it is more expensive than thermionic emitters, it is
still used nowadays for achieving higher beam intensities and image quality. The lens
system contains two magnetic condenser lenses that bundle the electron beam, a
magnetic objective lens that focuses the beam onto the sample, a deflection unit to
scan the sample and apertures to avoid lens aberrations.
3.3.3 Interaction volume
As the electron beam reaches the sample, different reactions may occur as shown in
Figure 3.5 [98].
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Figure 3.5: Schematic diagram illustrating the volume of material that is probed by
an incident electron beam together with the volumes from which x-rays and
backscattered, Auger and secondary electrons emanates.
Figure 3.5 represents the kind of information that the SEM gets from the sample and
the depths that can be gathered from an electron beam-sample interaction and
resulting signals. In other words, the most commonly interactions resulted from the
electron beam with the specimen comprise secondary electrons (SE), backscattered
electrons (BSE) and x-rays. From the surface of the specimen, Auger electrons are
emitted. They are low energy electrons carrying atomic information. Secondary
electrons (SE) can be found at a deeper volume. These electrons are the means of
getting topographical images with SEM. Due to elastic scattering; the backscattered
electrons (BSE) have energies close to primary beam electron energies. These
electrons are used for the detection of contrast between areas of different chemical
compositions.
Samples with high atomic numbers give better resolution due to heavy atoms
backscattering electrons more strongly. Characteristic X-rays can be found at a larger
volume. They give chemical compositional information An Everhart-Thornley-
detector is used to collect the SE. They possess only low energies so they arise from
the near-surface depth providing topographical information. The detection of BSE
requires another detector because they are much more energetic than SE. The
intensities of the signals are dependent on the atomic number of the material. Thus
BSE provides information about the quantity materials in the sample and crystallinity.
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The underlying effects are called material and phase contrast. X-ray detection is used
to determine the element composition of the sample using a semiconductor detector.
They are called EDX or WDX detectors, depending on the energy or wavelength
dispersive x-rays. Generally, the x-ray intensities are characteristic for every material.
3.4 Energy Dispersive X-Ray Analysis
An Energy Dispersive X-ray Spectrometer (EDX) mounted in a scanning electron
microscope (SEM) (Philips X L30) was used to identify and find out the local content
of pharmaceutical thin films such Tetracaine-HCl co-deposited with silver which was
done by thermal evaporation as shown in Figure 3.6. The transfer of energy from the
primary electrons to the solid, i.e., the inelastic interaction, leads to various secondary
process such as secondary electron (SE) emission, x-ray emission, Auger electron
(AE) emission as shown in Figure 3.5.
Figure 3.6: EDX spectra of the as-synthesized Tetracaine-HCl with Ag which
confirms the presence of Cl, C, O, N as well as Ag.
A primary electron incident with sufficiently high energy originally removes an
electron from an internal shell, for instance the K shell, and takes away it from the
atom. As a result, the atom attains a higher energy state. When the atom returns to its
ground state, an electron from an outer shell (e.g. L shell) fills the vacancy in the K
shell. The energy released in this process leads to the either photon (x-ray) or another
electron (Auger electron, e.g. from the L shell). The vacancy now left in the L shell is
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filled with a further transition of an electron from an outer shell, with the associated
emission of another x-ray or AE. This process will be repeated in a similar sequence
until the final return of the atom to its neutral ground state.
3.5 Raman Spectroscopy (RS)
Raman spectroscopy is a spectroscopic technique depending on inelastic scattering of
monochromatic light, typically from a laser source. Through inelastic scattering, the
frequency of photons in monochromatic light changes when it interacts with the
specimen.
Figure 3.7 showing the Raman system naturally contains four key components:
 Excitation source (Laser).
 Sample illumination system and light collection optics.
 Wavelength selector (Filter or Spectrophotometer).
 Detector (Photodiode array, CCD or PMT).
Figure 3.7: Schematic of the sample, incident light and collection optics in The
Raman spectrometer where illumination and collection are performed through
microscope objective.
RS is an essential fingerprint identification tool that distinguishes the chemical bonds
and function groups of materials. Raman could be employed in evaluation qualitative
and quantitative of chemical, biological, archaeological, semi conducting, polymeric
and solid state physics. In our research, RS is used particularly for the examination of
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the chemical composition of pharmaceutical samples after deposition, where
characteristic peaks of deposited compounds on various substrates are clearly
observed. Raman spectroscopy is also used to study the environmental of molecular
vibration and rotation which is mainly important in structure identification and
molecular dynamics.
When the sample absorbs photons of the laser light and reemits frequency of the
photons moving up or down in comparison with original monochromatic frequency
which is called the Raman Effect. RS also identifies the polarizability change of a
molecule. The Raman Effect is related to molecular deformations in electric field (E)
which distinguished by molecular polarizability α. The laser beam can be considered
as an oscillating electromagnetic wave with electrical vector E. Upon interaction with
the sample, it induces electric dipole moment P = αE which deforms molecules.
Because of periodical deformation, molecules start vibrating with characteristic
frequency m. a nuclear displacement is considered amplitude of vibration. Energy
levels and transitions are connected to the Raman result: Laser- formed,
monochromatic light of ultra- violet, visible, or infrared frequency used as the
excitation source. In predictable Raman spectroscopy, visible lasers are used (e.g.,
Ar+, Kr+, Nd: YAG, He-Ne, diode) to motivate the molecules to high-energy
"virtual" states of excitation. The Raman consequence takes place when light is
focused on a molecule and it interacts with the electron cloud and the bonds of that
molecule. The impulsive Raman Effect is a form of light scattering in which a photon
excites the molecule from the ground state to a virtual energy state. When the
molecule slows down, it emits a photon and it returns to a diverse rotational or
vibrational state.
The difference in energy between the original state and this new state directs to a shift
in the emitted photon's frequency away from the excitation wavelength. In other
words, the underlying principle is a depolarisation of the incident monochromatic
laser beam through molecular oscillations. The incident light waves interact with the
electron clouds of the molecules and their bonds. In case of this study, only matter in
solid state is taken into account, so molecular rotations can be ignored. The laser light
is directed towards the sample where more than 90% is transmitted. A small amount
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is elastically scattered and an even smaller amount is inelastically scattered at the
molecules. The elastic scattering process is referred to the Rayleigh-scattering.
As one can see from Figure 3.8, the energy state or the frequency of the molecules
will not change. The inelastic scattering process is referred to the Raman-scattering.
All molecules perform certain oscillations in their initial state. Due to inelastic
scattered photons, the molecules gain or lose some energy which will change the
initial state to a virtually intermediate energy state. As the molecule relaxes, it falls
down to a different exciting energy state whereupon a photon is emitted.
A change in frequency occurs. If the molecules gain some energy by reaching a
higher energy level than the initial one, the frequency and energy of the scattered
photons will be lower than 0 -m. This process is called Stokes-scattering. However,
Anti-stokes-scattering resulted from the higher frequency than 0 +m as well as the
higher energy of the scattered photons. It is only possible if the molecule resides in a
higher energy state before the collision with the photon taking place. The contributing
factor is the energy difference between incident and scattered photon which is called
Raman frequency shift. It is representative for every molecule. The energies of the
photon for the different processes mentioned above can be clarified by the following
equations. The energy EI of the initial photon is:
0vhE I  (3.7)
The energy of the photon after Rayleigh-scattering is:
0vhEI  (3.8)
From this, the energy difference before and after striking is zero. The energy ESR of
the photon after Stokes-Raman-scattering is:
RSR vhvhE  0 (3.9)
This leads to an energy difference bigger than zero. The energy EASR of the photon
after Anti-Stokes-Raman scattering is:
RASR vhvhE  0 (3.10)
It leads to an energy difference smaller than zero. In Rayleigh scattering including
three steps, the molecule excites any virtual state then the molecule relaxes back to its
original state. Finally, the photon is scattered elastically leaving with its original
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energy. In Stokes scattering, the molecule excites any virtual state. After that, the
molecule relaxes back to a higher vibrational state than it did originally. The photon
leaves with energy hν-ΔE and has been scattered inelastically.  
In scattering Anti-Stokes including 4 steps, the molecule starts in a vibrationally
exciting state. Then, the molecule is exciting in any virtual state. After that, the
molecule relaxes back to a lower vibrational state. In the end, the photon loses energy
hν+ΔE, and scatters elastically. Surface enhancing Raman usually occurs when a 
silver or gold colloid is used because Surface plasmons of silver and gold are
animated by the laser resulting in amplifying the electric fields surrounding the metal.
Particularly, Raman intensities are proportional to the electric field. So, the measured
signal increases.
Figure 3.8: Three types of scattering by a molecule are excited by a photon with
energy E = hν. The most common transition is marked with bold arrows. 
3.6 X-Ray Diffraction (XRD)
The X-ray diffractometer from RICH SEIFERT & Co GmbH (XRD 3000TT) was
used to investigate the nature of the deposited organic molecules which have been
done by thermal evaporation. XRD is a non-destructive technique that describes the
diffraction of monochromatic x-rays at a crystalline matter and can be used to define
crystallographic orientations, symmetries, crystal structures, lattice parameters,
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stresses and strains. Furthermore, XRD exposes information about the
crystallographic arrangement, chemical composition, and physical properties of
materials and thin films. It is also used to determine the size, shape inside stress of
small crystalline regions, thickness of thin films and multi-layers structures. So, the
crystal appears as a three-dimensional diffraction pattern for the incoming x-rays
which are diffracted at the electron shells of the sample atoms. So, both constructive
and destructive interference can occur. Destructive interference means that the optical
path difference of incoming waves and diffracted waves are different which do not
show an optical path difference. This phenomenon does only occur under specific
conditions which are described by Bragg’s law [99]:
n λ =2dsinθ                                                                       (3.11) 
N is a natural number that defines the order of the interference maximum starting
from the middle, λ is the wavelength of the incoming x-rays, d is  interplanar distance 
and θ is the angle toward the lattice plane as shown in Figure 3.9. Only if this law is
fulfilled, constructive interferences occur in case of cubic crystals.
From that a diffraction pattern arises showing the constructive interferences as peaks
which are directly related to the atomic distances. There are two main effects of x-
rays, the Bremsstrahlung and the characteristic x-rays. X-rays have energy ranging
from 120 eV to 120 KeV which is created whenever high-speed electrons have a
collision with a metal objective. A source of electrons includes hot W filament, a high
accelerating voltage between the cathode (W), the anode and the metal target like Cu,
Al, Mo and Mg. To produce x-rays, electrons have to be accelerated from a coiled
filament as cathode to an anode in an x-ray tube. At the anode, they are strongly
decelerated whereby Bremsstrahlung is generated. Deceleration means that electrons
give off their kinetic energy in terms of radiation. In addition, some electrons hit inner
shell electrons of the anode material atoms which are knocked out.
The holes are filled again with other electrons from higher shells. Because these ones
have higher energy than the inner shell electrons they have to give off the difference
as radiation. They are called characteristic X-rays because the energy differences are
specific elements. For the production of Bremsstrahlung, one can use synchrotron
radiation. Electrons are accelerated in an acceleration ring where they are deflected
from their direction of movement through magnetic coils. Concerning acceleration
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movements, deflection is a particular form of deceleration whereby Bremsstrahlung
also occurs.
Figure 3.9: The sketch shows the schematic diagram of the setup for XRD and
Schematic of incoming x-rays diffracted at lattice planes under a specific angle
fulfilling Bragg’s law.
In order to detect the diffracted x-rays, a counting tube, scintillation counter, or
photographic films can be used as demonstrated in Figure 3.9. The mean grain size of
the deposited film is calculated by using the Scherrer equation [100].


cos2/1
BL  (3.12)
B is a constant equal to 0.9, λ is the wavelength of the radiation used, η1/2 is the full
width at half maximum intensity and θ is the Bragg angle corresponding to the peak 
considered. Crystalline parameters can be calculated from Scherrer equation. The
grain size will decrease and the substrate temperature will be elevated. This is because
an increasing substrate temperature causes surface energy to become higher and
consequently make crystalline quality to become aggravated.
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3.7 Profilometer
A profilometer is a measurement device which scans the surface of a sample to gauge
its film thickness, Dektak 8000 profilometer (Veeco) was used for film thickness
measurements and calibration of monitored thickness as shown in Figure 3.10a.
Profilometer is a mechanical sensing system which measures also the roughness by
the mechanical moment of a diamond stylus over the sample of interest as indicated in
Figure 3.10b. In profilometer, the sharply pointed stylus has moves laterally across
the sample in a specified distance and specified contact force where a direct contact to
the surface and follows the height variations as the sample is moved. The height
variations are converted into electrical signals, producing a profile. The resulting trace
represents a cross-sectional view with height vertical resolution. The stylus force
typically spans from 0.1 to 50 mg, enabling step heights from 0.5 nm to 800 μm. The
radius of the stylus is 12.5 microns, and the horizontal resolution is controlled by the
scan speed and scan length. There is a horizontal broadening factor which is a
function of the radius of the stylus and of step height. This broadening factor is added
to the horizontal dimensions of the steps. Moreover, the technique does not require a
special sample preparation and almost any sample that will not be deformed by the
stylus can be measured very rapidly. In these experiments, the steps used for thickness
measurement were made by a thin narrow width mask before the film deposition
process. Additional scratching of the films after the deposition process was also used
as a method of conformation but not as a main method to determine the thickness of
the film. The instrument can measure small surface variations in vertical stylus
displacement as a function of position. The system provides a maximum of 65, 400
data points per scan for high horizontal resolution and excellent baseline stability for
superior measurement repeatability. However, the accuracy of stylus measurements is
affected by substrate roughness which gives excessive noise into the measurement
and the vibration of the equipment.
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Figure 3.10: The sketch shows Dektak 8000 profilometer (Veeco) (a), and diamond
tip scanning over the surface of the sample (b).
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Chapter 4
4 Experimental part
4.1 Introduction
As mentioned before various chemical and physical methods can be used for the
preparation of smaller drug particles. All these techniques have some limitations like
utilization of toxic solvents, higher investment, consuming the time, extensive efforts
and sometimes degradation the drug particles by mechanical stress. Indeed, thermal
evaporation in vacuum has been investigated as an alternative and attractive technique
to prepare and engineering the micro- and nano structures from organic molecules for
microtechnologies, it provides an alternative approach for controlling particle size and
crystal morphology. Hence, thermal evaporation method might be employed for
promising drugs that would otherwise be abandoned due to aqueous insolubility.
This chapter introduces the experimental procedure and setup for the deposition
experiments of active and non active ingredients by vacuum evaporation. This section
also deals with deposition parameters, biological screening methods and the setup for
current voltage measurements.
4. 2 Evaporation chamber
The experiments were carried out in a vacuum chamber that was constructed by the
Institute for Materials Science at CAU Kiel and modified in the framework of this
thesis. The evaporation chamber was basically designed to evaporate pharmaceutical
active molecules, inactive ingredients, polymers and metals. It allows to evaporate
two different materials simultaneously on various substrates at room temperature,
liquid nitrogen or various other temperatures as shown in Figure 4.1. The setup for
vacuum deposition consists beside the two evaporators of the vacuum chamber,
vacuum pumps, a pressure gauge, an observation window, substrate holder, crucible
with supply connections, and shutter inside of the chamber. The shutter is placed
between source and substrate and is used to control pausing or continuing the
evaporation process. The sample holder is designed as spherical plate or rotatable to
hold or fix the substrates which are typically made from metal. During deposition, the
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distance between the sources and the substrate has been adjusted to the range of
several decimetres. The evaporator itself is surrounded by a heating filament that is
connected by an electrical power to heat the evaporator. In this case a lower-current
filament is used with maximum current of 3 A. Thin film deposition involves a
material undergoing a phase transition from a vapour phase, which is subsequently
condensed onto a solid substrate [101].
Figure 4.1: Schematic showing the deposition chamber used for thin film
preparation: photo (a) and inner part of evaporation chamber (b).
Figure 4.2: Photographs of the evaporator. In the middle the fitting for the crucible is
situated. The crucible itself is shown in (b) and (c) with its dimensions tagged.
The centre is constructed in a way that allows the crucible with the dimensions to be
launched into it. In this work, graphite, alumina and metal crucibles are used to
guarantee ideal conditions for the evaporation for each individual material and the
thin film deposition as illustrated in Figure 4.2. The higher vacuum is important for
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this work to get the required mean free path. Vacuum should be at least 10-5 mbar
range but in an optimal way it reaches 10-7 mbar. In order to reach a good vacuum, a
standard setup of a pre-pump and a turbo molecular pump were used. The pre-pump
creates the pre-vacuum of about 10-1 mbar while the turbo molecular pump provides
the high-vacuum. The pre-pump was a scroll vacuum pump equipped with a set of
active carbon filters in order to remove the high load of pharmaceuticals from the
exhaust gas. To produce organic micro- nanostructure in various different shapes, two
different materials can be evaporated from the two separate sources simultaneously,
allowing a mixing on the molecular scale on the substrate. The observation window
allows rotating and mounting the sample holder perpendicular to the evaporated
materials.
4.3 Evaporation of Materials
4.3.1 Evaporation of active selected pharmaceutical molecules
Various active pharmaceutical ingredients and excipients were selected for this study,
see table 4.1. The large variety is necessary, as the evaporation of pharmaceuticals is
carried out here for the first time. All substances are commercially available materials
that are already in the marked, most of them were provided by the collaboration
partner in the department of Pharmaceutical Technology and Biopharmacy at the
Christian-Albrechts-Universität zu Kiel.
The standard evaporation procedure contains the following steps: In advance, the
crucible is cleaned several times with isopropanol and acetone to remove residues.
After that the sample holder has to be prepared. Different substrates such as titanium,
silicon and steel are used in this study because of their potential applications. Silicon
and glass have to cut into pieces with dimensions of about 2x2 cm2. The samples and
the sample holder also have to be cleaned with isopropanol then acetone. The amount
of the material to be evaporated is typically between 0.05 g and 0.2 g, depending on
the nature of the individual materials and their applications, but a minimum filling
height of about half of the crucible is valid for all materials to make sure that enough
material is evaporated so that thin film growth can be achieved. Finally, the crucible is
mounted in the evaporator.
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To mount the samples to the sample holder, special vacuum stable double bonded
carbon tape is used. For the calibration of the deposited film thickness, a step edge in
the deposited film was affected by covering parts of the samples with aluminium foil
as illustrated in Figure 4.3. This is important for subsequent thickness measurements
or thin film property analyses. After the sample holder is mounted in the chamber, it
can be closed to draw the vacuum. For appropriate heating of the evaporator, the
current through the heating-filament is raised to a value between 1.3 A and 1.7 A
which lead to moderate temperatures in order to avoid or reduce damages in the
chemical structure of the evaporated molecules. This depends individually on the
melting point of each material. A thin layer of active pharmaceutical drugs on the
surface of the substrate by vacuum evaporation is produced by heating materials to a
temperature t (°C) satisfying formula: T1≤ t ≤T2 where T1 is a melting point (°C). T2 is
a boiling point (°C) of the film-forming material. In a sequence of experiments, the
optimum current was determined for each material. During the evaporation process a
steep increase in pressure can be observed after the melting temperature is reached.
This is due to the evaporated particles that migrate from the evaporation source to the
sample holder. In order not to overshoot with the temperature the current is increased
at the point of pressure increase. To maintain the temperature constant for a certain
time, to make sure that all material in the crucible is evaporated, the current is kept
changeless. After a certain period the current is switched off. The chamber should
stay closed for some hours to avoid contamination with gas molecules that may
diffuse from the chamber to the environment. Crucible materials should be chosen to
avoid residual contaminants which are harmful to deposited film.
For the standard procedure, the ovens were heated stepwise over several minutes
towards the desired evaporation temperature. After having reached the deposition
temperature, shutters were opened allowing the deposition for a chosen time, followed
by closing the shutter and reducing the temperature. For co-deposition, two ovens
were mounted with an angle of 135° with respect to the sample holder that both ovens
have an angle of 90° with respect to each other. Each vacuum oven is equipped with a
mechanical shutter that permits blocking of the evaporated molecular flux. For
simultaneous organic/inorganic evaporation experiments, metals were evaporated at
temperatures much higher temperatures than the molecules, depending on their
melting point even above 1000 °C.
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Test Material;
Indication and
potential use of
solvent free
nanostructuring by
TE
Melting
point at
atmosphere
(typical
evaporation
temperature
range) [°C]}
Chemical Structure of tested materials
1.Chloramphenicol;
Antibiotic, Increased
solubility
150 (~ 90-
118)
2. Erythromycin
(base); Antibiotic,
Increased oral
bioavailability
190–193 (~
100-137)
3. Metronidazole;
Antibiotic, Dental
implant coating
159–163
(~100-194)
4.Propyl-p-
hydroxybenzoate
(Nipasol);
Preservative, pre-
preserved container
95 - 98 (~ 85-
165)
5. Neomycin
sulphate; Antibiotic,
Surface coating of
wound
dressings/implants
250 - 260 (~
160-300)
6. Novobiocin
sodium salt;
Antibiotic, Surface
coating of wound
dressings/implants
215-220 (~
150- 250)
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7. Tetracycline
hydrate; Antibiotic,
Device coating
170-175 (~
100-223)
8. Tetracycline
HCl; Antibiotic,
Device coating
220-223 (~
119-255)
9.VancomycinHCl;
Antibiotic, Increased
oral bioavailability
185 (~ 100-
197)
10.Clotrimazole;
Antimycotic,
Improved nail
coating
147–149
(~89-164)
11.Itraconazole;
Antimycotic,
Increased oral
bioavailability
166,2 (~100-
232)
12.Ketoconazole;
Antimycotic,
increased solubility
146 (~88-
226)
13. Pindolol; Beta
blocker, Contact lens
coating
167–171
(~110-215)
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14. Pilocarpine
HCl; Parasympatho-
mimetic, Contact
lens coating
200 -203
(~117-250)
15. Cholesterol;
Excipient,
Biocompatible
protection layer
148–150
(~90-165)
16. PLGA;
Excipient,
Controlled release
layer
224 - 226 (~
150-300)
17. 5-Fluorouracil;
Antimetabolite
(Anticancer)
283 (~115-
250)
18. Sulfathiazole;
Oral and topical
antibiotic
200–203 (~
110-250)
19. Acetylsalicylic
acid (ASA); Non
steroidal anti-
inflammatory drug
135 (~90-
140)
20. Paracetamol;
Non steroidal anti-
inflammatory drug
168 (~ 97-
130)
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21. Diclofenac
sodium; Non
steroidal anti-
inflammatory drug
284 (~135-
270)
22. Ascorbic acid
Antioxidant
190-192
(~123-200)
23. Tetracaine HCl;
Local anaesthetic
149 (~114-
220)
24. Trimethoprim;
Antibiotic
199–203
(~100-170)
25.Tombramycin;
Antibiotic for
surface coating of
implants
168-178 (~
153-260)
26. Indometacin;
Non steroidal anti-
inflammatory drug
155 (~150-
190)
27. Polyglycolic
acid; Biodegradable
polymer, Control
drug release
225-230
(~160-200)
28. Adipic acid;
Excipient
152.1(~ 119)
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29. Caffeine;
Psychoactive
stimulant drug
227–228
(~120-250)
30.Sphingomyelin
(SM);
Excipient,
phospholipide for
liposomes
215
(~ 186–233)
31. Lactose
Excipient
223
32. Polyethylene
glycol; Excipient
49-53
33. Chlorhexidine;
Antiseptic
134–136
34. Triclosan;
Antibacterial and
antifungal agent
56–58
Table 4.1: Overview of thermally evaporated different drug substances. First part (1-
12) lists the materials which have been successfully nanostructured by thermal
evaporation and have been tested with disk diffusion method. The second part (13-30)
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lists the successfully deposited materials. However, the biological tests are under
progress. The last part (31-34) lists the pharmaceutical substances which are not
suitable for thermal evaporation as they are decomposed during deposition.
Figure 4.3: Illustrated the optical image of titanium substrate before deposition (a)
and the growth of thin film by vapour deposition on titanium plate (b).
The film thicknesses of the evaporated materials is based on the substrate, geometry
of chamber, distance between the source and substrate and experimental condition.
Titanium, steel and silicon show high melting points (above 1400 0C) which make
them ideal substrates for vacuum deposition due to their inertness. An advantage
compared to glass is their conductivity which is beneficial for investigations in
electron microscopes. Co-deposition of metals and active pharmaceutical molecules
metals, typically gold and silver with 99.99% purity from "Goodfellow industry" are
evaporated in a high vacuum chamber from an integral crucible-heater assembly. The
internal representation design of the metal evaporator is illustrated in Figure 2.2 (see
chapter 2). Co-deposition permits the creation of a composite. This technique allows
to fabricate metallic nanoclusters dispersed in a drug matrix by co-evaporation of one
or more metals with drug from separate sources. In this case, a single metal is
evaporated simultaneously with drugs in a controlled rate of deposition from two
different sources.
Evaporation of metal and pharmaceutical materials at incident angles adjusted near
the centre of the substrate surface to achieve a metal concentration gradient in the
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composite film. This gradient films allow to examine, e.g., biological properties of the
nanocomposites within a large range of metal concentrations prepared in one
evaporation step under the same conditions. Moreover, these composite films were
deposited on different substrates (Silicon wafer, titanium, Glass and polymer foil).
4.3.2 Evaporation of polymer
The same evaporator design (see Figure 4.1) that was used for the evaporation of the
organic molecules was used to evaporate polymers as well. After the fabrication of the
drug thin film, a second layer from polymer can be beneficial to protect the
pharmaceutical molecules from degradation and controlling the drug release. In this
study, PLGA is used as drug carrier which is a biocompatible material. The crucible is
filled with PLGA powder or granulates. After applying a longer time or higher current
than used for the organic molecules, maximum 2 A, the cell is heated up, the polymer
melts and decomposes in molecular fragments like monomers which subsequently
evaporate. Compared with the metal evaporator, this will give a high deposition rate,
similar to the organic molecules. At enough rate of evaporation, molecular fragments
reach the substrate and re-polymerization can occurs. Because of the high molecular
of the polymer materials, the polymer thin films are traditionally prepared by
chemical methods like solvent casting method or spin coating. However, this is not
compatible with the vacuum process for coating the drugs and controlling release.
Therefore vacuum deposition is used here even though it can be expected that a much
lower molecular weight will be achieved compared to the traditional methods.
4.4 Biological screening of vacuum deposited pharmaceutical
molecules
This biological screening of this research project has been conducted at department of
Pharmaceutics and Biopharmaceutics, CAU Kiel. The efficacy of the preservatives,
antibiotics and antimycotics vacuum-deposited on round titan plates (Ø 0.1 cm,
thickness 0.04 cm) were examined by means of the agar diffusion test.
4.4.1 Sample preparation and antimicrobial test
The test organisms Staphylococcus aureus ATCC 6538 and Candida albicans ATCC
10231 were purchased from the German Collection of Microorganisms and Cell
Cultures (Braunschweig, Germany). Muller Hinton Agar Medium, Sodium Chloride
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Peptone Broth, buffered (SCPB), Tryptic Soy Broth and Tryptic Soy Agar Medium
were delivered as dehydrated powders by Merck (Darmstadt, Germany). The test
media were rehydrated with demineralised water and sterilized according to
instructions by the supplier. For Candida albicans the Muller Hinton Agar was
supplemented by 2 % glucose monohydrate prior to sterilization.
After sterilization and cooling down to about 50 °C, the agar medium was poured into
Petri dishes (Ø 9 cm) in aliquots of 10 ml. The coagulating medium titan plates
covered with vacuum deposited antimicrobial substances were placed on their sides in
an upright position. Each titanium plate was deposed in the middle of the agar layer of
a Petri dish. Test suspensions of Staphylococcus aureus and of Candida albicans were
prepared from overnight cultures at 34 °C by floating the cultures using sterile sodium
chloride peptone buffer. The cell concentrations in the resulting suspensions were
assessed by means of spectrophotometer and the suspensions were diluted in order to
adjust microbial numbers of 5 x 105 cfu/ml. 0.1 ml-aliquots of the suspensions were
used to inoculate 5 ml-portions of sterilized and cooled down agar medium to achieve
test concentrations of about 104 colony forming units per ml. Immediately after
inoculation and mixing, these portions of the fluid agar medium were poured into the
test dishes in order to get homogenous layers around the titan plates. Then the agar
was allowed to gelate.
Control plates were prepared using paper discs (Ø 0.6 cm) which were impregnated
with 20 µl of diluents containing the required test substance. In the case of poor water
solubility, dimethylsulfoxide was used and hydrophilic substances were dissolved in
sterile demineralised water. As final concentration per paper disc, 30 µg of the
respective substance were chosen. The discs were placed on the surfaces of inoculated
agar medium plates after their gelation. The test Petri dishes were incubated at 35 °C
for 20 hours and then the extents of the inhibition areas were measured.
4.5 Current-Voltage (FET) Response
The field of electrically conductive organic substances got significantly broadened in
recent years broad. It is applied in, for example, cell phone displays. But little is done
with pharmaceutical molecules in this respect which in principle offer many
opportunities. Visionary medical applications might utilize the deposited conductive
pharmaceutical materials in a multifunctional manner, e.g. for treating cancer by
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electrical induced hypothermia or controlling the amount of pharmaceuticals by
measuring the electrical resistance through the organic thin film. Therefore,
measurements of the current-voltage (I-V) and field effect transistor (FET) response
of selected nanostructured pharmaceutical drugs which were fabricated directly on a
microchip with gold contacts were carried out. Electrical characterization was done
using a Keithley 6485 pico-amperemeter (optimised for measuring small signals) to
measure current voltage curves at different gate voltages. The source and drain
contacts were fabricated by deposition through a shadow mask and the gate contact
was realised in the substrate consisting of a p++-doped silicon wafer covered with a
100 nm thick gate oxide.
Figure 4.4: This is a photo of the microchip holder device which was used to measure
the electrical properties of various pharmaceutical molecules. The inset (top left)
shows the microchip consists of horizontal organic molecules at each of the contact
junctions, and the number refers to the contact points.
4.6 Analysis by Optical, Atomic Force, Scanning Electron and Raman
Microscopies
Bright field optical micrograph images of deposited drugs on different substrates were
taken by Zeiss optical microscope equipped with a Leica DFC 280 digital camera
system at different magnifications. Atomic force microscopy (AFM) images were
recorded with Thermo Microscope-Veeco autoprobe AFM equipped with an optical
unit and electronic module in contact and non contact mode. Standard silicon nitride
tips mounted on cantilevers were used. Philips-FEI XL30 SEM equipped with an
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EDAX EDX detector was used to analyse the structural geometry of nano- or micro-
scale deposited drugs. In order to avoid the structural damage in the structures and the
charging, acceleration voltages were kept as small as possible down to 2 kV and
reduced currents were also applied. In order to get the actual morphologies of thermal
evaporated pharmaceuticals, no further coating (of carbon or gold thin film) was
performed on deposited drugs. This was the reason that the SEM images with higher
magnification appear less focused. Raman spectra of raw drugs as well as thermally
evaporated layers on different substrates were recorded to ensure the identity of
substance using a Senterra Raman Microscope (Bruker Optik GmbH, Bremen,
Germany) with OPUS software (Bruker). For the raw material, the sample was
prepared on a sample holder or on a mirror plate to obtain a flat sample surface for
measurement. The sample was mounted under the objective and the sample surface
was brought in focus using the light microscopic image. For all measurements, a 20x
magnification is identified as suitable and in combination with a slit aperture of 50 x
1000 µm ensures collection of the highest possible Raman intensity. Collection of the
Raman spectra has been performed in the dark field with 535 nm (green light) laser
excitation (50 mW) at a resolution of 3-5 cm-1 resulting in a full spectrum from 80 –
3500 cm-1 with 10 seconds integration time and 2 co-additions. The Raman shift was
calibrated automatically using the SURECAL option of the instrument. For analysis,
the Raman band positions in the fingerprint region of the vacuum deposited drugs
were compared with respect to the Raman spectrum of the raw material.
Due to interference colours, a visible inspection of the substrate is sufficient to decide
if a thin film is deposited on the substrates or not. To get a more detailed overview of
the surface the light microscope is used. It uses an ocular with a magnification of
10 x, as the objective lenses have magnifications between 20 x and 50 x. With this
microscope both bright field and dark field can be imaged. In bright field modus the
light is transmitted through the sample from below and can be seen above. Thicker
parts appear dark in the image. In dark field modus, the un-scattered beam is excluded
from the image thus these parts of the sample appear dark. This feature may help to
sharpen the contrast for various images. For further physical property investigations
like thin film adhesion, thickness or general structural appearance of the sample SEM,
AFM or profilometry can be applied. In certain cases, it is necessary to know the film
thickness because in the field of drug therapy it exerts influences on the dosage of the
medicament as well as on the release time. Film thicknesses measured for this thesis
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differed between some hundred nanometres to about 35 µm for all materials used.
Uniformly covered samples are also preferable. Leakages in the coating of a drug, for
example, can bear unacceptable risks because release of the drug can proceed
everywhere in the body without control. This in turn can have impact on the effect of
the drug. The SEM used for this thesis is provided by the company Hitachi and is
called “S-800”. It uses the principle of thermionic emission with a LaB6-filament as
described in chapter 4. The acceleration voltage of the electrons is 5 kV. For AFM
operation the non-contact mode was used because it diminishes the damage of both
probe and sample. The investigations were carried out in air. Concerning chemical
properties, Raman-spectroscopy or XRD can be considered. Raman spectra are
obtained from the raw material and the vacuum deposited layer on different carrier
materials to ensure substance identity utilising a Senterra Raman Microscope (Bruker
Optik GmbH, Bremen, Germany) with OPUS software (Bruker, Version ). For the
raw material, the sample is prepared on a sample holder or on a mirror plate to obtain
a flat sample surface for measurement. The sample is mounted under the objective
and the sample surface is brought in focus using the light microscopic image. For all
measurements, a 20x magnification is identified as suitable and in combination with a
slit aperture of 50 x 1000 µm2 ensuring collection of the highest possible Raman
intensity. Collection of the Raman spectra is performed in the dark field with 785 nm
laser excitation (50 mW) at a resolution of 3-5 cm-1 resulting in full spectra from 80 –
3500 cm-1 with 10 seconds integration time and 2 co-additions. The Raman shift is
calibrated automatically using the SURECAL option of the instrument. For analysis,
the band positions in the fingerprint region of the vacuum deposited substance are
compared to the spectrum of the raw material. The substance identity after vacuum
deposition is verified by Raman spectroscopy for a range of substances. It appears that
the substances are deposited without degradation on various carrier materials, whereas
for some parameters, the resulting substance layer spectrum does not match the raw
material indicating some changes during deposition.
Chemical compositions are important to be examined because a change in particular
bonds may change the pharmaceuticals and their specific desired features. For
biomedical applications, it is indispensable to know that changes occur during
deposition because the biodegradability or biocompatibility can be influenced by that.
As Raman-spectroscope Alpha A500 made by the company WiTec is used. X-ray
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diffraction (XRD) is used here to differentiate between crystalline and amorphous
state of the deposited material.
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Chapter 5
Results and Discussions
This chapter discusses the most important results obtained from the experiments that are
performed for the deposition of pharmaceutical molecules by thermal evaporation. For
simplicity, the following subsections discuss different properties including the
morphological and structural characterization corresponding to each individually
deposited drug. The morphological and structural investigations of deposited micro-
nanostructured material are also described by optical microscopy, atomic force
microscopy and scanning electron microscopy techniques. The crystalline nature and
chemical structures of the deposited organic molecules were confirmed by Raman
spectroscopy and XRD techniques respectively. Successful fabrication of single, hybrid
and multilayers from pharmaceutical drugs has been shown. The growth kinetics is also
discussed.
This chapter also provides the overview of different pharmaceutical drugs structured on
the micro scale by shadow mask lithography in a controlled manner. Preliminary results
for multifunctional applications of these fabricated solvent-free pharmaceutical drugs are
also presented. The data in this study also extend and confirm the present findings that
reducing the particles size of poorly soluble pharmaceutical compounds may increase
their efficiency. As a result, this procedure could be used to treat the side effects of the
free drugs.
Here, Table 5.1 provides the overview of all the different thermally evaporated
pharmaceutical substances. The first part includes the materials (1-30) which have been
successfully nanostructured by thermal evaporation. The last part (31-34) lists the
pharmaceutical substances which are not suitable for thermal evaporation as they are
decomposed during deposition.
This thesis introduces the main results of the first 21compounds (see table 5.1) which
have been characterized by Optical microscopy, SEM, AFM and Raman spectroscopy. In
the other hand, compounds (22-30) have been tested by disc diffusion method.
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Test Material; Indication
and potential use of solvent
free nanostructuring by TE
Melting point at
atmosphere (typical
evaporation
temperature range)
[°C]
Deposition remarks
and characterization tools
1.Parabens (Nipasol,
Nipagin); Preservative, pre-
preserved container
95 - 98 (~ 85-165) Crystalline deposits
Optical microscopy
Raman spectra, SEM,
AFM, diffusion test
2. Pilocarpine HCl;
Parasympatho-mimetic,
Contact lens coating
200 -203 (~117-250) Crystalline deposits /
Optical microscope,
Raman Spectra, SEM,
3. Pindolol; Beta blocker,
Contact lens coating
167–171 (~110-215) Crystalline deposits /
Raman Spectra, Optical
microscopy
, AFM
4. 5-Fluorouracil;
Antimetabolite (Anticancer)
283 (~115-250) Crystalline deposits
Optical microscopy
Raman Spectra , AFM
5. Chloramphenicol;
Antibiotic, Increased
solubility
150 (~ 90-118) Amorphous and crystalline
deposits; Raman spectra,
Optical microscopy and
diffusion test
6. Tetracaine HCl; Local
anaesthetic
149 (~114-220) Crystalline deposits
SEM, AFM, Raman
spectra, EDX
7. Acetylsalicylic acid
(ASA); Non steroidal anti-
inflammatory drug
135 (~90-140) Crystalline deposits
Raman spectra
AFM
8. Metronidazole;
Antibiotic, Dental implant
coating
159–163 (~100-194) Crystalline deposits;
Raman spectra, SEM, AFM
and diffusion test
9.Clotrimazole;
Antimycotic, Improved nail
coating
147–149 (~89-164) Crystalline deposits;
Raman spectra. AFM,
diffusion test
10. Trimethoprim;
Antibiotic
199–203 (~100-170) Amorphous and crystalline
deposits
11. Sulfathiazole; Oral and
topical antibiotic
200–203 (~ 110-250) Crystalline deposits
AFM, Raman spectra and
diffusion test
12. Tetracycline HCl;
Antibiotic, Device coating
220-223 (~ 119-255) Crystalline deposits
AFM, diffusion test
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13. Erythromycin (base);
Antibiotic, Increased oral
bioavailability
190–193 (~ 100-137) Amorphous and crystalline
deposits; Raman spectra
and diffusion test
14.Tombramycin;
Antibiotic, surface coating
of implants
168-178 (~ 153-260) Amorphous and crystalline
deposits; Raman spectra
AFM and diffusion Test
15. Ascorbic acid
Antioxidant
190-192 (~123-200) Crystalline deposits
SEM
16. Adipic acid; Excipient 152.1(~ 119) Crystalline deposits
SEM, Raman Spectra
17. Caffeine; Psychoactive
stimulant drug
227–228 (~120-250) Crystalline deposits
SEM, Raman spectra
18. Cholesterol; Excipient,
Biocompatible protection
layer
148–150 (~90-165) Crystalline deposits
SEM and Raman Spectra
19. Sphingomyelin (SM);
Excipient, phospholipide for
liposomes
215 (~186-230) Amorphous and crystalline
deposits
Optical Microscopy, SEM
and AFM
20. PLGA Excipient,
Controlled release layer
224 - 226 (~ 150-300) Amorphous deposits
SEM
21. Indometacin; Non
steroidal anti-inflammatory
drug
155 (~150-190) Amorphous and crystalline
deposits
SEM and Raman Spectra
22.Neomycin sulphate
Antibiotic, Surface coating
of wound dressings/implants
250 - 260 (~ 160-300) Amorphous and crystalline
deposits
Diffusion test
23. Novobiocin sodium
salt; Antibiotic, Surface
coating of wound
dressings/implants
215-220 (~ 150- 250) Amorphous and crystalline
deposits
Diffusion test
24. Tetracycline hydrate;
Antibiotic, Device coating
170-175 (~ 100-223) Crystalline deposits
Diffusion test
25.VancomycinHCl;
Antibiotic, Increased oral
bioavailability
185 (~ 100-197) Amorphous and crystalline
deposits
Diffusion test
26.Itraconazole;
Antimycotic, Increased oral
bioavailability
166,2 (~100-232) Amorphous and crystalline
deposits
Diffusion test
27.Ketoconazole;
Antimycotic, increased
solubility
146 (~88-226) Amorphous and crystalline
deposits
Optical microscopy
28. Paracetamol; Non
steroidal anti-inflammatory
drug
168 (~ 97- 130) Crystalline deposits
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29. Diclofenac sodium;
Non steroidal anti-
inflammatory drug
284 (~135-270) Crystalline deposits/
Raman spectra
Optical microscopy
30. Polyglycolic acid;
Biodegradable polymer,
Control drug release
225-230 (~160-200) Amorphous and crystalline
deposits
31. Lactose Excipient 223 Deposition not possible
32. Polyethylene glycol;
Excipient
49-53 Deposition not possible
(decomposed to gas)
33. Chlorhexidine;
Antiseptic
134–136 Decomposes, droplets on
the surface of substrate
34. Triclosan; Antibacterial
and antifungal agent
56–58 Deposition not possible
(Degrades to dioxin)
Table 5.1: Overview of thermally evaporated different drug substances. First part (1-30)
lists the materials which have been successfully nanostructured by thermal evaporation
and have been tested with disk diffusion method. The last part (31-34) lists the
pharmaceutical substances which are not suitable for thermal evaporation as they are
decomposed during deposition.
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5.1 Results
5.1.1 Structural engineering of Parabens
Parabens exhibit two classes of drugs called Nipasol and Nipagin. The following results
show different properties including the morphological and structural characterization at
different temperature regimes and different conditions.
5.1.1.1 Optical microscopy results of Nipasol nano-microstructures
Different characterization techniques such as AFM, SEM and light microscopy used to
study the morphologies of as-synthesized Nipasol micro-nanostructures. Nipasol nano-
microstructures has been deposited on various substrates by a simple thermal evaporation
technique without using any solvent or catalyst. These optical images of Nipasol micro-
nanostructures deposited on different substrates like silicon, titanium, Si pre-coated with
8 nm gold thin film, glass, Si pre-coated with 50 nm ZnO thin film.
Figure 5.1: ( a-d) Optical images of various Nipasol micro-nanostructured morphologies
on different substrates like Ti (a) Si pre-coated with 8 nm thick Au thin film (b), glass (c),
polymer foil (d), Si Pre-coated with ZnO 50 nm thick thin film (e and f) respectively.
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Figure 5.1(a)-(f) shows the optical images of highly oriented Nipasol micro-
nanostructures grown on different substrates at same condition. As expected, the
coverage density and morphology of Nipasol micro-nanostructures on Ti, glass, Si pre-
coated 8 nm Au thick thin film, Si pre-coated with ZnO 50 nm thick thin film, and
polymer foil are significantly different. Figure 5.1(d) also shows the high density as-
synthesized Nipasol structures consisting of micro-nanoparticles with various diameters
and lengths of several micrometers. In the other hand, less adhesion of Nipasol nano-
microstructures observed in case of utilizing glass substrate (c). It can be seen that the
particles with an average size of 1µm were obtained by using the glass substrate.
Meanwhile, as shown in Figure 5.1(e)-(f), particles about 2 µm by using Si Pr-coated
with ZnO 50nm thick thin film. Obviously, the particles size of Nipasol nano-
microstructures become much bigger and highly adhesion with the surface of ZnO as
substrate (e and f) due to the polarity of ZnO. Reduction or increasing in particles
diameter and the morphology of Nipasol can be observed in Figure 5.1(a)-(d) where the
nucleation and further growth of the nanostructures occur. Here, the morphology of
Nipasol nano-microstructures based on substrate surfaces.
5.1.1.2 AFM of Nipasol
Moreover, the morphology and microstructure of the deposited Nipasol were further
studied by AFM. Figure 5.2a-c often shows dissimilarity in morphologies for Nipasol
nano- microstructures deposited on Ti substrate at different substrate temperatures.
Figure 5.2: Three-dimensional AFM height image of Nipasol grown on Ti substrate at
various substrate temperatures ranging from -100 0C with different magnifications (a-b)
to room temperature (c).
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Figure 5.3a-c shows three dimensional (3D) topographical views of Nipasol nano-
microstructures grown on Ti substrate with different substrate temperatures. The scan
area of 30 x 30 µm2 and 20 x 20 µm2. The product was dominated by various dimensions
and structures.
The three-dimensional (3D) topographical view of Nipasol drug thin film grown on Ti
substrate (see Figure 5.2c) depicts that uniform micro-crystalline covering the substrate
at room temperature. Figure 5.2a-b illustrates that Nipasol drug film is nano-crystalline
in the case of deposition at-100 0C when substrate temperature which was maintained by
using liquid N2. A height gradient from left to right is recognizable. The highest point in
the left part of the scan is approximately 1.5 µm while on the right side it is around half
of this value. Briefly, 3D AFM images of Nipasol grown on Ti substrate at room
temperature resulting in a much larger crystal size as compared to that deposited at -100
0C (see Figure 5.3 a-c).
Clearly, Figure 5.3a-b shows the grain sizes as a function of evaporation temperature
and growth time. It was noted that @ ~ 220°C (27 min), the grain sizes of Nipasol
deposited on Ti substrate are greater than the other temperature @ ~ 165 °C (10 min) as
illustrated in Figure 5.3a-b. With further increase in temperature a smoother surface
might be expected due to an increased surface mobility of the species. According to our
expectation, diffusion length of molecules along the substrate and re-evaporated of the
molecules from substrate must be enhanced.
Figure 5.3: Two-dimensional AFM height image of Nipasol on Ti substrate at different
evaporation temperatures @ ~ 165 °C (10 min) (a) and @ ~ 220°C (27 min)(b).
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5.1.1.3 SEM of Nipasol
Figure 5.4: SEM images of Nipasol deposited on ZnO nanostructures at different
magnifications (a and b) and microspheres on titanium substrate with substrate
temperature at -100 0C (c).
The SEM image (Figure 5.4) shows nanoneedles, nanorods and NPs like structure of
Nipasol that are distributed homogeneously and uniformly over the surface.
The chemical intactness of synthesized Nipasol micro-nanostructures was further
confirmed by Raman investigations. Raman spectroscopy was performed on each at
sample to determine the structure of pharmaceutical ingredients and to identify the
presence of specific functional groups within a specimen after deposition if compared to
the control. The spectra of Raman microscopy of deposited pharmaceutical molecules on
carrier and the reference spectrum are comparable which confirm that the chemical
composition of deposited materials is same as their bulk.
5.1.1.4 Raman spectrum of Nipasol
Raman spectrum of Nipasol (νmax /cm-1) shows a broad band at 3071 cm-1 which indicates
the OH group. It is noted that bands located at 2958 cm-1 - 2880 cm-1 which are assigned
principally to (C-H aromatic and C-H aliphatic). Sharp peaks located also at 1667 cm-1
and 1598 cm-1 which are corresponding to (C=O) and (C=C) respectively. As one can see
here, other peaks can be observed at 1448 cm-1, 1273 cm-1 and 1100 cm-1 which belong to
(CH2 bend, CH3 bend and C-O-C) as illustrated in Figures 5.5 and 5.6.
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Figure 5.5: The Raman spectrum of Nipasol control sample. The inset shows the optical
microscope image of the control sample.
Figure 5.6: The Raman spectrum of Nipasol deposited sample. The inset shows the
optical microscope image of the deposited sample.
5.1.1.5 Raman spectrum of Nipagin
 Raman spectra of Nipagin (νmax /cm-1) after and before deposition are similar to each
other as shown in Figure 5. 7 and Figure 5. 8 respectively.
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Figure 5.7: The Raman spectrum of Nipagin control sample. The inset shows the optical
microscope image of the control sample.
Figure 5.8: The Raman spectrum of Nipagin deposited sample. The inset shows the
optical microscope image of the deposited sample.
One can expected that the presence of a broad intense band at ~3303 cm−1 corresponding
to the (OH stretch). The C-H aromatic located at 3083 cm-1 and C-H aliphatic at 2966 cm-
1. The Raman spectra of Nipagin also show sharp peaks located at 1675 cm-1 and 1579
cm-1 which assigned for (C=O stretch and C=C) respectively. It was shown that peaks
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located at 1450 cm-1 for CH2 bend and ring deformation, at 1252 cm-1 for (CH3 bend) and
at 1146 cm-1 for (C-O-C). Both spectra look similar to each other with relating to the
Raman peaks which imply that the deposited sample did not exhibit any change in
chemical structure. Therefore, one can assume that the deposition of crystalline Nipagin
was successful.
5.1.2 Structural engineering of Pilocarpine-HCl
5.1.2.1 Optical microscopy of Pilocarpine-HCl
The deposition of Pilocarpine-HCl nano-microstructures in the range of 15-25 µm
thicknesses is shown in Figures 4.9a)-4.9d) respectively.
Figure 5.9: a-e Representative optical images of various pilocarpine-HCl micro or nano
structured morphologies on different substrates like polymer foil (a), glass (b), Ti (c), soft
contact lens (d), copper grid on Ti substrate (e) and large grains size deposited on ZnO
substrate (f).
These structures typically exhibit high surface area to volume ratio which enable them to
dissolve faster if compared to their bulk counterparts. As it is typical for thermal
evaporation process, the substrate has a large influence on the structure especially in
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terms of crystallinity and shape of the deposited free solvent drug. Figures 5.9a)-5.9d)
show the differences in surface morphology of the deposition of Pilocarpine-HCl nano-
microstructures grown on different substrates like polymer foil (a) glass (b), titanium
substrate (c), soft contact lens (d), and through a copper grid as micro scale shadow mask
on´ a Ti substrate (e).
5.2.2.2 SEM of Pilocarpine-HCl
The SEM image of Pilocarpine-HCl (Figure 5.10) shows a dense structure of rods arises
from many small crystal nuclei that are distributed homogeneously and uniformly over
the silicon substrate pre-coated with 50 nm ZnO thin film.
Figure 5.10: (a-c) SEM images of Pilocarpine-HCl micro-nanostructures grown on Si
pre-coated with 50 nm thickness ZnO thin film with different magnifications.
5.1.2.3 Raman Spectroscopy of Pilocarpine-HCl
5.1.2.3.1 Raman Spectroscopy of Pilocarpine-HCl on Ti
The Raman shifts which imply that the deposited sample on Titanium plate ( see Figure
5.11) never change its chemical composition. Therefore, the deposition of crystalline
Pilocarpine-HCl is successful.
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Figure 5.11: Example of Raman identification (green: spectrum of Pilocarpin-HCl raw
material, red: spectrum of Pilocarpine-HCl layer vacuum deposited on titanium carrier).
5.1.2.3.2 Raman Spectroscopy of Pilocarpine-HCl on polymer foil
Both spectra in Figure 5.12 and Figure 5.13 contain the same functional groups of
Pilocarpine-HCl. It looks to be related to the Raman shifts which imply that the deposited
sample on titanium substrate does not change in chemical composition. However, in
Figure 5.13, the foil carrier is very sensitive to energy input. It shows an irregular
surface. The deposited layer shows a spectrum which is not truly 100% comparable to the
reference spectrum of deposited materials. This is Raman spectrum of Pilocarbine-HCl
(νmax /cm
-1), Figure 5.12 shows some characteristic peaks at 2944 cm-1 (CH aromatic),
2903 cm-1 (C-H aliphatic), broad peak in reference drug and sharp peak in deposited drug
due to Raman signal might be enhanced by crystallinity. It is noted that characteristic
peaks at 1598 cm-1 (C=O), 1487 cm-1 (C=C, C=N), 1429 cm-1 due to (CH2 bend),
1367cm-1 for (CH3 bend) and 1022 cm-1 due to (C-O-C).
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Figure 5.12: Raman-spectrum and optical microscope image (inset) of Pilocarpine-HCl
reference drug.
Figure 5.13: Pilocarpine-HCl sample after deposition on polymer foil with its optical
image(inset) and Raman-spectrum.
5.1.3 Structural engineering of Pindolol
5.1.3.1 Optical microscopy of Pindolol nano-microstructures
The material is deposited on polymer foil and titanium substrate. Figure 5.14a shows
small droplets of Pindolol grown on polymer foil with the magnification of 50 x. They
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are < 300 nm as estimation can be done from the scale bar. They are randomly distributed
over the whole sample surface. This may indicate that the island growth is the
predominant mechanism. The substrate in the right figure is Titanium and Pindolol nuclei
seem to be a densely porous structure.
Figure 5.14: Both optical images show deposited Pindolol on polymer foil (a) and Ti
substrate (b) respectively.
5.1.3.2 AFM of Pindolol nano-microstructures
Figure 5.15 depicts AFM images of vacuum evaporated Pindolol deposited on Ti
substrate.
Figure 5.15: a-b Two- and three dimensional AFM (non contact mode) images of
Pindolol nano-microparticles deposited on Ti substrate.
The 2D and 3d AFM images of Pindolol nano-microstructures were recorded in scan area
at 20×20 μm2. Obviously, uniform spherical particles were obtained and distributed
homogenously on the substrate surface and bounded to each other to make clusters. The
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AFM image (Figure 5.15) shows surface features with an average diameter of 500 nm
and a maximum height variation of 400 nm.  
5.1.3.3 Raman Spectroscopy of Pindolol nano-microstructures
5.1.3.3.1 Raman Spectroscopy of Pindolol nano-microstructures on Ti
Figure 5.16 illustrates that the Raman spectra of Pindolol nano-microstructures are
identical to each other (not changed) after evaporation.
Figure 5.16: Raman identification (red: spectrum of Pindolol raw material, blue:
spectrum of Pindolol layer vacuum deposited on Ti carrier).
5.1.3.3.2 Raman Spectroscopy of Pindolol deposited on Si
As shown in Figure 5.17 and Figure 5.18, the spectra similar to each other and contain
the same functional groups of Pindolol. This is Raman spectrum of Pindolol (νmax /cm-1).
Figures 5.17 and 5.18 show characteristic peaks located at ~ 3293 cm-1 (NH, OH), 3130
cm-1 (C-H arom.), 2838 cm-1 (CH aliph.), and 1580 cm-1 (C=C), at 1500-1339 cm-1 (CH3
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bend) and at 1098 cm-1 for (C-O-C), as a result the deposition of crystalline Pindolol is
successful.
Figure 5.17: The Raman spectrum of Pindolol control sample. The inset shows the
optical microscope image of the control sample.
Figure 5.18: Raman-spectrum with its appropriate optical image (inset) of Pindolol
sample after deposition.
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5.1.4 Structural engineering of 5-Fluorouracil
5.1.4.1 Optical spectroscopy of 5-Fluorouracil
The optical images of 5-Fluorouracil show magnifications of 20 x on the left and 50 x on
the right image of Figure 5.19. The material was deposited on Titanium substrate. From
Figure 5.19, one can see Fluorouracil covers the sample surface uniformly although
some scratches appear probably due to incautious handling with the tweezers when
removed from the sample holder. The crystallization can be seen in the right image.
Figure 5.19: Optical images of 5-Fluorouracil with (a) 20 x and (b) 50 x magnification
grown on titanium substrate that show crystallization process after thermal evaporation
deposition.
5.1.4.2 AFM of 5- Fluorouracil
Figure 4.20 shows 2D and 3D topographical images of 5-Fluorouracil on Ti. The left
scan has a scrutinizing area of 5 µm x 5 µm2 whereas the right one is a zoomed-in scan
with scan area of 1 x 1 µm2. AFM images show surface features with an average diameter
of 200 nm and a maximum height variation of 110 nm.
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Figure 5.20: Two-dimensional AFM height images of 5-Fluorouracil on Ti substrate with
a scan area of (a) 5 x 5 µm2, (b) 1 x 1 µm2. Also, three-dimensional AFM height image of
Fluorouracil on Ti is shown with a scan area of 1 x 1µm2 and a maximum height of
0.1 µm.
5.1.4.3 Raman microscopy of 5-Fluorouracil nano- microstructures
The confirmation of 5-Fluorouracil nano-microstructures synthesis was further
determined by Raman microscopy. The spectra are very similar to each other with only
very subtle differences. Raman signals in Figures (5.21 and 5.22) show that the three
strong characteristic peaks located at 3100-3076 cm-1 due to the presence of (OH, NH). It
was noted that peaks located at 1660 cm-1 for (C=O), 1491cm-1 for (C=N, C=C), and at
~1227 cm-1 - 737 cm-1 for (C-F). Figures 5.21 and 5.22 show the main functional groups
and their specific Raman shifts. Both spectra contain the same functional groups as seen
from the peaks in the spectra in Figures 5.21 and 5.22 that seem similar. Thus, the
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deposition of crystalline Fluorouracil was successful. Crystallization can be seen clearly
from the enhancement of the Raman signal of deposited sample.
Figure 5.21: Raman spectrum and optical image (inset) of 5- Fluorouracil reference
drug.
Figure 5.22: Raman spectrum and optical image (inset) of 5- Fluorouracil after
deposition.
Results and discussions
84
5.1.5 Structural engineering of Chloramphenicol
5.1.5.1 Optical spectroscopy of Chloramphenicol
The growth process of deposited Chloramphenicol is based on the growth time. The
Chloramphenicol thin film is characterized by light microscopy where the images are
taken after 1min, 3h and 1 day after evaporation process. Figure 5.23 shows droplets of
Chloramphenicol deposited on glass substrate. Concerning the upper left image, the
diameter of the droplet in the upper left corner is approximately 240 µm in diameter, the
smallest in the upper middle part of the image is about 30 µm. Their distance to each
other is quite big comparing to the whole sample surface area. The upper right image
shows Chloramphenicol droplets with diameters between 100 µm and 220 µm.
concerning the same sample 3h after evaporation, the droplets expand a bit (see also
Figure 5.23).
Figure 5.23: (a) and (b): Images for different positions on the sample show
Chloramphenicol deposited on glass illustrated with a magnification of 10 x. Images
were taken 1 min after evaporation. Images (c) and (d) were taken 3h after evaporation.
They show different positions on glass sample with droplets of deposited
Chloramphenicol. The magnification is 10 x.
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When relating the diameter of the big droplet in the lower left image to the previous, its
diameter increased to 280 µm. The small one actually increased to 60 µm in diameter.
The droplets in the lower right image show diameters of about 100 µm to 200 µm.
Considering the growth of the droplets after 1 day (see Figure 5.24). It is recognized that
the diameter gained has incredible dimensions. The smaller one in the left image is about
350 µm. In the image on the right, two droplets start growing together. After two days,
the agglomeration starts (c). Also, characterized Chloroamiphencol, after 10 days in the
initial specific area, starts to produce. (Figure 5.25a). To accelerate the crystallization
process, one sample with Chloramphenicol on glass was heated for 1 hour at about 50 °C
after the evaporation process. The result can be seen in Figure 5.25b and c. The structure
shows blossom-like or fan-like crystallites growing together.
Figure 5.24: Chloramphenico microstructures deposited on glass substrate after 1 day
(10 x magnification)(a, and b) after 2 days (c).
Figure 5.25: Optical micrographs show the initial specific area of Chloramphenicol on
glass after 10 days (a) and its higher surface area Blossom-like crystalline structure after
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heating 1 h at 100 °C on glass at lower and higher magnification b and c respectively.
Chloramphenicol on polymer foil appears after 1 month (d). b) after 2 days (c).
5.1.5.2 Raman spectroscopy of Chloramphenicol nano-microstructures
Figures 5.26, 5.27 and 5.28 show Raman spectra consecutively recorded to examine the
chemical structure of Chloramphenicol after and before thermal evaporation. The spectra
are very similar to each other with only very subtle differences. The first one is the
reference sample of Chloramphenicol powder. The second one shows the deposited
Chloramphenicol immediately after evaporation process. and the third one after a certain
time. Raman spectra of Chloramphenicol (νmax /cm-1) shows characteristic peaks placed at
3087 cm-1 (OH, NH), 2962 cm-1 (C-H aromatic), 1598 cm-1 (C=O) cm-1 and 1513 cm-1
(C=C). In the other hands, some peaks located at 849 cm-1 assigned to (C-Cl) and at
1345-1194 cm-1 for (NO2) (see Figures 5.27 and 5.28).
Figure 5.26: Raman spectrum and optical image (inset) of Chloramphenicol reference
drug.
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Figure 5.27: Raman spectrum and optical image (inset) of Chloramphenicol deposited
drug directly after evaporation.
Figure 5.28: Raman-spectrum and optical image (inset) of deposited Chloramphenicol
sample after a certain time.
It appears that Raman spectrum offers an overview of the most important functional
groups and their dedicated Raman shift peaks. All peaks from Figures 5.27 and 5.28
exhibit the specified Raman-shifts similar to the reference sample (Figure 5.26.).
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Additionally, the Raman intensity and the number of counts increased in the sample
examined after a certain time. This is due to the advancing crystallization process of the
material as shown in Figure 5. 28. Crystallinity has relationships with orientation and the
polarizability of the material.
5.1.6 Structural engineering of Tetracaine-HCl
5.1.6.1 SEM of Tetracaine-HCl nano-microstructures
The SEM image of Tetracaine-HCl shows a dense structure of fibres, needles and
tetrapods that are distributed homogeneously and uniformly over the surface. Figure 5.29
shows further examples for different nanoscale roughnesses and large surface areas
formed by self organisation during growth. The appearance of thermally evaporated films
on different substrates visualised by scanning electron microscopy. Furthermore, when
silicon substrate pre-coated with 20 nm gold thin film (e), in this case, much more
materials deposited on the substrate. The surface morphology is flowers-like structure
due to the hydrophilicity of the gold particles resulted in the aggregation and much
adhesion of adsorbing molecules on substrate. In particular, inorganic-organic hybrids
have attracted considerable attention as a subject of extensive research in materials
chemistry because of the potential of combining distinct properties of organic and
inorganic behaviours as shown in Figure 5.29.g and h.
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Figure 5.29: a-h Representative SEM images of various Tetracaine-HCl nanostructures
morphologies grow on different substrates: Silicon wafer at higher temperature (a),
Silicon wafer at lower temperature (b), Titanium substrate(c), Silicon coated with 20 nm
Au thin film (d), Silicon coated with 4 nm Au thin film(e) co-deposition of Tetracaine-HCl
with Ag on silicon wafer(f) and Ti substrate (g) and co-deposition of Tetracaine-HCl with
Au on Si substrate( h) The inset is a high-magnification SEM images.
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Figure 5.29 illustrates also the morphology and dimensions of the synthesized products
depend on processing parameter adapted such as evaporation temperature, evaporation
time period and substrate surfaces.
5.1.6.2 AFM of Tetracaine-HCl nanomicrostructures
The deposited Tetracaine-HCl nano-structures are also characterized by AFM to detect its
morphology. AFM observations clearly showed 2D image of the topography of
Tetracaine-HCl with a scan area of 20 x 20 µm2. Obviously, the film is homogeneous and
comprises nanorods like structure of about 80–100 nm in size as shown in Figure 5.30.
Figure 5.30: Two-dimensional AFM height image of Tetracaine-HCl on Ti. The scan
area is about 20 µm x 20 µm.
5.1.6.3 Raman Spectroscopy of Tetracaine-HCl
The reference sample and deposited sample of Tetracaine-HCl are identified by Raman
spectroscopy (νmax /cm-1). Both spectra contain the same functional groups as seen from
Figures 5.31 and 5.32.
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Figure 5.31: The Raman spectrum of Tetracaine-HCl control sample. The inset shows
the optical microscope image of the control sample.
Figure 5.32: Tetracaine-HCl sample is shown after deposition with its appropriate
optical image (inset) and Raman-spectrum.
The spectra are very similar to each other with only very subtle differences in Raman
intensity. Raman spectrum of Tetracaine-HCl shows characteristic bands located at 3366
cm-1 corresponding to the (NH), 3050 cm-1 for (C-H aromatic) and 2958 cm-1 for (C-H
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aliphatic). Sharp peaks located at 1663 cm-1 and 1587 cm-1 which corresponding to
(C=O) and (C=C). It is noted that peaks at 1260 cm-1 which belong to (CH2 bend) and
1171 cm-1 for (CH3 bend) and 1033 cm-1 for (C-O-C). Thus, the deposition of crystalline
Tetracaine-HCl is functioning properly.
5.1.6.4 EDX Results of Tetracaine-HCl nano-microstructures with silver and
gold
The EDX of Tetracaine-HCl samples are done by the SEM. The EDX reveals that the
required phase has been presented. Figures 5.33 and 5.34 show the existence of peaks
related to Ag and Au in the samples after deposition. The EDX spectra of the analyzed
thin films also confirm the presence of oxygen, chloride and carbon; these elements are
the constituents of thin film of Tetracaine-HCl composite.
Figure 5.33: EDX spectrum of co- deposition of Tetracaine-HCl nanostructures with Ag
by thermal evaporation.
Figure 5.34: EDX spectrum of co-deposition of Tetracaine-HCl nanostructures with Au
by thermal evaporation.
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5.1.7. Structural engineering of Acetylsalicylic acid
5.1.7.1 SEM of Acetylsalicylic acid
Acetyl Salicylic acid is uniformly deposited on Ti substrate as seen in Figure 5. 35. The
microstructure appears to be uniformly and homogeneously composed of porous particles
with higher surface area. Eventually, lateral structured systems are formed by using
shadow masks which suited for the fabrication of micro-scale (or nanoscale)
heterostructures on different substrates. When the shadow mask is in contact with the
substrate (h = 0), the growth area is determined by the geometry of the mask apertures
and the position of the mask on the substrate as demonstrated in Figure 5.35 c, d.
Figure 5.35: Representative SEM images of Acetylsalicylic acid grown on Ti substrate
(a, b) and though a copper grid as micro scale shadow mask (c, d) with different
magnifications.
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5.1.7.2 AFM of Acetylsalicylic acid
Figure 5.36 shows a two-and-three dimensional image of the topography with a scan area
of 10 x 10 µm2. Obviously, a uniform crystalline structure is obtained. A uniform cover
of the surface of titanium with Acetyl Salicylic acid can be observed as well as the
crystalline structure of the deposited material. The shape of the nanostructured peaks
resemble pyramided like structure.
Figure 5.36: Two-and-three dimensional image of the topography of Acetylsalicylic acid
with a scan area of 10 x 10 µm2.
5.1.7.3 Raman spectrum of Acetyl Salicylic acid
Figure 5.37: Microscopic images of Acetylsalicylic acid deposited on Ti substrate and
copper grid through a microscopic shadow mask (a, b) respectively and Raman spectra
of the deposited and reference Acetylsalicylic acid (c).
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Raman-spectra also are recorded for Acetyl Salicylic acid analysis. Figure 5.37 shows a
clear Raman spectrum after deposition which is similar to the Raman of raw material..
The spectra are very similar to each other with only very subtle differences in intensity.
The spectrum after deposition is identical to the reference spectrum, so the substance
identity can be verified in Figure 5.37.
5.1.8 Structural engineering of Metronidazole
5.1.8.1 SEM of Metronidazole
Figure 5.38 shows the morphology of Metronidazole nano-microstructures deposited on
Ti substrate. The structure appears to be pillars like structure with higher surface area.
Figure 5.38: a-c SEM images of Metronidazole nano-microstructures fabricated on
titanium substrate with different magnifications.
5.1.8.2 AFM of Metronidazole nano-microstructures
Figure 5.39 shows a two-dimensional image and three-dimensional topographical image
with a scan area of 10 x 10 µm2.
Figure 5.39: AFM 2D and 3D images of Metronidazole deposited on glass substrate with
a scan area of (a, b) 10 x 10 µm2.
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Obviously, Figure 5.39 shows the AFM images of as-prepared Metronidazole thin film.
For Metronidazole thin film, the uniform grains are densely packed, implying a three-
dimensional island. The AFM view of the image shows that the grain looks particles
structure covering the substrate surface and coalescence to each other to form clusters.
The surface is slightly roughness.
5.1.8.3 Raman spectrum of Metronidazole
The chemical composition of Metronidazole is examined with Raman spectroscopy.
Raman spectra of Metronidazole (νmax /cm-1) in both Figures 5.40 and 5.41 contain the
same functional groups. Figures below show characteristic bands observed at 3109 cm-1
for (OH), 3028 cm-1 for (C-H aromatic) and ~2940 cm-1 for (C-H aliphatic). A sharp
peak is located at 1543 cm-1 assigned to (C=C) and (C=N). Different bands observed at
1484, 1260 cm-1 which are corresponding to (NO2), band at 1458 cm-1 for (CH2 bend)
and band at 1389 cm-1 for (CH3 bend).
Figure 5.40: The reference sample of Metronidazole with optical microscope image
(inset) and its Raman spectrum.
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Figure 5.41: Metronidazole sample after deposition with its appropriate optical image
(inset) and Raman-spectrum.
5.1.9 Structural engineering of Clotrimazole.
5.1.9.1 Optical Light Spectrum of Clotrimazole nano-microstructures
Figure 5.42 shows Clotrimazole deposited on Si pre-coated with ZnO nanostructures and
Ti substrate with magnification of 50 x. Optical images show that the morphology of
Clotrimazole depend on the employed substrate, where grains are slightly smaller and
more dispersed.
Figure 5.42: Optical images of Clotrimazole micro-nanostructures deposited on Si
coated with ZnO nanostructures (a) and Ti substrate (b).
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5.1.9.2 AFM of Clotrimazole nano-microstructures
AFM image was recorded from clotrimazole thin film which has been deposited on
different substrates, the topography with a scan area of 20 x 20 µm2. From Figure 5.43,
it is clear that the surface morphology of the as-evaporated structures depend
significantly on substrate surface. Figure 5.43 a-b shows uniform particles from
Clotrimazole which distributed homogenously on Ti substrate. Figure 5.43c shows
uniform Clotrimazole nano-microstructures covering the glass surface with growing rod
like structures.
Figure 5.43: Two-dimensional and three-dimensional AFM height images of
Clotrimazole growing on Ti (a and b) and two-dimensional AFM of clotrimazole on glass
substrate(c).
5.1.9.3 SEM of Clotrimazole nano-microstructures
Figure 5.44. shows the SEM of Clotrimazole deposited on Ti substrate. It was noted that
the surface of thin films consists different shapes of aggregates. These aggregates in thin
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film are dendrite-like structures which grown after evaporation. The SEM image shows
uniform formation of the seeds with an average size of ~ 40-60 nm on the film surface.  
Figure 5.44: SEM images of Clotrimazole deposited on Ti substrate.
5.1.9.4 Raman Spectrum of Clotrimazole nano-microstructures
Figure 5.45: The reference sample of Clotrimazole with optical image (inset) and its
Raman-spectrum.
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Figure 5.46: Clotrimazole sample after deposition with its appropriate optical image
(inset) and Raman-spectrum.
The spectra are very similar to each other with only very subtle differences in Raman
intensity. Both Figures 5.45 and 5.46 show the functional groups of Clotrimazole. It is
noted that the characteristic bands for Clotrimazole located at ~ 3300-3100 cm-1 for (CH
aromatic) and large bands located at 1689 cm-1 and 1583 cm-1 and 817 cm-1 for (C=C) and
(C=N) and (C-Cl) respectively. The presence of these bands in deposited materials
suggests the existence of Cotrimazole without decomposition.
5.1.10 Structural engineering of Trimethoprim
5.1.10.1 AFM of Trimethoprim nano-microstructures
Figure 5.47 shows 2D and 3D AFM images of Trimethoprim nano-microstructures
deposited on Ti substrate with different scan area of 10 x 10 µm2 and 6 x 6 µm2.
Obviously, a uniform film consists of many tiny particles with higher surface area which
grown on Ti substrate. AFM images show surface features with an average diameter of
200 nm and a maximum height variation of 390 nm. The surface is slightly roughness. 
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Figure 5.47: Two dimensional AFM and a three-dimensional AFM height image of
Trimethoprim on Ti with different scan area of 10 x 10 µm2 (a-b) and 6 x 6 µm2(c-d)
5.1.10.2 Raman spectrum of Trimethoprim nano-microstructures
Raman spectrum of Trimethoprim is (νmax /cm-1). Figure 5.49 shows observed peaks at
~3474 cm-1 which assigned to the (NH2), at 3006 cm-1 for (CH aromatic), at 2900-
2922.25 cm-1(CH aliphatic), the large band is located at 1587.77 cm-1 which is
corresponding to (C=C) and (C=N), peaks located at 1350 cm-1 and 1448 cm-1 which are
describing (CH3 and CH bend), and at 1049 cm-1 for (C-O-C). The presence of these
bands also in deposited materials suggests that the existence of Trimethoprim without
decomposition.
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Figure 5.48: The reference sample of Trimethoprim shows optical image (inset)) with its
Raman-spectrum.
Figure 5.49: Trimethoprim sample after deposition with appropriate optical image
(inset) and it’s Raman-spectrum.
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5.1.10.3 XRD Spectrum of Trimethoprim nano-microstructures
The XRD spectrum has been recorded to emphasize the statement that some materials are
in amorphous state directly after deposition. In this case, Trimethoprim is being
investigated.
Figure 5.50: XRD pattern of Trimethoprim deposited on glass substrate at different
growth times after 1h (blue line), 3 day (red line)s and ten days (black line).
The crystallinity of Trimethoprim drug thin film has been checked by XRD after
evaporation immediately, 3 days and after 10 days as illustrated in Figure 5.50. The
spectrum in Figure 5.50 shows many peaks from different angles but without projecting
single specific ones. This is typical for materials in amorphous state which have been
investigated after one hour and three days. XRD results also show that the film of
Trimethoprim is still in amorphous nature after 3 days. Figure 5.50 represents that the
good crystalline nature and sharp intense peaks of Trimethoprim achieved after 10 day
due to the mobility of the condensing particles on the substrate surface is more which
provides the crystallization and the growth of large crystals. Films of nano-microparticles
can be also controlled by post deposition heat treatment. The Crystallization process
started slowly with the formation of nuclei then growth follows. Obtaining this kind of
information is important in the area of pharmaceutical formulations.
Crystalline
Amorphous
Amorphous
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5.1.11 Structural engineering of Sulphathiazole
5.1.11.1 AFM of Sulphathiazole nano-microstructures
Figure 5.51 shows the AFM images of 2D and 3 D Sulphathiazole thin films deposited
on Ti. For thin films, the uniform grains are densely packed, implying a three-
dimensional island. The enlarged view of the image shows that the grain looks rod-
shaped (see Figure 5.51d). The AFM images show surface features with an average
diameter of 450 nm and a maximum height variation of 480 nm.  
Figure 5.51: AFM 2D and 3D image of Sulphathiazole deposited on Ti with different
magnifications.
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5.1.12 Characterization of Tetracycline-HCl nano-microstructures
5.1.12.1 AFM of Tetracycline-HCl nano-microstructures
Figure 5.52a-d shows a two-dimensional image and three dimensional of the topography
with different a scan area of 20 x 20 µm2, 4 x 4 µm2, 2 x 2 µm2 and three dimensional
image with a scan area of 20 x 20 µm2 with various height 0.31, 0.013, 0.010. Clearly,
uniform nanoparticles were obtained on titanium substrate (see Figure 5.52a-b) and glass
substrate (Figure 5.54c-d). The AFM images shows surface features with an average
diameter of ~20 nm.
Figure 5.52: AFM 2D and 3D images of Tetracycline-HCl deposited on Ti(a-b) and
glass (c-d) with different scan area.
5.1.13 Structural engineering of Erythromycin
5.1.13.1 AFM of Erythromycin nano-microstructures
Figure 5.53a-d shows 2D and 3D AFM images of the topography of Erythromycin with
different a scan area of, 20 x 20 µm2, 4 x 4 µm2, 2 x 2 µm2. Also 3D AFM image appears
with a scan area of 20 x 20 µm2 with various heights 0.31, 0.013, and 0.010. Clearly, a
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uniform nanoparticles and smaller grain sizes for Erythromycin after evaporation covered
and distributed on the titanium substrate with higher surface area as well as the crystalline
form occurred after time.
Figure 5.53: AFM 2D and 3D images of Erythromycin deposited on Ti with different
magnifications.
5.1.14 Structural engineering of Tobramycin
5.1.14.1 AFM of Tobramycin nano- microstructures
Tobramycin is also deposited on Ti substrate. Figure 5.54 shows 2D AFM image of the
topographical scan with a scan area of 10 x 10 µm2. Obviously, a uniform of crystalline
structure is attained. In some regions, the deposited material not sufficient to cover all the
surface. The overall roughness is low. The lighter parts on the upper and lower end of the
scan arise from problems while scanning the sample and may falsify the actual image. A
three-dimensional topographical scan of this area can be seen in Figure 5.55. It proves
the previous conclusion about the surface structure. But, the irregularities on the upper
and lower end of the scan occur. Nevertheless, the surface is rather smooth. The
maximum height reaches about 0.1 µm.
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Figure 5.54: AFM 2D image of Tobramycin deposited on Ti. The scan area is about
10 µm x 10 µm. The surface roughness is minor as the legend on the left implies a
maximum height of < 30 nm.
Figure 5.55: AFM 3D image of Tobramycin on Ti is shown with a scan area of 10 µm x
10 µm and a maximum height of 0.1 µm.
5.1.15 Structural engineering of Ascorbic acid
5.1.15.1 SEM of Ascorbic acid nano-microstructures
Apart from the standard growth of nanoscale thin films with a certain degree of
crystallinity, formation of rather complicated dendrite or hierarchical like structures may
be triggered, as illustrated for Ascorbic acid in Figure 5.56. The SEM images show
uniform formation of the hierarchical structures with an average size of ~60 nm on the 
film surface.
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Figure 5.56: a-c SEM images of Ascorbic acid on Ti substrate with different
magnifications.
5.1.16 Characterization of Adipic acid nano-microstructures
5.1.16.1 SEM of Adipic acid micro-nanostructures
The SEM image of Adipic acid shows dense structures of nano needles like structures
that are distributed homogeneously and uniformly over the surface (see Figure 5.57).
Figure 5.57: (a-c) SEM images of Adipic acid grown on Ti substrate with different
magnifications.
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5.1.16.2 Raman Spectrum of Adipic acid nano-microstructures
Figure 5.58: The Raman spectrum of Adipic acid control sample. The inset shows the
optical microscope image of the control sample.
Figure 5.59: The Raman spectrum of Adipic acid deposited sample. The inset shows the
optical microscope image of the deposited sample.
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Figures 5.58 and 5.59 described that both spectrum are similar. Therefore, no change
occurs in the chemical structure of Adipic acid. Raman spectrum of Adipic acid (νmax
/cm-1) shows band at 2932 cm-1 (CH aliphatic). The large band is located at 1638 cm-1
corresponding to (C=O) at 1450 cm-1for (CH2 bend) and at 1273 cm-1 assigned to (OH
bending). So, the presence of these bands also in deposited materials suggests the
deposition of Adipic acid in exists successfully.
5.1.17 Structural engineering of Caffeine
5.1.17.1 SEM of Caffeine nano-microstructures
From Figure 5.60 the SEM image of caffeine with different magnifications, the uniform
structure with higher surface area appears clearly. Scanning electron microscope (SEM)
images also show that our film products consist of densely-aggregated particles with
average diameter ~10 nm.
Figure 5.60: SEM images show different magnifications of Caffeine nanostructures
deposited on Ti substrate.
5.1.17.2 Raman spectrum of Caffeine nano-microstructures
Visibly, both spectra are similar to each other as shown in Figures 5.61 and 5.62. Thus,
the chemical composition of Caffeine is still the same after vacuum deposition. Raman
spectrum is of Caffeine (νmax/cm-1) show characteristic peaks located at ~3105.7 cm-1 and
2958 cm-1 which assigned to the (CH aromatic) and (CH aliphatic) respectively. It was
noted that bands located at 1689.7 cm-1and 1642.1 cm-1 which assigned to (2C=O) and
peak at 1609 cm-1 for (C=C and C=N) and sharp peak located at 1319 cm-1corresponding
to (CH bend). The presence of these bands also in deposited materials implies the proper
existence of Caffeine.
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Figure 5.61: The Raman spectrum of Caffeine control sample. The inset shows the
optical microscope image of the control sample.
.
Figure 5.62: Caffeine sample after deposition with its appropriate optical image (inset)
and Raman-spectrum.
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5.1.18 Structural engineering of Cholesterol
5.1.18.1 SEM of Cholesterol nano-microstructures
Figure 5.63: SEM image of Cholesterol nonostructures deposited on Ti (a, b) and Si
coated with 4 nm Au thickness (c, d) with different magnifications.
The SEM image of Cholesterol shows a dense structure of nano needles and flower like
structures that are distributed homogeneously and uniformly cover the surface of
substrate using as shown in Figure 5.63. A uniform cover of the sample surface is
achieved. The structure exhibits both needle and tetrapod forms which show high density
and cross linking. The diameter of a needle is in the nanometer range of a few nm. As
there are some free dark spaces one can presume that the growing of the structure arises
from many small crystal nuclei.
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5.1.18.2 Raman-spectra of Cholesterol nano-microstructures
For Cholesterol analysis, Raman-spectra have also been investigated the reference sample
and deposited thin film of Cholesterol on Si coated with 4 nm Au thickness.
Figure 5.64: Raman spectrum and optical image (inset) of Cholesterol reference drug.
Figure 5.65: Raman-spectrum and optical microscope image (inset) of Cholesterol
sample after evaporation.
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Both spectra are likely related to the Raman shifts which imply that the deposited sample
does not change in chemical composition. Raman spectra of Cholesterol (νmax /cm-1)
appear in Figure 5.64. and Figure 5.65 showing the surface enhanced Raman intensity.
Characteristic peaks at 2925-2874.6 cm-1 for (CH stretch).The large band is located at
1656 cm-1 for (C=C), 1436.1cm-1 assigned to (CH2 bend),1326 cm-1 for (CH3 bend) and
1172 cm-1 due to the (OH bend), The occurrence of these bands in deposited materials
suggests that the proper condition of the chemical structure of Cholesterol.
5.1.19 Structural engineering of SM nano-microstructures
5.1.19.1 Optical image of SM nano-micro structures
The material is deposited on glass and titanium; both results can be seen in Figure 5.66.
The left image shows small droplets of SM on glass at a magnification of 50 x. They are
< 500 nm as estimated from the scale bar. They are randomly distributed over the whole
sample surface. They indicate that island growth is the predominant mechanism. The in
the right figure is. SM nuclei seem to be a bit smaller and denser on titanium substrate if
compared with glass substrate. But, they still follow the same growth mechanism as the
nuclei form islands on the substrate. The optical image of the SM also does not show any
interesting morphological features.
Figure 5.66: (a) Small droplets of SM directly after deposition on glass sample with a
magnification of 50 x. (b) shows droplets of SM also directly after deposition but on
titanium sample with a magnification of 20x.
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5.1.19.2 SEM of SM nano-microstructures
SM is uniformly deposited onto Ti as seen in Figure 5.67. The structure appears to be
uniformly and homogeneously composed of rods or pillars like structure that have
rounded down head pieces. The pillars are thick in the submicron range and they increase
of the surface area. A uniform cover of the surface with SM can be observed as well as
the crystalline structure of the deposited material. The shape of the nanostructure peaks
resembles rounded down rods.
Figure 5.67: a-c SEM images of SM grown on Ti with different magnifications revealing
uniform dispersity.
5.1.19.3 AFM of SM nano-microstructures
The two-dimensional topographical view of SM on Ti (Figure 5.68) depicts uniform
crystalline shape covering the substrate. However, some white parts hypothesize that
there are differences in the height.
Figure 5.68: AFM 2D image of SM on Ti substrate. The lighter parts in the image
display particles that are higher than 2 µm. The particle size amounts roughly < 2 µm.
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The scan area is about 30 x 30 µm2 and the size of crystallites is < 2 µm. Comparing this
scan to the three-dimensional ones in Figure 5.69 shows that SM is in fact crystallized
uniformly. A height gradient from left to right is recognizable. The highest point in the
left part of the scan is approximately 1.5 µm while on the right side it is around half of
this value.
Figure 5.69: AFM 3D images of SM. (a) has a scan area of 10 x 10 µm2 whereas (b) has
a scan area of 2 x 2 µm2. The maximum height is around 1.5 µm.
5.1.20 Structural engineering of PLGA
5.1.20.1 SEM image of PLGA
Figure 5.70 shows the SEM image of PLGA which deposited on Ti substrate. The image
is taken directly after evaporation with the exception of some island formations locally
which are sufficiently separated from each other with average diameter of 5 µm
Figure 5.70: SEM image of PLGA on Ti substrate. The images are taken directly after
evaporation. They show small droplets of PLGA.
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5.1.21 Structural engineering of Indometacin
5.1.21.1 SEM of Indometacin nano-microstructures
The surface morphology of prepared Indometacin nano-microstructures has been
characterized by SEM (see Figure 5.71). The surface of thin films consists of dendrite
like structures. The hierarchical structures are essential for increasing the higher surface
area to volume ratio.
Figure 5.71: SEM images of Indometacin with hierarchical structures growing on Ti
with different magnifications.
5.1.21.2 Raman spectrum of Indometacin nano-microstructures.
The reference substance of Indometacin shows a good Raman spectrum whereas the
spectra derived from the samples are varying. The microscopic images from Indometacin
deposited on Ti show an inhomogeneous surface with a thin film like layer with some
incorporated crystals. Whereas the film spectrum does not resemble the reference
spectrum at all, the crystal spectrum might be related to the reference. The foil carrier is
very sensitive to energy input and shows an irregular surface with small “hairs”. The
deposited layer shows a spectrum which is not truly comparable to the reference
spectrum of Indometacin. Briefly, the vacuum deposition of Indometacin does not look
very promising with respect to substance integrity 100 %.
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Figure 5.72: Microscopic image of Indometacin deposited on titan (film (a) reference
sample (b) its Raman spectra of Indometacin reference substance (blue) and as film
deposited substance on titanium substrate (red).
Figure 5.73: Microscopic image of Indometacin deposited on polymer foil (film (a)
reference sample (b) its Raman spectra of Indometacin reference substance (blue) and as
film deposited substance on polymer foil (red).
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Figure 5.74: Raman spectra of Indometacin reference substance (blue) and deposited
substance crystal on titanium substrate (red) after one week.
5.1.22 Structural engineering of multilayers
5.1.22.1 Characterization of two layers
Here, layer by layer deposition from antibiotic drug (Metronidazole) as first layer and
PLGA as second layer which can be fabricated by using thermal evaporation to control
the release of Metronidazole as illustrated in Figure 5.75. Drug release from bioerodible
polymers require that the polymers break down into smaller molecular weight and
nontoxic materials which removed or metabolized by the body.
Figure 5.75: SEM of two layers sample composed of (1) Metronidazole, (2) PLGA with
higher and lower magnification a and b respectively.
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Paying attention to the properties of polymeric materials, such as physical and chemical
stability, viscoelasticity, electric action, have extended the area of their applications to the
biology and medicine.
5.1.22.2 Characterization of (4 Layers)
Investigating the adhesion between different layers and their growing process to form
liposomes. Generation of a sample with 4 layers composed of (1) SM, (2) Cholesterol, (3)
Fluorouracil and (4) SM (see Figure 5.76). From the SEM image, all materials are
clearly seen deposited effectively on one another. They exhibit thicknesses in the
nanometer range (for Fluorouracil) as well as in the micrometer range (for SM and
Cholesterol).
Figure 5.76: SEM of a four-layers sample composed of (1) SM, (2) Cholesterol, (3)
Fluorouracil and (4) SM on Ti substrate with higher and lower magnification a and b
respectively. Thicknesses of the single layers are: (1) >20 µm, (2) 15 µm, (3) few nm, (4)
>20 µm.
5.2 Discussion
5.2.1 Control over the crystallinity of the deposited drug films and their
morphology
Thermal evaporation for pharmaceutical drugs is not so far reported in the literature
which has been successfully established in this work [102]. Even though organic
molecules for light emitting displays are of similar complexity like pharmaceutical
molecules, surprisingly, their direct fabrication by thermal evaporation was not used in
pharmaceutical engineering till now. A general precondition for TE is that the thermal
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energy (here >300 °C meaning ~ 0.05 eV) injected into the molecules stays far away
from the range of the intermolecular binding energies of typically 2-7 eV, which seems to
be fulfilled. For getting a clearer view of the process, it should be understood in which
steps of energy a single molecule can leave the different bonding force fields in its
surrounding liquid and enter the vapour phase. Otherwise, energy barriers have to be
taken in sequence to decompose a molecule. Such sophisticated calculations are difficult
to carry out and not yet known. The large variety of possibilities for the molecules to
wiggle, swing or rotate in its liquid state complicates it to foresee which of the molecules
find their way into the gas phase and which decompose. Even if decomposition occurs in
some fragments, a re-composition on the substrate may occur. This result seems to be
confirmed by or arbitrary choice of molecules. But, an obvious prediction of the
suitability for TE needs significant efforts to be done in future. When the vaporized
atoms have reached the surface then condensed on it, extra mass transfer may occur by
diffusive processes which may vary the shape, size and crystallinity of the organic
material deposited. Different morphologies and structures may result when depositing
from the vapour phase depending on the experimental parameters such as substrate
surface, temperature [103] and evaporation rate. For example, the surface morphology of
active pharmaceutical ingredients thin films show that the final film surface structure
depends strongly on deposition rate. However, limited reports appear on organic thin film
materials vs. deposition rate [104]. Organic molecules are often challenging to produce
stable films on a substrate since they are often physisorbed, requiring a low surface
energy at the film/substrate interface. Most organic materials have a low sublimation
temperature where the vapour pressure is relatively high even at room temperature. These
characteristics are in complete opposition with those of metal or inorganic materials
which possess low vapour pressure even at high temperatures and often form strong
chemical bonds with the substrate. The relationship between surface morphology and
deposition parameters has been widely investigated, including metals, inorganic and
organic thin film materials. However, the influence of vapour flux on surface morphology
has not been confirmed to be the dominating factor. In order to evaluate the suitability of
thermal evaporation for pharmaceuticals, several (>30) pharmaceutical substances under
different parameters and several application examples have been demonstrated.
Surprisingly, the vast majority of drugs (>80%) show (see Table 5.1) the deposition of
high quality crystalline films without decomposition. The formation of nano-micro scale
pharmaceutical crystals on the substrate by thermal evaporation already indicates a high
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Purity and high surface area to volume ratio if compared with the bulk material before
evaporation as shown in Figure 5.77.
Figure 5.77: SEM images of Acetylsalicylic acid on Ti substrate after and before
deposition a and b respectively. The inset shows higher magnification SEM image.
In view of a variety of molecules capable of thermally evaporated, there seems to be of
no regularity which of the complex molecules stay intact and which decompose. In
principle, the evaporation of the molecules may have a positive effect by purifying the
evaporated substance since the contaminants with a lower melting point are evaporated
early when the substrate is still covered by a shutter of the evaporation oven, or, in case
of a higher melting point of the contaminant, it will not evaporate at all. With the
molecules suitable for evaporation, the full versatility of thermal evaporation can be
utilised. This means that by changing the deposition rate, the crystallinity of the deposited
film can be controlled in a wide range from amorphous to almost single crystalline.
Figure 5.2 a-c illustrate this outcome with an example of a Nipasol drug film which
might be amorphous or nanocrystalline in the case of deposition at -100 °C to crystalline
film deposited at room temperature. With a liquid N2 cooled substrate holder, even
completely amorphous films can be deposited with a relatively high free surface energy.
Also the coating thickness can be varied since the pharmaceutical drugs are used from a
few nm to many µm simply by changing the evaporation rate and time as confirmed by
AFM and profilometer measurements. Fabrication of nanostructured coatings of
pharmaceutical drugs on desired substrates in a controlled manner is a very promising
aspect of thermal evaporation technique after deposition. Moreover, the morphology of
pharmaceutical molecules strongly depends on temperature, experimental condition,
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compounds nature, substrate used and substrate temperature. For instance, when the
evaporation temperature of Nipasol is reduced to ~ 165 0C or increased to ~220 0C as
shown in Figure 5.3. The product is dominated by various dimensions and structures.
Figures 5.1, 5.9, 5.14, 5.29a-f, 5.38 and 5.42 demonstrate the morphology of
pharmaceutical molecules which depends on the substrate surfaces. Besides, the nano-
microstructures of the other compounds can be obtained by controlling the growth time
and substrate surfaces. Figure 5.29a-h shows further examples of different nanoscale
roughnesses and large surface areas formed by self organization during growth and
appearance of thermally evaporated thin films of Tetracaine-HCl on different substrates
as visualized by scanning electron microscopy. The inset images in Figure 5.29 a-h are
the corresponding higher magnification SEM images showing a clear visibility of
microstructural patterns of the deposited Tetracaine-HCl drugs. The choice of substrate
may comprise a wide range of materials and even highly soluble substances employed to
carry pharmaceutical thin films without the risk of side effects like dissolution of the
substrate. The Tetracaine-HCl deposited films are strongly affected by the deposition
conditions as confirmed in Figure 5.29. Branched nanostructures can be obtained by
using 20 nm gold thickness deposited on Si substrate due to the aggregation of the
particles along faces other than the polar faces [105] as illustrated in Figure 5.78. Rods
form mostly in the direction of the dipole moment which fabricated by using 4 nm gold
thickness (see Figure 5.79). In general, intermolecular compounds within the Tetracaine-
HCl deposits, internal stress, and crystal coherency between Tetracaine-HCl deposited
film and substrate are probably known to be the key to cause rods or other morphological
formation. Interactions between internal stresses and intermolecular compounds formed
within the Tetracaine-HCl deposits are still under investigation.
Figure 5.78: a-c SEM images of Tetracaine HCl deposited on Si pre-coated with 20 nm
Au thin film at different magnifications.
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Figure 5.79: a-b SEM images of Tetracaine- HCl Si pre-coated with 4 nm Au thin film at
different magnifications.
However, for the substitutional deposition, it is assumed that while the same conditions
are used for deposition, the morphology of Tetracaine-HCl films are changed by the
structure of the substrates, such as the crystal grain size and surface morphology. This is
because by using the substitutional deposition, the rate of deposited film growth depends
on the dissolution rate of the substrate. Additionally, the dissolution rate of the substrate
mainly depends on the structures of the substrates such as grain size, orientation
relationship and segregation of impurities. With the molecules suitable for evaporation,
the full versatility of thermal evaporation can be utilised. This means that by changing the
deposition rate, the crystallinity of the deposited film can be controlled in a wide range
from amorphous to almost single crystalline. A limitation is given for pharmaceutical
drugs which are instable or altered in vacuum.The 3D atomic force microscopy (AFM)
image of the deposited Aspirin film in Figure 5.36 depicts the formation of large Aspirin
crystals. Similar investigations for several drug materials are performed and most of them
are found to be structurally intact (see Table 5.1). For example, the deposition of
nanostructures of Tetracaine-HCl and Cholesterol and drugs in the range of ~100 nm to
~500 nm thicknesses are shown respectively in Figures 5.29 a-h) and 5.67). These
structures typically exhibit high surfaces which enable them to dissolve faster since they
are solvent free if compared to their bulk counterparts. Typical for TE, the substrate has a
large influence on the structure in terms of crystallinity and shape of the deposited drug.
Figure 5.9a)-e) shows the differences in the deposition of Pilocarpine-HCl as active
pharmaceutical drug on glass, polymer foil and titanium. Apart from the standard growth
of nanoscale thin films with a certain degree of crystallinity, formation of rather
complicated hierarchical structures may be triggered, as illustrated by SEM images for
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Ascorbic acid shown in Figure 5.56 at different magnifications. It should be noted that
the hierarchical assembly of drug structures down to the nanoscale leads to a huge surface
and volume ratio which significantly increases the solution kinetic processes by giving
more possibilities for drug molecules to step into the liquid phase and to increase in
solubility.
Figures 5.4, 5.38 show further examples for different nanoscale roughnesses and large
surface areas formed by self organisation during growth. They also show the appearance
of thermally evaporated films on different substrates visualised by scanning electron
microscopy. The choice of substrate may comprise a wide range of materials and even
highly soluble substances that can be employed to carry the pharmaceutical films without
the risk of side effects like dissolution of the substrate. A limitation is given for
pharmaceutical drugs which are instable or altered in vacuum.
5.2.2 Time-related Process
Optical microscope images show the time-related crystallization process by means of
Chloramphenicol (see Figures 5.23, 5.24, and 5.25). Another example is Trimethoprim
as illustrated in Figure 5.50. One can clearly see the increase of the particle diameters of
the evaporated material through coalescence after certain waiting periods as one observed
from Figures 5.80. The SEM mages of Chloramphenicol deposited on glass show the
amorphous nature of deposited film (see Figure 5.81). The mobility of condensing
particles on the substrate surface is more which provides the crystallization and the
growth of large crystals after significant time. This phenomenon is explained by
comprising energies, substrate and particle temperatures. To evaporate the material,
energy is applied in form of heating until the melting point. When these particles
condense and adsorb the substrate. In this study, post-deposition heat treatment
processing methods have developed that are decoupled from the initial deposition
conditions to induce different out-of-plane molecular orientations in Chloramphenicol
thin film. As-deposited Chloramphenicol thin films lack any long-range order; subjecting
it to post-deposition processing, such thermal annealing induces crystallization with
increasing extents of preferential edge-on orientation. The XRD patterns of
Chloramphenicol grown on glass substrate show the amorphous and crystalline nature of
Chloramphenicol after deposition (see Figure 5.82). It noted that the crystallininty as a
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function of time or temperature as demonstrated in Figure 5.81 and Figure 5.82. The
exhibited thermal energy of the particles is significant for the movement. Also the
migration energy barrier has to be considered which is defined the minimum energy
needed to move from one surface site to another. Now these energies have to be related
for the prediction of motion of a particle. If the thermal energy is smaller than the
migration energy barrier (see equation 5.1), the particle sticks to its energetically
favourable position.
MB ETk  (5.1)
KB is the constant Boltzmann. T is the Kelvin temperature and EM is the migration
energy. If the thermal energy exceeds these values due to the energy (or rather
temperature) exchange between particle and substrate, the particle will carry out random
jumps on the substrate surface. That means that the particle is distributed on the substrate
surface and found at different places in different times. This process is called surface
diffusion. Fick's first law suggests that the flux goes from regions of high concentration
to regions of low concentration, with a magnitude that is proportional to the concentration
gradient (spatial derivative). In one (spatial) dimension, the law is
x
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where
 J is the "diffusion flux" (amount of substance) per unit area per unit time which
measures the amount of substance that will flow through a small area during a
small time interval.
 D is the diffusion coefficient or diffusivity in dimensions of [length2 time−1].
  ф (for ideal mixtures) is the concentration in dimensions of [amount of substance 
per unit volume].
x is the position [length].
Fick's second law predicts how diffusion causes the concentration to change with time:
2
2
x
D
t 



 (5.3)
Results and discussions
127
The particles perform these jumps until they reach their potential energy minimum. The
frequency (f) of successful jumps is given by:
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v0 is in the order of vibrational frequency of atoms. The number of jumps per unit time is
given by the diffusion constant D:
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Whereas r (t) denotes a position of the particle at a given time, t and d is the dimension of
the diffusion path. The surface diffusion considered in this case is 2. Combining equation
5.4 and 5.5 leads to the constant diffusion:
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The particle can also fulfil rotations since molecules are assumed to be evaporated in this
process. With material of higher concentration, interactions with other particles can occur
as well. After random diffusion the particles arrive at neighbouring sites, they
agglomerate and form clusters. It is also possible for clusters to move on the surface. As
they have bigger mass they need higher energies to overcome the migration energy
barrier. Due to the random movements and the condition for the constant diffusion, the
crystallization process is a function of time-related process. [106, 107, 108].
Figure 5.80: SEM images of Tetracaine-HCl grown on Si substrate at different
evaporation times with 16 min (a), 23 min (b) and 30 min (c).
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Figure 5.81: SEM images of Chloroamphenicol deposited on glass substrate which
obtained after 3 h.(a) and 10 days(b) respectively.
Figure 5.82: XRD pattern of Chloroamphenicol deposited on glass substrate at different
times of 3h and 10 days.
5.2.3 Temperature-related Process
Chapter 5 illustrates the crystallization process is a function of growth temperature. This
study showed that the effect of post-deposition annealing and changing in substrate
temperature on the thermal stability and structural characteristics of the as-grown
Chloramphenicol thin film. From equation (5.1), one can reckon that if the temperature is
increased, the thermal energy will also increase. That is due to the fact that the particles
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gain kinetic energy. Heat refers to the state of energy an object has in relation to the
kinetic energy of its molecules or atoms. The more energy the particles have the higher
the probability for them to overcome the migration energy barrier. That means that high
frequency and coefficient diffusion will be much larger than normal diffusion processes
without the assistance of heat. So, it is more probable for the particles to form clusters on
the surface and withal nuclei. The time needed for crystallization of the evaporated
material on the substrate diminishes here. The rapidness of the crystallization really
depends on the amount of added heat. The structure-zone model proposed by Movchan
and Demichishin is illustrated in Figure 5.83 which correlates the substrate temperature
with the structure of the appropriate thin film. The substrate temperature is mentioned as
ratio of the melting temperature of the thin film material. In zone 1 the substrate
temperature is low. Here, the assumptions in Chapter 5.2.2 can be considered as the
surface diffusion is low. Clusters form and grow through further particles sticking to
them. But overall structure is not yet homogeneous. Zone 2 shows increased surface
diffusion due to higher energy impact. The density of the structure is increased through
bigger clusters that grow. Due to high temperature in zone 3 the particles attain high
energies for diffusion mechanisms. A fast developing crystalline structure is the result.
The problem with this model is that the pressure is disregarded. So, it is suggested for
high vacuum processes. Also, the temperature depending on atmospheric pressure has to
be considered. Therefore, the substrate temperatures have to be raised a bit more to
maintain the same thin film structure.
Figure 5.83: Representative Structure-zone model after Movchan and Diminishin
relating the substrate temperature to the corresponding arising thin film structure [109].
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5.2.4 Control over the lateral structuring of the deposited drug films
A lateral structuring, the positioning of thermal evaporated thin films, is relatively
straightforward by utilising lithography or shadow masks. Possible applications for
laterally structured systems are smart or multifunctional pharmaceutical drug coatings for
implants or contact lenses. Specific examples are contact lenses for drug delivery [110]
which should not affect the vision and thus require a lateral structuring as shown in
Figure 5.84 of the drug film. Selective area depositing pharmaceutical drugs on contact
lenses is possible with TE technique using a suitable mask. Such a structuring could also
be used in complex implant coatings like stents or dental implants that require different
drugs in different places in contact with bone, mucosa or the oral cavity. Bacterial
adhesion is an important step in the pathogenesis of an infection (periimplantitis).
Placement of different antibacterial active molecules on specific areas of the implant
surface (depending on the intraoral contact to bone, mucosa or the oral cavity) will also
be possible with thermal evaporation. To demonstrate the possibilities, Figure 5.84 a- b
shows thermally deposited Pilocarpine-HCl and Acetylsalicylic acid through a
microscopic shadow mask resulting in lateral structuring of the deposited drug. The
feature of lateral structuring also gives the possibility to cover the different surfaces such
as inner and outer walls of stents with different drugs. Visionary, this micro-structured
film could be used for multifunctional medical coatings that help to know the status of
the drug layer like thickness. This 3D structuring may be used to build nano or
microscopic particles with a predefined shape which might be beneficial for special
applications like particulate drug uptake [111]. In principle, the demonstrated techniques
of micro-structuring enable the formation of miniaturised drugs on micro or nanoscopic
carriers which can be used to overcome the blood brain barrier or accumulated cancer
tumours due to the enhanced permeability and retention (EPR) effect.
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Figure 5.84: SEM images of lateral structures of Pilocarpine-HCl (a) and Acetylsalicylic
acid (b) respectively.
5.2.5 Characterisation of chemical composition and Raman shifting
Relatively large molecules like Pindolol, Erythromycin or Tetracaine-HCl remain intact
(confirmed, e.g. by Raman spectroscopy). The formation of micro-nanoscale
pharmaceutical crystals on the substrate by thermal evaporation already indicates a high
purity further confirmed in several cases by Raman spectroscopy investigations. For
example, the Raman spectra of corresponding bulk and thermally evaporated Aspirin are
similar to each other as shown in Figure 5.37. It clearly demonstrates that after thermal
evaporation the micro-nanostructured film exhibits almost the same chemical structure if
compared to its bulk (see Figures 5.85, 5.86, 5.87 and 5.88). The choice of substrate may
comprise a wide range of materials and even highly soluble substances that can be
employed to carry the pharmaceutical films without the risk of side effects like
dissolution of the substrate. A limitation is given for pharmaceutical drugs which are
instable or altered in vacuum. The possible causes of fibrous or rod formation has been
discussed in this study. Most of the materials are still identical after evaporation.
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Figure 5.85: Raman spectra of the deposited and reference 5-Fluorouracil, showing
clear Raman peaks in the thermally deposited 5-Flurouracil on titanium substrate.
Figure 5.86: Raman spectra of the deposited and reference Metronidazole.
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Figure 5.87: Raman spectra of the deposited and reference Clotrimazole.
Figure 5.88: Raman spectra of the deposited and reference Adipic acid.
The sample has some defined peaks which do not belong to deposited materials and
might derive from the substrate carrier. Other peaks are shifted to indicate a probable
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change in the substance whereas the spectra derived from the samples are varying.
Sometimes the microscopic images from deposited materials show an inhomogeneous
surface with a thin film like layer with some incorporated crystals. Whereas the film
spectrum does not resemble the reference spectrum at all due to things like the operator,
the material thickness, intensity of laser beam, and substrate. From Raman microscopy
data, if the thickness of materials is thinner and intensity of laser beam is higher, the
material will start to decompose or burn. Therefore, the Raman is not identical. What one
already observed here, some peaks or functional groups are missing due to atoms on the
surface of the adsorbent; these atoms are not entirely surrounded by other adsorbent
atoms. Therefore, the atoms cannot attract adsorbents. The exact nature of bonding
depends on the details of the species involved. After some time, the molecules or atoms
are arranged themselves and accumulated on the substrate surface to provide the
formation of chemical bonds. Furthermore, the foil carrier is very sensitive to energy
input and shows an irregular surface. The deposited layer shows a spectrum which is not
truly comparable to the reference spectrum of deposited materials as shown in Figure
5.89. Also, in Raman spectrum, some sharp peaks are found enhanced with substrate
used. From Figures 5.64 and 5.65, one can see the Raman signal of the deposited
cholesterol enhanced with using gold as deposited on substrate. The increase in intensity
of the Raman signal for adsorbates on particular surfaces occurs because of an
enhancement in the electric field provided by the surface. When the incident light in the
experiment strikes the surface, localized surface plasmons are excited. The field
enhancement is greatest when the plasmon frequency. In order for scattering to occur, the
plasmon oscillations must be perpendicular to the surface; if they are in-plane with the
surface, no scattering will occur. It is because of this requirement that roughened surfaces
or arrangements of nanoparticles are typically employed in SERS experiments as these
surfaces provide an area on which these localized collective oscillations can occur [112].
In brief, the measured intensity of a Raman line is dependent up on number of factors, the
relationship of which is given in equation [113].
I(ν) = I0K(ν)C                                                                                                             (5.7) 
Where I(ν) is the measured intensity of the Raman line, Io is the intensity of the excitation
laser line, ν is the Raman shift, C is the concentration of the scattering species and K(ν) 
describers the overall spectrometer response. For Nipasol, the reference sample and
another sample after evaporation are studied. The spectra are very similar to each other
with only very subtle differences. Only very small wave number shifts in a number of
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Raman scattering bands can be observed. Intensity changes in the spectra are taken into
account. Both spectra contain the same functional groups. But, some peaks with lower
density can be seen (see Figure 5.6). In the other hand, the Raman spectra of deposited
Chloroamphenicol and Niopagin enhanced by time due to crystallinity has relationships
with orientation and the polarizability of the material as illustrated in Figures 5.90 and
5.91 respectively.
Figure 5.89: Raman spectra of the deposited (on polymer foil) and reference
Pilocarpine-HCl.
Moreover, Raman of deposited of materials is based on many things like the laser
intensity, operator, materials nature, sample thickness or volume. Some functional groups
take time to reconnect and arrange themselves to find each other to deposit and diffuse on
the substrate.
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Figure 5.90: Raman spectra of the deposited (on glass at different time) and reference
Chloroamphenicol.
Figure 5.91: Raman spectra of the deposited and reference Nipagin.
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5.3.6 Sequential deposition: Multilayers of different drugs and hybrid
materials
The fabrication of pharmaceutical multilayers controls the drug release. A fast dissolving
drug can be protected by a second layer that needs to be dissolved first. For example, a
film of Metronidazole, being rapidly dissolved after TE, is covered with PLGA by
subsequent depositions from two sources on a polished Ti-substrate. The release profile is
shown in Figure 5.75 and the effect of delayed drug release could be verified. Being a
polymer, PLGA is expected to depolymerise during evaporation and to re-polymerise on
the substrate. In addition to the delayed release, such multilayered systems may be used
to release a combination of drugs in a desired time pattern, e.g., having a drug I for a few
days, after completing dissolution of layer I, a subjacent drug II could be effective. This
approach of fabricating multilayer pharmaceutical drugs by TE could be used for coronal
stents, which first require an antiplatelet medication and subsequently an antiproliferative
drug to prevent restenosis in coronary arteries and effect an optimal integration.
PLGA is one of the most accepted biocompatible and biodegradable polymer used in
drug delivery and tissue engineering [114]. PLGA is produced from the polymerization
of glycolic acid and lactic acid. In addition, PLGA is aliphatic polyester depending on the
acid monomer ratios used. Different ratio of PLGA can be obtained. These polymers
have a glass transition temperature of about 50 °C and show high solubility to a wide
variety of nonpolar solvents. The degradation process occurs due to hydrolysis of ester
bonds in water or physiological fluids. This process finally degrades or divides lactic acid
and glycolic acid which enter the Kreb’s cycle to produce carbon dioxide and water and
removed during regular routes where by the duration can be changed by changing the
monomer composition. Figure 5.75 presents an example of a double layer of
Metronidazole and PLGA. The image shows a cross section to visualise that the
individual layers are maintained during thermal evaporation. Another promising route of
a new drug designed thermal evaporation is the co-deposition from two evaporators
simultaneously in a vacuum chamber. This allows the formation of a molecular scale
mixing of pharmaceutical active substances or excipients to form nanostructured hybrid
drugs exhibiting synergetic responses at the same time. With conventional solution based
processing, such a mixing requires very special preconditions, e.g., the possibility for co-
crystallisation. Evaporation of molecules from two different sources typically gives no
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time for a demixing process on the substrate, as molecules directly loose most of their
energy when they hit the substrate surface. A sample composed of four layers (1) SM, (2)
Cholesterol, (3) Fluorouracil and (4) SM is produced (see Figure 5.76). Here, amorphous
mixtures can be formed with structurally incompatible drugs, leading to synergistic
effects. The approach is useful for controlling the dissolution of drugs. Furthermore, the
solubility can be significantly increased. If a molecule with poor ability to dissolve is
only surrounded by molecules of good solubility, a total increase in dissolution can be
affected. This is very beneficial in increasing the solubility of poorly soluble drugs by
deposition of a low soluble molecule in parallel with a highly soluble one and with this
forming a solid solution. The co-deposition approach also allows the creation of a
molecular mixture in terms of a solid solution from nearly every thermally evaporated
drug. To show an example for such a combination, the efficacy of the above mentioned
antifungal Itraconazole and antibacterial Erythromycin drugs were evaluated in
combination by co-deposition. In agar plate diffusion tests, both antifungal and antibiotic
effect of these combined deposits could be confirmed and were in the same degree as for
the individual substances (as shown in Chapter 6.).
Vapor phase of co-depositing noble metals and pharmaceuticals molecules such as
Tetracaine-HCl is effective to produce Tetracaine-HCl /metal nanocomposite as
illustrated in Figure 5.92.
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Figure 5.92: SEM images of co-deposition of Tetracaine-HCl with gold (a and b) and
silver (c and d).
One can assume that the formation of metal nanoclusters in an organic matrix can be
described analogously to cluster formation on an organic surface. When energetic metal
atoms impinge on a organic surface, which grows simultaneously by organic fragment
deposition and reconnection, the arriving metal atoms undergo various processes [115]
including random walk on the organic surface, diffusion into the grown Tetracaine-HCl,
or desorption. Within the diffusion distance, metal atoms may encounter each other or are
captured by a surface defect. The metal volume fraction and the microstructures of co-
evaporated composites depend strongly on the coefficient sticking of the metal atoms on
the organic surface and the metal-organic molecules deposition rate ratio. A completely
new way of pharmaceutical engineering is the combination of inorganic materials with
pharmaceutical active substances. Such combinations could be potentially used as smart
implant coatings that form nanoporous structures with medication filled pores in the
inorganic material. In terms of the oral implant example given above, these molecules
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may be embedded in nanoscale sponge like ceramic structures by co-evaporation to have
a potential depot function of antibacterial factors in order to reduce the risk for
periimplantitis. An example for such co-evaporation is shown in Figure. 5.92c-d where
Ag and Tetracaine-HCl are combined.
For comparison, Figure 5.29a-f shows the deposited Tetracaine-HCl without silver. The
inorganic part of the hybrid structures could also be an active ingredient in wound
dressings, e.g., silver nano-particles are known for their antimicrobial effect [116]. There
has been increasing interest in deposition of pharmaceutical molecules like Nipasol on
ZnO nano-micro structures (see Figure 5.93) due to their many exclusive characteristics.
Zinc oxide (ZnO) nanostructures have been of great importance due to various fabrication
methods available and different morphologies obtained. EDX spectra of the as
synthesized Nipasol grown on ZnO nano structures which confirms the presence of Zinc,
carbon as well as oxygen as shown in Figure 5.94.
The deposition of Nipasol nano microstructures on ZnO might provide the combination
therapy for enhancement the antimicrobial activity and treatment of serious infections.
Generally, ZnO has a wide band gap of 3.37 eV with a large excitation binding energy
(60 meV), exhibiting near UV emission, transparent conductivity and piezoelectricity.
Sawai et al reported that ZnO possessed strong antibacterial activity [117]. Akiyama et al.
also studied the efficiency of ZnO as a treatment for a topical dermatitis related to S.
aureus [118]. The efficacy of ZnO for topical dermatitis may be based on the strong
attraction between ZnO and S. aureus to inhibit the fibrin formation by coagulate of S.
aureus. Furthermore, the higher antibacterial activity of ZnO against Escherichia coli is
because H2O2 is generated from the surface of ZnO powder, when ZnO is irradiated by
(UV or visible) which brings a separation of charge, creating a hole (h+) in the valence
band and an electron (e–) in the conduction band:
ZnO + hυ→ e
– + h+ (on the surface of ZnO particles)
At the surface of the excited ZnO particle, the valence band holes abstracts electrons
from water and/or hydroxyl ions, producing hydroxyl radicals (OH•). Moreover, electrons
can diminish O2 to generate the superoxide anion O2–• [119]:
h+ + H2O → OH• + H+
e– + O2 → O2–•
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The obtained OH• and O2–• can induce lipid peroxidation in membranes. DNA damage
occurs due to strand breakage or oxidized nucleotides and oxidation of amino acids and
protein catalytic centres [120]:
(O2–•, OH•) + organic material → CO2 + H2O
Another possibility is the devastation of organic material in a direct reaction with
positively charged ZnO particles.
Figure 5.93: a-d SEM images of Nipasol coated on the surface of ZnO nano-
microstructures.
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Figure 5. 94: EDX spectra of the as-synthesized Nipasol grown on ZnO nano structures
which confirms the presence of Zinc, carbon as well as oxygen.
In addition, it is found that ZnO nano microstructures exhibits antiviral activity like
Herpes simplex virus type-1 (HSV-1) [121]. It is regarded that ZnO is used as
photosensitizer in photodynamic therapy for curing cancer with better selectivity for
targeted tumour. When ZnO is exposed to light of exact wavelength, it is able to produce
cytotoxic reactive oxygen species (ROS) such as hydroxyl radical, hydrogen peroxide
and superoxide, making it possible for decomposition of some organic compounds and
destroying the tumour cells [122]. Using combination therapy or nano sized drug carriers
such as liposomes, polymeric micelles, dendrimers, superparamagnetic iron oxide
crystals, and colloidal gold has been examined in cancer therapy in order to minimize the
cytotoxicity of ZnO to the host cells, to decrease the side effects of anticancer drugs and
to enhance the antitumoral drug effectiveness of the targeted therapies [123]. It is well
known that ZnO has piezoelectric properties for passing electrical charge through the
guidance channel during mechanical deformation to accelerate the healing of neural
tissue and reduce the sticking and density of staphylococcus epidermidis which colonized
the implanted biomaterials [124].
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Chapter 6
6-Application of Thermal Evaporation
This chapter describes some application scenarios of the pharmaceutical thin films
obtained by thermal evaporation in vacuum. This includes the antimicrobial screening,
experiments for the control about the drug release profiles and some basic electronic
properties.
6.1 Antimicrobial screening:
The vacuum deposited antimicrobial substances revealed bacteriostatic and accordingly
fungistatic activities in similar degrees compared to the controls (see material and
methods chapter 4). The substances which were tested are listed in Table 6.1 and 6.2.
The maximum extent of inhibition areas around titan plates was mostly observed in front
of the coated surfaces while at the small sides and the non-coated backside the
bacteriostatic activity was reduced. The present study examines vitro activities of series
of antimicrobial agents. Figures 6.1 and 6.4 make it clear that inhibition areas of vacuum
deposited Erythromycin and Itraconazole are presented on agar plates with
Staphylococcus aureus or Candida albicans, respectively. Major changes are in the use of
antimicrobial agents for growth promotion. In the case of antimicrobial substances, the
nanostructured thin films were deposited directly on titanium substrates and their
antibacterial or antifungal activities were tested (Table 1). Even very poorly water
soluble substances such as Metronidazole, Erythromycin and Itraconazole have been
found to be more active when deposited by thermal evaporation. The test objects are
discs made of titanium at one side coated with the test drug by vacuum deposition.
Some of the agar test plates with TE drugs are compared to the controlled sample where
they all are compared with their higher doses (30 µg) conventionally controlled. This
significant increase in the area of inhibition zones for thermally evaporated antibacterial
drugs and also antibiotics are compared to their control samples as seen in (Figures 6.1,
6.3, 6.4 and 6.6 respectively) and Tables 6.1 and 6.2. They are clearly visible and can be
explained by increasing the dissolution rate which is due to an almost amorphous
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assembly of the deposited drugs or reducing the particles size after deposition if
compared with reference drug as shown in Figures 6.2 and 6.5.
Figure 6.1: shows the antimicrobial activity of Erythromycin against Staphylococcus
aureus, positive control (a), deposited film (b).
Figure 6.2: SEM images of Erythromycin as bulk material before evaporation (a) and
deposited film after evaporation (b).
The antimicrobial activity of vacuum deposited films of Nipasol and Tetracycline-HCl,
Chloramphenicol were measured by using test organism Staph. Aureus as illustrated in
Figure 6.3. When titanium plates are placed in agar medium, inhibition zones are
measured after 24 h at 34 ° C. Inhibition zones for Tetracycline and Chloramphenicol are
the area around the whole platelets, Tetracycline - 3 samples in a Petri dish in the middle
Filter paper disk with Tetracycline control. It is found that the deposited films have
higher inhibition zone if compared with control samples.
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Figure 6.3: illustrates the antimicrobial activities of deposited films of Nipasol (a),
Tetracycline-HCl (b), Chloramphenicol (c) against Staphylococcus aureus.
The process of superimposition on a titanium surface without prior dissolution of a
substance appears to have no reducing effect on its antimicrobial efficacy. Evidence for
the integrity of the chemical structures is established by Raman analyses in the case of
the substances investigating Erythromycin and Clotrimazole (see Chapter 5).
Maximum extent of inhibition area [cm2]Test substance
experimentals (titanium
plates)
controls (paper, 30
µg/disc)
Chloramphenicol
2.55 1.36
Erythromycin(base)
3.11 1.38
Metronidazole
2.06 1.67
Nipasol 1.16 0
Neomycinsulfate 0.57 0.68
Novobiocin sodium salt 3.95 1.64
TetracyclinH2O 1.44 1.82
Tetracyclin HCl 1.65 not performed
Vancomycin HCl 0.67 0.80
Table 6.1: shows the bacteriostatic effect of various antibiotics and of Nipasol deposited
by evaporation under vacuum against Staphylococcus aureus ATCC 6538.
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Maximum extent of inhibition area [cm2]Test substance
Experimentals (titanium
plate)
Controls (paper, 30
µg/disc)
Clotrimazole 1.76 1.72
Itraconazole 1.82 0.97
Ketoconazole 2.83 1.07
Table 6.2: The fungistatic effect of antimycotics deposed by evaporation under vacuum
against Candida albicans ATCC 10231.
Figure 6.4: The antimicrobial activity of Itraconazole against Candida albicans, positive
control (a), deposited drug (b) by evaporation under vacuum.
Figure 6.5: SEM images of Itraconazole as bulk material (a) and deposited drug (b) by
evaporation under vacuum.
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Another promising route of a new drug design by thermal evaporation is the co-
deposition of two different drugs from two separate evaporators simultaneously in a
vacuum chamber. This allows the formation of a molecular scale mixing of
pharmaceutical active substances or excipients to form nanostructured hybrid drugs
exhibiting synergetic responses at the same time. With conventional solution based
processing, such a mixing requires very special preconditions, e.g., the possibility for co-
crystallisation. Evaporation of molecules from two different sources typically gives no
time for a demixing process on the substrate, as molecules directly loose most of their
energy when they hit the substrate surface. Here, amorphous mixtures can be formed with
structurally incompatible drugs leading to synergistic effects. The approach is very
helpful for controlling the dissolution of drugs. In addition, the solubility can be
significantly increased. If a molecule with poor ability to dissolve is only surrounded by
molecules of good solubility, a total increase in dissolution can be affected. This is very
beneficial in increasing the solubility of poorly soluble drugs by deposition of low
soluble molecules in parallel with a highly soluble one and with this forming a solid
solution. Thermal evaporation also provides amorphous deposited film which has a
random structure and is completely and more easily dissolved.
The co-deposition approach also allows the creation of a molecular mixture in terms of a
solid solution from every thermally evaporated drug (overviewed Table 3.1). To show an
example for such a combination, the efficacies of the above mentioned antimicrobial
agents such as Erythromycin and Itraconazole were evaluated in combination. In agar
plate diffusion tests, both antifungal and antibiotic effect of these combined deposits
could be confirmed and were in the same degree as for the individual substances (as
shown in Figures 6.1 and 6.4. From our first biological tests, it is obvious that thermally
evaporated substances can in principle exhibit higher activities as compared to their
conventionally controlled sample. However, further biological experiments with other
pharmaceuticals should be performed to reveal the full potential of thermal evaporation
for pharmaceutical engineering.
It is obvious that superimposition on a surface by evaporation under vacuum particularly
in the case of poorly water soluble substances like Chloramphenicol, Erythromycin,
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Nipasol, Clotrimazole and Itraconazole is a very appropriate technique to provide an
antimicrobial ambience without the necessity to dissolute the substance.
Additionally, Chloramphenicol and Tetracylin-HCl were evaporated under vacuum on
glass plates. The antibacterial efficacy of these objects could also be confirmed. As
shown above, vacuum deposition on surfaces of different materials is effective.
The application of materials with surfaces antimicrobial equipped by this technique may
be many-sided. But, particularly for the use of implantable devices as bone pins or
artificial teeth, it may open new perspectives in the defence of infections. Therefore, the
production of vacuum-deposed coatings, from which antimicrobials are released over a
long period, is to be established. Furthermore, structural factors, such as defects or guest
ions in the crystal, can facilitate dissolution by reducing the bond strength in the crystal.
Lowering the lattice energy could facilitate dissolution although enthalpy and entropy of
dissolution probably play a role for antimicrobial agents after deposition by vacuum
technique. This material has still anti-microbial properties to decrease the chances of
bacterial and fungal infections.
The antimicrobial activity of Tobramycin against Staph aureus (Figure 6.6) is
demonstrated in Agar plate with 15 ml Caso-Agar (Petri-dish) using Staph aureus as
pathogenic bacteria with Absorption: 0.116 (Factor: 7.3 x 108) 1:10 dilution 0.1 ml into
5 ml Caso-Agar incubating at 24 hours at 37 C°. Clearly, from the Figure (6.6),
Tobramycin after deposition by thermal evaporation technique is still active. However,
the activity depends on the substrate used and the surface morphology.
The results of utilizing Titanium oxide substrate coated with Tobramycin show much
higher Inhibition zone: 24.70 mm which is measured by Gauge (diameter) after 24 h as
compared to the Positive Control, 25 µm Tobramycin has Inhibition zone: 22.64 mm.
This significant increasing in the area of inhibition zones for thermally evaporated
Tobramycin if compared to its control samples as seen in Figure 6.6. It was found that
the Inhibition zone based on the employed substrate: titanium substrate gives 21.47 mm
inhibition zone in the other hand stales steel provides 15.98 mm inhibition zone. No
inhibition is observable after 1 day. For the negative control which is measured without
any deposition (Anod. Ti type II).
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Figure 6.6: Illustrates the antimicrobial activity of Tobramycin against Staph aureus,
Negative Control (Anod. Ti type II) (a), Positive Control (Tobramycin) (b), deposited
Tobramycin film grown on Titanium oxide (c), Titanium (d), stales steel (e).
In Summary, The antimicrobial activity of Erythromycin inhibits the growth of
Staphylococcus aureus by higher inhibition zone than the same amount of control
experiments. The fungistatic effect of antimycotics (Intracanzol) deposited by
evaporation under vacuum against Candida albicans ATCC 10231 shows significant
inhibition zone if compared with the control sample. The activity of Tobramycin against
Staph aureus (Figure 6.6) is questionable as it suggests a more detailed research. Thus,
the growth of the colonies Staph aureus completely inhibited in the presence titanium
oxide substrate gives much higher Inhibition zone than the reference drug.
According to the interpretation suggested for thermal evaporation coating process. These
results revealed that this procedure provides a stable and homogeneous coating with
higher surface area as illustrated in Figure 6.7.
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Figure 6.7: 3D AFM images of nano-microstructured pharmaceutically active
molecules.
Antimicrobial activity was strongly dependent on particle size of antimicrobial agents,
with smaller sized nano-microstructures having more efficient antibacterial activity than
larger size. The vacuum deposition of active anti microbial agents is found to enhance
surface reactivity due to their extremely small size and high surface area. Higher surface
area of active molecules allows many particles to cover the bacteria cells to a high extent
and bring deposited molecules in an active form in high concentration in proximity to the
cell. This indicates that, after reduction of particle size, increased saturation solubility, an
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enlarged surface area, and a thinner diffusion layer could dramatically increase the
dissolution velocity as described by Noyes Whitney equation [38].
 xs CCvh
DA
dt
dc
 (6.1)
Where dC/dt = dissolution rate, D = diffusion coefficient, A = surface area, V = the
volume of the dissolution medium, Cs = saturation solubility, Cx the drug concentration
of bulk solution and h= hydrodynamic boundary layer thickness.
6.2 Controlled drug release from biodegradable polymers
In Figure 6.8 Metronidazole is detectable in the elution profile in phosphate buffer, pH
7.4 at 35 °C. The titanium plate was dissolved in 1 ml sterile phosphate buffer, pH 7.2
and incubated in closed tubes. Where each 10 µ l of sample is removed, diluted with 3 ml
of buffer and measured, mmodified release formulations show a sustained (= extended =
delayed) release of the drug. The modified release concept is suitable for drugs with short
half life to maintain therapeutic plasma concentrations over a longer period of time. The
administration intervals can be reduced.
Figure 6.8: Illustrates drug release profile of Metronidazole.
Moreover, high plasma peak levels which go along with side effects that can be
optimized. Modified release formulations are important for long-term treatment. In the
test with the layer by layer deposition (PLGA (50/50) with Metronidazole), stronger
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release takes place after five days period. Additional to the delayed release, such
multilayered systems may be used to release a combination of drugs in a desired time
pattern, e.g., having a drug I for a few days, after complete dissolution of layer I, a
subjacent drug II could take effect. In this case a thin film of Metronidazole, being
rapidly dissolved after TE (see Figure 6.9 b) which is covered with PLGA by subsequent
depositions from two sources on a polished Ti-substrate. The construction of multilayer's
by chemical method is difficult due to the nature of fluids. From the release kinetics
shown in Figure 6.8 the effect of delayed drug release could be verified. Being a
polymer, PLGA is expected to depolymerise during evaporation and to repolymerise on
the substrate. This approach of fabricating multilayer pharmaceutical drugs by TE could
be used for coronal stents, which first require an antiplatelet medication and subsequently
an antiproliferative drug to prevent restenosis in coronary arteries and effect an optimal
integration. The morphology at the interface between the individual layers also plays very
important role in controlling the drug release kinetics.
Figure 6.9 : SEM images of Metronidazole as bulk material (a) and deposited drug (b)
by vacuum evaporation. The inset shows higher magnification SEM image.
6.3 Thermal evaporation for enhanced activities
By using thermal evaporation approach, it was possible to produce different
concentration from the deposited drug starting from lower to higher concentration
depending on the experimental conditions. The amount of material deposited on the
substrate was calculated by measuring four samples from Tetracycline hydrate, different
weights 3.25 µg, 4.8 µg, 5.14 µg and 7.99 µg were obtained. In case of Pilocarpine-HCl,
three samples are measured, different weights also 1.78 mg, 1.87 mg and 1.87 mg appear.
With Tetracaine-HCl, two samples were also investigated to provide (205.7 µg and 230.0
Application of Thermal Evaporation
153
µg). Furthermore, the antibacterial activity against pathogenic bacteria and fungi
powerfully depended on the specific surface area of the deposited film of the active
pharmaceutical molecules. The activity increases with the increase of the surface area,
irrespective of the shape and the crystallinity of their deposited films. In the case of
Staphylococcus aureus, however, it was found that there was difference in the activity if
compared to the reference drugs. Using of biodegradable polymers to control the release
of pharmaceutical agents, these polymers have great efficacy for the control release of
different drugs like antibiotic, antimicrobial, vaccines, human growth hormone, insulin,
anti-tumour agents, contraceptives and vaccines. Long circulation of drugs in the body
explains how drug delivery and drug targeting to the site of desired action. Definitely,
surface modification is helpful in attaining these goals. Manufacture of nanostructures by
using the environmentally processes like thermal evaporation is fairly a promising area of
research to develop the materials liberated from the unwanted toxic residual solvents.
Although many important goals have been reached in achieving stabilization of drugs in
circulation, more investigations are needed to expand the novel products in this area.
6.4 Pharmaceutical field effect transistor (PFET)
Organic semiconductors have appeared as an enticing alternative for the development of
low cost electronics. These materials have the potential to be solution processed which
lowers production costs and increases substrate compatibility. Anyway, in contrast to
organic light emitting diodes, organic field effect transistors couldn't be realized in a
sufficient manner till today. Due to the similarities of the utilized molecules for the
pharmaceutical thin films used here and the type of molecules used for organic field
effect transistors, In order to fabricate a pharmaceutical field effect transistor,
Pilocarpine-HCl semiconductors were chosen as active layer due to its conductivity
behaviour. This conduction mechanism can be either ballistic or diffusive of the charge
carriers through deposited layers or based on tunnelling in nature. Charge transport in
conductive organic materials is dependent on π-bonding orbitals and quantum mechanical
wave-function overlap.
Visionary, the thermal evaporation approach could be useful for fabrication of a PFET in
future for different potential applications such as bioelectronic devices and biosensors.
Another promising possibility can be by coat integrated silicon chips to design a PFET
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for different applications ranging from new generations of organic electronic devices to
biomedical engineering [125, 126].
Figure 6.10: The basic layout and conductivity curves of a PFET based on Pilocarpine-
HCl by deposition through a shadow mask directly on a silicon microchip.
Figure 6.10 shows the basic layout and conductivity curves of a PFET based on
Pilocarpine-HCl by deposition through a shadow mask directly on a silicon microchip. A
gate voltage allows blocking a source-drain current. Visionary, this micro-structured film
could be used for multifunctional medical coatings that help to know the status of the
drug layer like thickness. When the Gate is made more negative, it depletes the majority
carriers from a larger depletion zone around the gate. This reduces the current flow for a
given value of Source-to-Drain voltage. Modulating the Gate voltage modulates the
current flow through the device.
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6.5 Room Temperature Current - Voltage Characteristic
Challenge with other electrically conductive pharmaceutical materials that have recently
been explored for photo-thermal therapy is that these materials are absorbed across wide
range of infrared light in order to optimize both biological transport and heat transfer. In
therapeutical conductive substances, several studies have been done for example in bone
repairing which has semiconductor behaviour in some respects. For instance, the basic
functional unit in bone appears to be a PN junction diode formed by exactly molecular
association between collagen fibres (N-type material) and the mineral apatite crystals (P-
Type material). Basically, the conductivity is determined by the number of free charge
carriers and their mobility. The charge carriers are sensitive to radiation which used in
clinical situation [127]. Moreover, the conductive drugs used for Iontophoresis [128]
which has many advantages as drug administration method. Inonotphoresis used for
delivery the conductive drugs through the surface tissues by using a small electric charge.
Figure 6.11: The I-V characteristic of pilocarpine-HCl thin film deposited on glass
substrate.
Here, Pilocarbine-HCl was selected as an example for conductivity measurement. The
room-temperature electrical measurements were performed under ambient conditions by
using Au contact pins connected to the fabricated micro or nanostructure circuits. The
current through the micro-nanostructure circuit was measured by using a Keithley 6485
picoamperemeter (which is optimized for measuring the extremely small electrical signal)
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while increasing the voltage from 0 to 10 V. The resistance of Pilocarpine- HCl thin film
was extracted from the slope of the current-voltage (I-V) curve. Figure 6.11 shows a set
of I-V curves Pilocarpine-HCl thin film which acts like semiconductor behaviours.
Actually, conducting organic materials have backbones of contiguous sp2 hybridized
carbon centres. One valence electron on each centre resides in a pz orbital, which is
orthogonal to the other three sigma-bonds. Thus, the conjugated p-orbitals form a one-
dimensional electronic band, and the electrons within this band become mobile when it is
partially emptied.
6.6 The unique requirements of thermal evaporation
Indeed, thermal evaporation technology has been investigated as an alternative and
attractive technique to prepare and engineering the micro- and nano structures from drugs
and pharmaceutical excipients. Thermal evaporation is solvent free and environmentally
friendly. A good variety of drugs can be produced with this technique. These drugs would
require least amount of dosage because of higher solubility and also least side effects
owing to higher purity. Thermal evaporation offers a considerable promise as alternative
technique for formation a multi-component mixture making micro-nanostructures rapid,
efficient and suitable for coating the surface implants. In this work, the versatile
fabrication of solvent free micro-nanostructured pharmaceutical drugs had been
introduced in a controlled way on various substrates.
Designing delivery systems, and the unprecedented recent growth in the field, has driven
a great deal of research into novel means of drug delivery. The search for techniques that
offer formulations that are stable, bioavailable, manufacturable, and acceptable to the
patient, has led to major advances in development of transdermal and implantable
delivery and controlled release technology. The conventional area of formulation
technology has achieved scientific advances to meet the needs of these compounds. s.
Biomaterial-associated bacterial infections present common and challenging
complications with medical implants. As a result, prevention of bacterial colonization and
biofilm formation is an important consideration and may be supported by the use of
antiseptic surface coatings.
Results showed an initial peak of release layer by layer test after 5 days. Then stronger
release takes place faster. Drug release from bioerodible polymers is used in both topical
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and systemic applications. Both of them require that the polymers break down to
nontoxic materials, and polymers used in systemic applications must also degrade to low-
molecular-weight fragments that can be removed or metabolized by the body. In topical
applications, retainment of high molecular weight of the degradation products is
desirable, since systemic absorption of the polymer will occur, and toxicological hazards
will be reduced.
A lateral structuring, the positioning of thermal evaporated thin films, is relatively
straightforward by utilising lithography or shadow masks. Possible applications for
laterally structured systems are smart or multifunctional pharmaceutical drug coatings for
implants [129] or contact lenses. Specific examples are contact lenses for ophthalmic
drug delivery [130] which should not affect the vision and thus require a lateral
structuring as shown in Figure 5.35 of the drug film. Selective area for depositing
pharmaceutical drugs on contact lenses is possible with TE technique through suitable
microscopic shadow mask. Such a structuring could also be used in complex implant
coatings like stents or dental implants that require different drugs in different places in
contact with bone, mucosa or the oral cavity. Bacterial adhesion is an important step in
the pathogenesis of an infection (periimplantitis). Placement of different antibacterial
active molecules on specific areas of the implant surface (depending on the intraoral
contact to bone, mucosa or the oral cavity) will also be possible with thermal evaporation.
Highly complicated drug delivery systems are developed to apply their effects after they
are injected to the body, particular, into the systemic circulation. The study of drug
delivery expands and proves that the reduction of poorly soluble active ingredients to
nanoscales increases the solubility, bioavailability, controlled release and biological site-
specific targeting. This new group of delivery systems is definitely an important
component of modern drug delivery technology. Many novel drug delivery technologies
are under development and significant progress nearly in all branches of drug delivery
and local pharmacodynamic effects by physical or chemical binding of the drug to a
carrier system.
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Chapter 7
7 Summary and Outlook
The aim of this thesis was to evaluate weather vacuum evaporation of drugs could be
utilized as a new method to create thin film coatings that posses potential pharmaceutical
use.
Briefly, it was found that thermal evaporation of pharmaceutical molecules can be
utilized as a completely solvent free technique where drugs as powders or crystalline
materials are directly formulated into desired nano or micro structures and shapes on
preferred substrates. Thermal evaporation is based on the principle of physical vapor
deposition. The drugs and the drug carrier materials were heated up in a crucible to their
melting temperature. The whole procedure was carried out in a vacuum chamber. High-
vacuum (10-5-10-7 mbar) guaranteed a long mean free path of the evaporated particles on
their way to the substrate as well as the avoidance of contaminations.
The performed deposition experiments and their structural analyses suggest that by
thermal evaporation technique, most of pharmaceutical substances (>80%) can be micro-
nanostructured in different desired complex forms as illustrated in table 5.1. Other
pharmaceutical molecules such as Triclosan and PEG used in this study could not be
structured by thermal evaporation, they tend to decompose irreversibly.
To examine the resulting structures and morphologies, diverse techniques were used.
These techniques include optical microscopy, SEM, AFM, Raman-spectroscopy, XRD
and profilometry (see chapter 5). In order to avoid the structural damage in the structures
and charging, acceleration voltages in the SEM were kept as small as possible down to 2
kV and reduced currents were applied. In order to get the actual morphologies of thermal
evaporated pharmaceuticals by using SEM, further coating (of carbon or gold thin film)
was performed on deposited drugs. Raman spectra of raw (control) drugs as well as
thermally evaporated layers on different substrates were recorded to ensure the identity of
structured pharmaceutical substances.
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The spectral and microscopic data show that substrate surface and employed
temperatures have a strong influence on structural evolutions of the pharmaceutical drugs
during thermal evaporation as shown in Figures 5.1, 5.2 and 5.9 respectively. Thermal
evaporation as fabrication technique for drug delivery systems has many advantages such
as simple process, solvent free and low cost if compared to other techniques. It appears
that the chemical structures of the evaporated materials such as Chloramphenicol are
unmodified for offering crystalline structures as illustrated in Figures 5.23, 5.24 and 5.25
respectively. It is important to note that it takes some time after evaporation for the
sample to become crystalline due to diffusion processes. Further attempts have been
made to improve the crystallization process by annealing of the deposited pharmaceutical
substance at certain temperatures as demonstrated in Figure 5.50. It turned out that the
energy imparted in heating leads to a faster crystallization process. Relevant parameters
are taken into account in relation to the thin film structures including the concentration of
the material to be evaporated, the temperature, the vacuum and the deposition time.
In general, an appropriate delivery system is very necessary for drugs with poor
solubility. At the same time, one needs to minimize side effects. So, site-specific delivery
(i.e., drug targeting) would be the most desirable aspect. In addition, one of the main
challenges in medications is the dosage, for which the most helpful schedule is
determined by the toxicity of the clinical agents used. The observed features of vacuum
deposited films like enhanced solubility, activity and controlled release movement of
synthesized drugs in present case seem to be a powerful alternative for the traditional
physical structuring of pharmaceutical drug molecules. The variety of new possibilities
for pharmaceutical engineering utilizing thermal evaporation is expected to cover a wide
range and will be potentially beneficial for many branches of medicine, pharmacy and
engineering. Since a large number of drugs are accessible to the approach, thermal
evaporation tests could result in reduction of dose and side effects for many approved
drugs. The possibility of smart designing like hybrid, multilayer and/or implant coatings
or solid solutions could lead to a re-assessment of insoluble molecules and thus could be
very promising for many new therapies. So, the thermal evaporation technique can be
versatily employed for micro-nanostructuring of different pharmaceutical drugs in
various desired forms with increasing responses. A completely new way of
pharmaceutical engineering is the combination of inorganic materials with
pharmaceutical active substances. Such combinations could be potentially used as smart
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implant coatings i.e., in form of nanoporous structures with medication filled pores in the
inorganic material. An example for such co-evaporation is shown by SEM measurement
in figure 5.29 where Ag and Tetracaine-HCl are combined.
Furthermore, it was possible with thermal evaporation to design multiple layers of
different desired active and non-active ingredients. They can be used to increase the
activity of the drug, control the drug release and in combination therapy. Co-deposition
approach also allows the creation of a molecular mixture in terms of a solid solution from
nearly every thermally evaporated drug. The efficacies of the antimicrobial agents such
as Erythromycin and Itraconazole are an example for such a combination. In agar plate
diffusion tests, both antifungal and antibiotic effect of these combined deposits could be
confirmed and were in the same degree as for the individual substances (as shown in
Figure 6.1 and Figure 6.4) for Erythromycin and Itraconazole respectively. It appears
that the pure titanium plate polishing does not show antibacterial properties, but the
antimicrobial effect of deposited film after evaporation from antimicrobial agents and
antibiotic is confirmed as illustrated in table 6.1 and 6.2. The results show that the
deposition of pharmaceutical molecules is reproducible and their biological activities are
very efficient.
The first biological tests starting in this research project make it obvious that thermally
evaporated substances can in principle exhibit higher activities as compared to their
conventional control sample. However, further biological experiments with other
pharmaceuticals should be performed to reveal the full potential of thermal evaporation
for pharmaceutical engineering. It is confirmed that thermal evaporation can be used to
effect a delayed release, such multilayered systems may be used to release a combination
of drugs in a desired time pattern. For example, having a drug I for a few days, after
complete dissolution of layer I, a subjacent drug II could take effect. In this case, a thin
film of Metronidazole, being rapidly dissolved after thermal evaporation is covered with
PLGA by subsequent depositions from two sources on a polished Ti-substrate. Being a
polymer, PLGA is expected to depolymerize during evaporation and to re-polymerize on
the substrate. This approach of fabricating multilayer pharmaceutical drugs by thermal
evaporation could be used for coronal stents, which first require an antiplatelet
medication and subsequently an antiproliferative drug to prevent restenosis in coronary
arteries and affect an optimal integration. Experimentally, in this study, thermal
evaporation of pharmaceutical molecules is applied in a field effect transistor. Another
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promising possibility can be to coat the integrated silicon chips to design a
pharmaceutical field of the effect transistor (PFET) for different applications ranging
from new generations of organic electronic devices to biomedical engineering. The basic
layout and conductivity curves of a PFET are based on Pilocarpine-HCl by deposition
through a shadow mask directly on a silicon microchip. Results suggested that the
deposition of pharmaceutical molecules is more reproducible and the biological activities
are very efficient due to the higher surface area and reducing the particle size of the
drugs.
An essential point for pharmaceutical practices that should not be ignored is that many
solvents have been used to combine active and non-active ingredients which may provide
acute toxicity in vivo. The chemical compositions of deposited material are a significant
factor in the field of biomedical applications to assure that there are no changes occurring
from abnormalities in the chemical structures. It also rendered possible to reduce the
particle size to nano-micro-range and increase the surface area. These facts advance the
acceptance to mammalian cells. They also help to change the dosages well. Thermal
evaporation of drugs and drug carriers offers great opportunities concerning biomedical
applications like coating surfaces of stents and implants in particular. It is used to prevent
these from bacterial affections to avoid restenosis and osteomyelitis. This dissertation
pays our attention to the fabrication of various thin films from various materials such as
pharmaceutical compounds, polymer and metals by using physical vapor deposition
process. Finally, this dissertation explores thermal evaporation of pharmaceutical
molecules to achieve drugs solubility and reduce their toxicity towards normal tissues.
As an outlook, the use of thermal evaporation is not limited to the drugs listed but
also it can be employed for developing and restructuring unrestricted pharmaceutical
materials into new forms of medications with improved responses. It is hoped that this
will enable and contribute further detailed examinations of various thin film deposition
from many more pharmaceutical substances, metals and semiconductors which can be
used in medical devices. Visionary, the improvements in solubility and the absence of
toxic solvents could lead to novel therapies and finally to increased patients survival.
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